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SUMMARY 
 
Numerous studies conducted internationally have identified and described several endemic 
methicillin-susceptible Staphylococcus aureus (MSSA) clones.  However, only some of these 
clones are associated with methicillin resistance (CC5, CC8, CC22, CC30 and CC45).  To date, 
studies reporting on the population structure of S. aureus isolated in South Africa represent limited 
demographic areas, focus on methicillin-resistant S. aureus (MRSA) only and have displayed little 
emphasis on virulence.  This study was undertaken to elucidate the population structure of S. aureus 
isolated from specific clinical sources at Tygerberg hospital, and to investigate specific host-
pathogen interactions of representative isolates. 
Consecutive non-repetitive clinical S. aureus isolates were collected over one year (September 
2009/2010) with patient demographics and limited clinical information.  Strains were typed by 
PFGE and molecular markers (spa, multi-locus sequence typing (MLST), agr, Staphylococcal 
Chromosome Cassette mec and Panton-Valentine leukocidin (PVL)).  Representative isolates were 
selected and investigated for the presence of virulence genes, adherence (to immobilised fibronectin 
[Fn], fibrinogen [Fg], collagens IV [CnIV] and VI [CnVI]), cellular invasion and cell death 
induction.  Statistical association were determined between all in vitro results and methicillin-
resistance, clonality, patient HIV status and bacterial PVL status. 
Fifteen percent of the isolates (n = 367) were MRSA.  Forty four present of isolates were PVL+. 
agr I-IV and SCCmec I-V were identified.  The MSSA population was diverse: ST22 (dominant), 
ST1865 and ST121 were PVL+. ST45, ST1863 and ST15 were PVL-.  PVL- MRSA were diverse: 
ST612-MRSA-IV (dominant), ST5-MRSA-I, ST239-MRSA-III, ST36-MRSA-II and ST22-MRSA-
IV.  The genes fnbA/B (fibronectin-binding protein A/B), clfA/B (clumping factor A/B), eap 
(extracellular adherence protein), nuc (nuclease), coa (coagulase) and hld (delta toxin) were 
detected in all representative isolates. 
The CC8 and CC6 isolates adhered strongly to all ligands (100-700% of control, ligand dependent), 
while isolates of CC45, CC22 and CC88 adhered strongly only to Fg and Fn.  The CC30, CC15, 
and CC12 isolates adhered extremely strongly to CnIV (>300%) and CC8, CC15, and C6 to CnVI 
(>200%).  Isolates from CC30, CC8, CC15, CC6, CC12, CC97, CC88 and CC45 were highly 
invasive (>100%).  ST121 was non-invasive (>50%). Isolates of CC5, CC30 and CC121 were non-
cytotoxic (<50%), while isolates of CC22, CC8, CC15, CC45 and CC88 were very cytotoxic 
(>70%). 
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No significant difference was observed in adherence or cell death induction of MRSA vs. MSSA 
clones or between isolates from HIV+ vs. HIV- persons.  PVL- isolates displayed higher cellular 
invasiveness than PVL+ isolates. 
The presence of ST612-MRSA-IV, ST22-MRSA-V and ST8-MRSA-V points to local SCCmec 
acquisition, as we found MSSA isolates with the same spa types.  Numerous MSSA clones were 
prevalent, but do not appear to have a major common genetic background with MRSA.  PVL was 
highly prevalent among MSSA, indicating acquisition of PVL genes independently of SCCmec.  
The abilities to adhere to specific immobilised ligands in vitro were diverse and grouped with the 
genetic background, while the vast majority of isolates were invasive and induced significant cell 
death. 
We can conclude that the population of S. aureus at Tygerberg hospital is composed of a vast 
number of MSSA and MRSA clones, which display varying patters of adherence to selected ligands 
and of which, the majority clones are invasive and cytotoxic. 
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OPSOMMING 
 
Talle internasionale studies het verskeie endemiese metisillien vatbare Staphylococcus aureus 
(MSSA) klone geïdentifiseer en beskryf.  Slegs 'n paar van hierdie klone word geassosieer met 
metisillien weerstandigheid (Klonale kompleks (KK) 5, KK8, KK22, KK30 en KK45).  Studies oor 
die bevolking struktuur van S. aureus geïsoleer in Suid-Afrika is tot dusver beperk tot demografiese 
gebiede, fokus slegs op metisillien-weerstande S. aureus (MRSA) en het min klem op virulensie 
geplaas.  Hierdie studie is onderneem om die bevolking struktuur van S. aureus, geïsoleer vanaf 
spesifieke kliniese bronne, in die pasiëntpopulasie van Tygerberg-hospitaal te ondersoek en om 
ondersoek in te stel na spesifieke gasheer-patogeen interaksies van verteenwoordigende isolate. 
Opeenvolgende, nie-herhalende en suiwer kliniese S. aureus isolate is versamel oor ´n periode van 
een jaar (September 2009/2010), tesame met pasiënt demografiese- en beperkte kliniese inligting.  
Stamme is deur PFGE en molekulêre merkers (spa, MLST, agr, SCCmec en PVL) beskryf.  
Verteenwoordigende isolate is gekies en ondersoek vir die teenwoordigheid van virulensie gene, 
aanhegting ( aan geïmmobiliseerde fibronektien [Fn], fibrinogeen [Fg], kollageen IV [CnIV] en 
kollageen VI [CnVI]), sellulêre indringing en die induksie van seldood.  Statistiese assosiasies is 
bepaal tussen alle in vitro resultate en methicillin-weerstandigheid, klonaliteit, pasiënt MIV status 
en bakteriese PVL status. 
Fyftien persent van die isolate (n = 367) was MRSA.  Vier-en-veertig van die isolate was PVL+.  
agrI-IV en SCCmec I-V is geïdentifiseer.  Die MSSA bevolking was divers: ST22 (dominant), 
ST1865 en ST121 PVL +. ST45, ST1863 en ST15 was PVL+. PVL- MRSA was divers: ST612-
MRSA-IV (dominant), ST5-MRSA-I, ST239-MRSA-III, ST36-MRSA-II en ST22-MRSA-IV.  Die 
gene fnbA/B (fibronektien A/B), clfA/B (klontings faktor A/B), eap (ekstrasellulêre aanhegtings 
protein), nuc (nukease), coa (koagulase) en hld (delta toksien) was aangetref in alle 
verteenwoordigende isolate. 
Isolate van KK8 en KK6 het sterk aan alle ligande (100-700% van kontrole, ligand-afhanklike) 
aangeheg, terwyl isolate van KK45, KK22 en KK88 slegs sterk aand fibronektien en fibrinogeen 
aangeheg het.  Isolate van KK30, KK15, en KK12 het baie sterk aan CnIV (> 300%) aangeheg en 
KK8, KK15, en KK6 and CnVI (> 200%).  Isolate van KK30, KK8, KK15, KK6, KK12, KK97, 
KK88 en KK45 was hoogs indringend (> 100%). ST121 was nie-indringende (> 50%).  Isolate van 
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KK5, KK30 en KK121 was nie-sitotoksiese (<50%), terwyl isolate van KK22, KK8, KK15, KK45 
en KK88 baie sitotoksies was (> 70%). 
Geen betekenisvolle verskil is waargeneem in die aanhegting of seldood induksie van MRSA 
teenoor MSSA klone of tussen isolate van MIV+ teenoor MIV- persone nie.  PVL- isolate het hoër 
sellulêre indringing as PVL+ isolate vertoon. 
Die teenwoordigheid van ST612-MRSA-IV, ST22-MRSA-V en ST8-MRSA-V verwys na die 
plaaslike verwerwing van SCCmec, aangesien ons MSSA isolate beskryf het met dieselfde spa-
tipes.  Talle MSSA klone was algemeen, maar het nie 'n beduidende genetiese agtergrond met 
MRSA vertoon nie. PVL was baie algemeen onder MSSA isolate en die PVL gene is dalk 
onafhanklik van SCCmec verkry. 
Die vermoë om aan spesifieke geïmmobiliseer ligande in vitro aan te heg was divers en groepeer 
met die genetiese agtergrond, terwyl die meerderheid van die isolate indringend was en kon 
betekenisvolle sel dood veroorsaak. 
Ons kan aflei dat die bevolking van S. aureus by die Tygerberg hospitaal saamgestel is uit 'n groot 
aantal van MSSA en MRSA klone, wat verskillende patrone van aanhegting aan geselekteerde 
ligande vertoon en waarvan die meeste klone indringende en sitotoksies is. 
 
Stellenbosch University http://scholar.sun.ac.za
vii 
 
RESEARCH OUTPUTS 
 
ORAL PRESENTATIONS: 
The following oral presentations were presented (reverse chronological order): 
1. W. Oosthuysen.  “In vitro characterisation after population structure analyses of clinical S. 
aureus isolated at Tygerberg hospital, South Africa”.  15th International Symposium on 
Staphylococci and Staphylococcal Infections (ISSSI), 26-30th August 2012, Lyon, France. 
2. W. Oosthuysen.  “In vitro characterisation after population structure analyses of clinical S. 
aureus isolated at Tygerberg hospital, South Africa”.  Stellenbosch University, Faculty of 
Medicine and Health Sciences Academic Year Day: Pathology session, 14-15th August, 2012. 
3. W. Oosthuysen.  “In vitro characterisation after population structure analyses of clinical S. 
aureus isolated at Tygerberg hospital, South Africa”.  4th IRTG International Symposium, 24-
26th June 2012, Würzburg, Germany. 
4. W. Oosthuysen.  “Host cell invasion and cell death induction by Staphylococcus aureus”.  
MedVet-Staph meeting, 1-2nd December 2011, Neustadt am Rübenberge, Mariensee, Germany. 
5. W. Oosthuysen.  “Molecular Epidemiology of S. aureus at Tygerberg Hospital, Western Cape, 
South Africa”.  3rd IRTG1522 International Symposium, 24-26th February 2011, STIAS, 
Stellenbosch, South Africa. 
6. W. Oosthuysen.  “Population structure, host cell interactions and pathogenesis of 
Staphylococcus aureus strains isolated at Tygerberg hospital, South Africa”.  2nd IRTG1522 
International Symposium, 14-15th May 2010, Bad Staffelstein, Germany. 
 
POSTER PRESENTATION: 
The following poster was presented: 
1. W. Oosthuysen, H. Orth, C. Lombard, B. Sinha and E. Wasserman.  “In vitro characterisation 
after population structure analyses of clinical S. aureus isolated at Tygerberg hospital, South 
Africa”.  4th IRTG International Symposium, 24-26th June 2012, Würzburg, Germany. 
 
 
Stellenbosch University http://scholar.sun.ac.za
viii 
 
AWARD RECEIVED: 
The following award was bestowed upon Mr. Wilhelm Oosthuysen: 
1. Best Oral Presentation: Pathology.  Stellenbosch University Faculty of Medicine and Health Sciences 
Academic Year Day 2012, 14-15th August 2012. 
 
PLANNED RESEARCH PUBLICATION: 
The following manuscript originating from this research have been prepared for publication: 
1. Wilhelm F. Oosthuysen, Heidi Orth, Carl J. Lombard, Bhanu Sinha and Elizabeth Wasserman.  
2013.  Population structure analyses of S. aureus at Tygerberg Hospital, South Africa, reveals a 
diverse population, high prevalence of Panton-Valentine leukocidin genes and the local 
emergence of MRSA clones. Submitted to the journal Clinical Microbiology and Infection. 
2. Wilhelm F. Oosthuysen, Heidi Orth, Carl Lombard, Bhanu Sinha and Elizabeth Wasserman.  In 
vitro characterisation of representative clinical South African Staphylococcus aureus isolates 
from various clonal lineages.  Submitted to the journal PLoS One. 
 
Mr. Oosthuysen was co-author in the following publications originating from other research 
projects: 
1. K. Karayem, W.F. Oosthuysen, K. Hoek, H. Orth and E. Wasserman.  2013.  The correlation of blood 
and nasal Staphylococcus aureus isolates in patients admitted to an academic hospital in South Africa.  
Submitted to the Journal of Clinical Microbiology. 
2. H. Orth, Z. Salaam-Dreyer, E. Makgotlho, W. Oosthuysen, B. Sinha and E. Wasserman.  2013.  
Characterization of Staphylococcus aureus bacteraemia at Tygerberg hospital.  South African Journal of 
Epidemiology and Infection, vol. 28(1). 
 
 
Stellenbosch University http://scholar.sun.ac.za
ix 
 
DEDICATION 
 
To my family 
 
 
 
“Imagination is more important than knowledge.” – Albert Einstein 
“Change is the only constant in the world.” - Anonymous 
“Once we accept our limits, we go beyond them.” – Albert Einstein 
 
 
 
 
Stellenbosch University http://scholar.sun.ac.za
x 
 
ACKNOWLEDGEMENTS 
 
First and foremost, I would like to thank my family (Melissa and Jacques Visagie, Wilhelm and 
Marie Oosthuysen) for their tremendous love and support.  I would also like to thank my friend 
(Mark Nicol) and fellow colleagues (Shaleena Naidoo, Karayem Karayem) for their love and 
support. 
 
I would like to acknowledge and thank the DFG/NRF International Research and Training 
Group (IRTG) 1522 “HIV and associated infectious diseases in Southern Africa” for the Ph.D. 
scholarship and giving me the opportunity to be part of such a wonderful international 
collaboration. 
 
I would like to thank my supervisors, Prof. Elizabeth Wasserman and Dr. Heidi Orth from the 
Division of Medical Microbiology, Stellenbosch University, and Prof. Bhanu Sinha from the 
University Medical Centre Groningen (Groningen, The Netherlands) for the support they have 
given me over the duration of this Ph.D.  I would also like to thank Prof. Carl Lombard (Bio-
Statistics Unit - MRC) for assisting with the statistics.  Nothing I have achieved would have been 
possible without you! 
 
I would like to thank and acknowledge my colleague at the Division of Medical Microbiology (Ms 
Nina du Plessis) for all the assistance she has provided me.  I would also like to thank the staff 
from the NHLS Microbiology laboratory at Tygerberg hospital for assisting me with the 
collection of S. aureus isolates.  I would especially like to thank Joan Basson, Judy Beukes and 
Wilma van der Horst. 
 
I would like to thank the following institutions for providing funding required for the research 
conducted during this Ph.D.: National Research Foundation, Medical Research Council, Medi-
Clinic and Harry Crossley Fund (Stellenbosch University).  I would like to thank Stellenbosch 
University for providing me with travel grants. 
Stellenbosch University http://scholar.sun.ac.za
xi 
 
TABLE OF CONTENTS 
 
DECLARATION ............................................................................................................................... II 
SUMMARY ..................................................................................................................................... III 
OPSOMMING ................................................................................................................................... V 
RESEARCH OUTPUTS................................................................................................................ VII 
DEDICATION ................................................................................................................................. IX 
ACKNOWLEDGEMENTS.............................................................................................................. X 
TABLE OF CONTENTS................................................................................................................ XI 
LIST OF FIGURES .................................................................................................................. XVIII 
LIST OF TABLES .................................................................................................................... XXIII 
LIST OF DEFINITIONS .......................................................................................................... XXVI 
LIST OF ABBREVIATIONS ................................................................................................. XXVII 
 
CHAPTER 1: GENERAL INTRODUCTION ................................................................................ 1 
1.1 The Organism ........................................................................................................................ 1 
1.1.1 Methicillin-resistant S. aureus (MRSA): ....................................................................... 2 
1.1.1.1 Staphylococcal Chromosome Cassette mec (SCCmec): .............................................. 4 
1.1.1.2 The evolution of MRSA: .............................................................................................. 6 
1.1.1.3 Community-associated MRSA (CA-MRSA): .............................................................. 8 
1.1.2 The global regulator agr: ............................................................................................... 9 
1.1.3 Pathogenicity and virulence of S. aureus: ...................................................................... 9 
1.1.3.1 Pathogenesis of infection: .......................................................................................... 12 
1.1.3.2 Host cellular invasion: ................................................................................................ 12 
1.1.4 Clinical outcome of S. aureus infections: .................................................................... 13 
 
 
 
 
Stellenbosch University http://scholar.sun.ac.za
xii 
 
CHAPTER 2: THE POPULATION STRUCTURE OF STAPHYLOCOCCUS AUREUS AT 
TYGERBERG HOSPITAL ............................................................................................................ 14 
2.1 Introduction ......................................................................................................................... 14 
2.1.1 S. aureus in South Africa: ............................................................................................ 14 
2.1.2 S. aureus and HIV/AIDS: ............................................................................................ 16 
2.1.3 Molecular typing of S. aureus: ..................................................................................... 17 
2.1.3.1 Macro-restriction analysis (MRA) with pulsed-field gel electrophoresis (PFGE): ... 18 
2.1.3.2 spa typing: .................................................................................................................. 19 
2.1.3.3 Multi-locus sequence typing (MLST): ....................................................................... 20 
2.1.3.4 agr typing: .................................................................................................................. 21 
2.1.4 S. aureus in the Western Cape province: ..................................................................... 21 
2.2 Aims and Objectives ........................................................................................................... 22 
2.2.1 Study aim: .................................................................................................................... 22 
2.2.2 Study objectives: .......................................................................................................... 22 
2.3 Materials and Methods ........................................................................................................ 24 
2.3.1 Study design and setting: ............................................................................................. 24 
2.3.2 Ethical considerations: ................................................................................................. 24 
2.3.3 Sample collection and patient demographics: .............................................................. 24 
2.3.4 Chemicals, reagents and media: ................................................................................... 25 
2.3.5 Bacterial strains and growth conditions: ...................................................................... 25 
2.3.6 Total genomic bacterial DNA extraction: .................................................................... 25 
2.3.7 Macro-restriction analyses (MRA) and pulsed-field gel electrophoresis (PFGE): ...... 26 
2.3.7.1 Agarose plug preparation: .......................................................................................... 26 
2.3.7.2 SmaI and ApaI restriction enzyme digestion: ............................................................. 26 
2.3.7.3 Pulsed-field gel electrophoresis (PFGE): ................................................................... 27 
2.3.7.4 PFGE gel analysis and UPGMA dendrogram construction: ...................................... 27 
2.3.8 spa typing: .................................................................................................................... 28 
2.3.8.1 DNA amplification and detection: ............................................................................. 28 
2.3.8.2 DNA nucleotide sequencing: ...................................................................................... 29 
2.3.8.3 DNA nucleotide sequence analysis: ........................................................................... 29 
2.3.9 Multi-locus sequence typing (MLST): ......................................................................... 30 
2.3.9.1 DNA amplification, detection and nucleotide sequencing: ........................................ 30 
2.3.9.2 DNA nucleotide sequence analysis: ........................................................................... 30 
2.3.10 SCCmec typing: ........................................................................................................... 30 
2.3.11 agr typing: .................................................................................................................... 31 
Stellenbosch University http://scholar.sun.ac.za
xiii 
 
2.3.12 PCR detection of Panton-Valentine leukocidin (PVL): ............................................... 31 
2.3.13 PCR detection of selected virulence factors: ............................................................... 32 
2.3.14 Statistical analyses: ...................................................................................................... 33 
2.3.14.1 Associations between clonality and clinical/bacterial characteristics: ....................... 33 
2.3.14.2 Associations between virulence factors and methicillin-resistance or clonality: ....... 33 
2.3.14.3 Discriminatory power of typing techniques: .............................................................. 34 
2.3.15 List of PCR primers used during the study: ............................................................... 35 
2.3.16 Control strains used during the study: ........................................................................ 39 
2.3.17 Composition of media, buffers and solutions: ............................................................ 41 
2.4 Results ................................................................................................................................. 42 
2.4.1 Sample collection: ........................................................................................................ 42 
2.4.2 Methicillin-resistance: .................................................................................................. 42 
2.4.3 Patient demographics: .................................................................................................. 42 
2.4.4 Clinical sources of collected isolates: .......................................................................... 43 
2.4.5 Macro-restriction analyses (MRA) with pulsed-field gel electrophoresis (PFGE): .... 44 
2.4.6 spa typing: .................................................................................................................... 51 
2.4.7 SCCmec typing: ........................................................................................................... 51 
2.4.8 agr typing: .................................................................................................................... 54 
2.4.9 PCR detection of Panton-Valentine leukocidin (PVL): ............................................. 55 
2.4.10 ApaI MRA and PFGE of clone THW-V: ..................................................................... 55 
2.4.11 Multi-locus sequence typing (MLST): ......................................................................... 57 
2.4.12 Combined molecular data: ........................................................................................... 57 
2.4.13 Statistical analyses: ...................................................................................................... 60 
2.4.14 Selection of representative isolates: ............................................................................. 61 
2.4.15 Virulence factor PCRs: ................................................................................................ 62 
2.5 Discussion ........................................................................................................................... 71 
2.5.1 High prevalence of PVL: ............................................................................................. 71 
2.5.2 Diversity of MSSA and MRSA clones identified: ....................................................... 71 
2.5.3 PFGE as the main typing technique: ............................................................................ 72 
2.5.4 Population structure of S. aureus at Tygerberg hospital: ............................................. 73 
2.5.5 Local SCCmec evolution and acquisition: ................................................................... 76 
2.5.6 Statistical association with HIV and other virulence factors: ...................................... 77 
2.6 Conclusion ........................................................................................................................... 79 
2.7 Appendix A ......................................................................................................................... 80 
 
Stellenbosch University http://scholar.sun.ac.za
xiv 
 
CHAPTER 3: ADHERENCE OF REPRESENTATIVE CLINICAL S. AUREUS ISOLATES 
TO SPECIFIC IMMOBILISED HUMAN LIGANDS ................................................................. 84 
3.1 Introduction ......................................................................................................................... 84 
3.1.1 Host extracellular matrix (ECM) components involved in bacterial adherence: ......... 84 
3.1.2 Staphylococcal adherence proteins: ............................................................................. 84 
3.1.2.1 Protein A (SpA): ......................................................................................................... 85 
3.1.2.2 Fibronectin-binding proteins (FnbPs): ....................................................................... 85 
3.1.2.3 SD repeat proteins (Sdr): ............................................................................................ 86 
3.1.2.4 Collagen adhesin (Cna): ............................................................................................. 86 
3.1.2.5 Extracellular adherence protein (Eap): ....................................................................... 86 
3.1.2.6 Plasmin-sensitive protein (Pls): .................................................................................. 88 
3.2 Aims and Objectives ........................................................................................................... 89 
3.2.1 Study aim: .................................................................................................................... 89 
3.2.2 Study objectives: .......................................................................................................... 89 
3.3 Materials and Methods ........................................................................................................ 90 
3.3.1 Chemicals, reagents and media: ................................................................................... 90 
3.3.2 Bacterial strains and growth conditions: ...................................................................... 90 
3.3.3 Preparation of human plasma and serum: .................................................................... 90 
3.3.4 Coating of 96-well micro-titre plates with human-derived ligands: ............................ 91 
3.3.5 Adherence assay: .......................................................................................................... 91 
3.3.6 Statistical associations: ................................................................................................ 92 
3.3.6.1 Associations between adherence and methicillin-resistance or clonality: ................. 92 
3.3.6.2 Associations between adherence and patient HIV status or bacterial PVL status: .... 93 
3.3.7 Composition of media, buffers and solutions: ............................................................. 93 
3.4 Results ................................................................................................................................. 95 
3.4.1 Adherence per ligand: .................................................................................................. 95 
3.4.2 Statistical associations: ................................................................................................ 99 
3.5 Discussion ......................................................................................................................... 102 
3.5.1 Discussion per ligand: ................................................................................................ 102 
3.5.2 Discussion per clonal complex: ................................................................................. 104 
3.6 Conclusion ......................................................................................................................... 111 
3.7 Appendix B........................................................................................................................ 112 
 
 
Stellenbosch University http://scholar.sun.ac.za
xv 
 
CHAPTER 4: HOST CELLULAR INVASIVENESS AND HOST CELL DEATH 
INDUCTION OF REPRESENTATIVE CLINICAL S. AUREUS ISOLATES ....................... 118 
4.1 Introduction ....................................................................................................................... 118 
4.1.1 Pathogenesis of infection: .......................................................................................... 118 
4.1.2 Host cellular invasins: ................................................................................................ 118 
4.1.2.1 Fibronectin-binding proteins (FnbPs): ..................................................................... 118 
4.1.2.2 Extracellular adherence protein (Eap): ..................................................................... 119 
4.1.2.3 Plasmin sensitive surface protein (Pls): .................................................................... 120 
4.1.3 Phagosomal escape of internalised staphylococci: .................................................... 120 
4.1.4 Intracellular persistence of S. aureus: ........................................................................ 120 
4.1.5 Induction of host cell death: ....................................................................................... 121 
4.1.5.1 α-toxin: ..................................................................................................................... 122 
4.1.5.2 Panton-Valentine leukocidin (PVL): ........................................................................ 122 
4.1.5.3 Other toxins: ............................................................................................................. 123 
4.1.6 Regulation of host cellular invasion and host cell death induction: .......................... 123 
4.2 Aims and Objectives ......................................................................................................... 124 
4.2.1 Study aim: .................................................................................................................. 124 
4.2.2 Study objectives: ........................................................................................................ 124 
4.3 Materials and Methods ...................................................................................................... 125 
4.3.1 Chemicals, reagents, media and kits: ......................................................................... 125 
4.3.2 Bacterial strains and growth conditions: .................................................................... 125 
4.3.3 Control strains and compounds: ................................................................................. 125 
4.3.4 Flow cytometric invasion assay: ................................................................................ 125 
4.3.4.1 FITC-labelling and fixation of bacteria: ................................................................... 126 
4.3.4.2 Mammalian cell culture: ........................................................................................... 126 
4.3.4.3 Invasion assay: ......................................................................................................... 127 
4.3.4.4 Flow cytometry: ....................................................................................................... 127 
4.3.4.5 Analyses of flow cytometric data: ............................................................................ 128 
4.3.5 Induction of cell death assays: ................................................................................... 128 
4.3.5.1 Nicoletti assay: ......................................................................................................... 129 
4.3.5.2 LDH assay: ............................................................................................................... 131 
4.3.5.3 WST-1 cell viability assay: ...................................................................................... 132 
4.3.6 Statistical associations: .............................................................................................. 134 
4.3.6.1 Associations between invasion or host cell death induction and methicillin-resistance 
or clonality: ............................................................................................................................... 134 
Stellenbosch University http://scholar.sun.ac.za
xvi 
 
4.3.6.2 Associations between invasion or host cell death induction and patient HIV status or 
bacterial PVL status: ................................................................................................................. 134 
4.3.7 Composition of agar, broth, media and buffers: ........................................................ 135 
4.4 Results ............................................................................................................................... 136 
4.4.1 Cellular invasiveness: ................................................................................................ 136 
4.4.2 Induction of host cell death: ....................................................................................... 138 
4.4.2.1 Nicoletti assay: ......................................................................................................... 138 
4.4.2.2 LDH assay: ............................................................................................................... 141 
4.4.2.3 WST-1 cell viability assay: ...................................................................................... 143 
4.4.3 Statistical associations: .............................................................................................. 145 
4.5 Discussion ......................................................................................................................... 148 
4.5.1 Host cellular invasiveness: ......................................................................................... 148 
4.5.2 Induction of host cell death: ....................................................................................... 150 
4.5.2.1 Nicoletti assay: ......................................................................................................... 150 
4.5.2.2 LDH assay: ............................................................................................................... 151 
4.5.2.3 WST-1 cell viability assay: ...................................................................................... 152 
4.5.2.4 Combined host cell death induction data: ................................................................ 154 
4.6 Conclusion ......................................................................................................................... 157 
 
CHAPTER 5: GENERAL DISCUSSION.................................................................................... 158 
5.1 Population Structure: ......................................................................................................... 158 
5.2 In Vitro Host Cell Interactions: ......................................................................................... 162 
5.2.1 In vitro interactions per clonal complex: ................................................................... 162 
5.2.2 In vitro correlation analyses: ...................................................................................... 169 
5.2.2.1 Correlations between adherence assays (ligands): ................................................... 170 
5.2.2.2 Correlations between adherence and invasion assays: ............................................. 176 
5.2.2.3 Correlations between adherence and cell death assays: ........................................... 180 
5.2.2.4 Correlations between invasion and cell death assays: .............................................. 186 
5.2.2.5 Correlations between cell death assays: ................................................................... 187 
 
CHAPTER 6: GENERAL CONCLUSIONS ............................................................................... 189 
 
CHAPTER 7: REFERENCES ...................................................................................................... 192 
 
Stellenbosch University http://scholar.sun.ac.za
xvii 
 
LIST OF FIGURES 
 
Chapter 1: 
Figure 1.1 Structures of SCCmec types I – VI (A) and SCCmec types V – VIII (B)……………5 
 
Chapter 2: 
Figure 2.1 A schematic representation of the spa gene…………………………………..…….20 
Figure 2.2 The distribution of isolates collected according to patient HIV status and methicillin-
resistance…………………………………………………………………………....43 
Figure 2.3 The distribution of isolates collected by according to source………………………44 
Figure 2.4 Collapsed UPGMA dendogram of the 366 typed S. aureus isolates………………..47 
Figure 2.5 Graphical representations of identified spa-clonal complexes………………...……53 
Figure 2.6 agr distribution according to methicillin-resistance………………...………………54 
Figure 2.7 lukS/F PCR results according to methicillin-resistance…………….………………55 
Figure 2.8 Clustering of isolates from clone THW-V by ApaI macro-restriction………...……56 
 
Chapter 3: 
Figure 3.1 The structural organisation of the S. aureus MSCRAMM proteins (a) fibronectin-
binding protein A; (b) collagen-binding protein; (c) clumping factor A; and (d) 
protein A………………………………………...………………………...………...87 
Figure 3.2 Relative adherence of isolates using an uncoated 96-well plate………………..…..96 
Figure 3.3 Relative adherence of isolates using a 96-well plate coated with human plasma 
proteins.…………………………………………………..…………………………96 
Figure 3.4 Relative adherence of isolates using a 96-well plate coated with human serum 
proteins.……………………………………………………………….....………….97 
Stellenbosch University http://scholar.sun.ac.za
xviii 
 
Figure 3.5 Relative adherence of isolates using a 96-well plate coated with human 
fibronectin……………………………………………………..…………………….97 
Figure 3.6 Relative adherence of isolates using a 96-well plate coated with human 
fibrinogen…………………………………………………..…………………….…98 
Figure 3.7 Relative adherence of isolates using a 96-well plate coated with human collagen 
IV………………………………………………………………..………………..…98 
Figure 3.8 Relative adherence of isolates using a 96-well plate coated with human collagen 
VI…………………………………………………………………..………………..99 
Figure 3.9 Adherence of CC22 isolates in the absence/presence of various immobilised 
ligands…………………………………………………………………………...…105 
Figure 3.10 Adherence of CC30 isolates in the absence/presence of various immobilised 
ligands………………………………………………………………...……………105 
Figure 3.11 Adherence of CC8 isolates in the absence/presence of various immobilised 
ligands………………………..…………………………………………………….106 
Figure 3.12 Adherence of CC15 isolates in the absence/presence of various immobilised 
ligands………………………………………………………….…………………..107 
Figure 3.13 Adherence of CC5 isolates in the absence/presence of various immobilised 
ligands……………………………………………………………………………...108 
Figure 3.14 Adherence of various singleton STs in the absence/presence of various immobilised 
ligands..…………………………………………………………………………….109 
Figure B1 Relative adherence of isolates using an uncoated 96-well 
plate……………………………………………………………………….……….112 
Figure B2 Relative adherence of isolates using a 96-well plate coated with human plasma 
proteins..……………………………………………………………………..…….112 
Figure B3 Relative adherence of isolates using a 96-well plate coated with human serum 
proteins. ……………………………………………………………………..…….113 
Figure B4 Relative adherence of isolates using a 96-well plate coated with human 
fibronectin………………………………………………………………………….113 
Stellenbosch University http://scholar.sun.ac.za
xix 
 
Figure B5 Relative adherence of isolates using a 96-well plate coated with human 
fibrinogen………………………………………….………………………………114 
Figure B6 Relative adherence of isolates using a 96-well plate coated with human collagen type 
IV………….……………………………………………………………………….114 
Figure B7 Relative adherence of isolates using a 96-well plate coated with human collagen type 
VI………….……………………………………………………………………….115 
 
Chapter 4: 
Figure 4.1 Schematic representation of the co-localisation of the FnbPs-fibronectin bridging 
complex and the human host cellular receptor, α5β1………….…………………..119 
Figure 4.2 Differences in host cellular invasiveness of the representative South African S. 
aureus isolates in 293 cells, expressed as a percentage relative to the invasive 
control, Cowan I……………………………………………………….…………..137 
Figure 4.3 Invasiveness of representative South African S. aureus isolates grouped according to 
MLST CC and displayed according to HIV status…………………..…………….138 
Figure 4.4 Differences in induction of host cell death of the representative South African S. 
aureus isolates in Ea.hy926 cells, expressed as a percentage relative to the cells only 
control……………………………………………………………………...………139 
Figure 4.5 Induction of host cell death of representative South African S. aureus isolates 
grouped according to MLST CC and displayed according to HIV status…………140 
Figure 4.6 Differences in induction of host cell death of the representative South African S. 
aureus isolates in Ea.hy926 cells, expressed as a percentage relative to the cytotoxic 
chemical control, 1% Triton-X…………………………………………………….142 
Figure 4.7 Induction of host cell death of representative South African S. aureus isolates 
grouped according to MLST CC and displayed according to HIV 
status………………………………………………………………………...……..143 
Figure 4.8 Differences in cell viability after induction of host cell death of the representative 
South African S. aureus isolates in Ea.hy926 cells, expressed as a percentage relative 
to the cells only control………………………………………………………...….144 
Stellenbosch University http://scholar.sun.ac.za
xx 
 
Figure 4.9 Cell viability after induction of host cell death of representative South African S. 
aureus isolates grouped according to MLST CC and displayed according to HIV 
status……………………………………………………………………………….145 
Figure 4.10 Kruskal-Wallis bar-graph of the cellular invasiveness of the representative 
isolates………………………………………………………………..……………149 
 
Chapter 5: 
Figure 5.1 Combined results of all the in vitro assays CC22 isolates……….………..….……162 
Figure 5.2 Combined results of all the in vitro assays for CC30 isolates……………..………164 
Figure 5.3 Combined results of all the in vitro assays for CC5 isolates………………………165 
Figure 5.4 Combined results of all the in vitro assays for CC15 isolates…………….……….166 
Figure 5.5 Combined results of all the in vitro assays for the singleton STs…………..……..166 
Figure 5.6 Combined results of all the in vitro assays for CC8 isolates………………………168 
Figure 5.7 Scatter plot of uncoated vs. serum.………………………………..……….………171 
Figure 5.8 Scatter plot of uncoated vs. plasma…………………………………...……..……..171 
Figure 5.9 Scatter plot of ucoated vs. fibronectin.………………………………….…………171 
Figure 5.10 Scatter plot of uncoated vs. fibrinogen..………………………………..………….171 
Figure 5.11 Scatter plot of uncoated vs. collagen IV..……………………………….…………172 
Figure 5.12 Scatter plot of uncoated vs. collagen VI.………………………………..…………172 
Figure 5.13 Scatter plot of plasma vs. serum.………………………………………..…………172 
Figure 5.14 Scatter plot of plasma vs. fibronectin.……………………………………………..172 
Figure 5.15 Scatter plot of plasma vs. fibrinogen.…………………………………..………….173 
Figure 5.16 Scatter plot of plasma vs. collagen IV.………………………………….…………173 
Figure 5.17 Scatter plot of plasma vs. collagen VI.…………………………………………….173 
Figure 5.18 Scatter plot of serum vs. fibronectin..……………………………………….…..…173 
Stellenbosch University http://scholar.sun.ac.za
xxi 
 
Figure 5.19 Scatter plot of serum vs. fibrinogen………………………………….…………….174 
Figure 5.20 Scatter plot of serum vs. collagen VI…………………………………….….……..174 
Figure 5.21 Scatter plot of serum vs. collagen VI………………………………………....……174 
Figure 5.22 Scatter plot of fibronectin vs. fibrinogen.…………...……….…………………….174 
Figure 5.23 Scatter plot of fibronectin vs. collagen V.…………...………….…………………175 
Figure 5.24 Scatter plot of fibronectin vs. collagen VI.………….…………….……………….175 
Figure 5.25 Scatter plot of fibrinogen vs. collagen IV.…………..……………….…………….175 
Figure 5.26 Scatter plot of fibrinogen vs. collagen VI.…………..………………….………….175 
Figure 5.27 Scatter plot of collagen IV vs. collagen VI.………………………………....……..176 
Figure 5.28 Scatter plot of uncoated vs. invasion.………………….…………………………..177 
Figure 5.29 Scatter plot of serum vs. invasion.……………………….………………….……..177 
Figure 5.30 Scatter plot of plasma vs. invasion.………………………………………….…….177 
Figure 5.31 Scatter plot of fibronectin vs. invasion. .……………………….………………….177 
Figure 5.32 Scatter plot of fibrinogen vs. invasion. .…………………………….……………..178 
Figure 5.33 Scatter plot of collagen IV vs. invasion.……………………………….…………..178 
Figure 5.34 Scatter plot of collagen VI vs. invasion.…………………………………….……..178 
Figure 5.35 Scatter plot of serum vs. Nicoletti.…………………………………………....……180 
Figure 5.36 Scatter plot of uncoated vs. Nicoletti.……………………………………………...180 
Figure 5.37 Scatter plot of plasma vs. Nicoletti. .……………………….……………………...181 
Figure 5.38 Scatter plot of fibronectin vs. Nicoletti..………………………..………...………..181 
Figure 5.39 Scatter plot of fibrinogen vs. Nicoletti..……………..……………..……...……….181 
Figure 5.40 Scatter plot of collagen IV vs. Nicoletti..………………………………..…………181 
Figure 5.41 Scatter plot of collagen VI vs. Nicoletti..……………………………………..……182 
Figure 5.42 Scatter plot of serum vs. LDH..…………………………………………………....182 
Stellenbosch University http://scholar.sun.ac.za
xxii 
 
Figure 5.43 Scatter plot of uncoated vs. LDH..………………………………..………………..182 
Figure 5.44 Scatter plot of plasma vs. LDH..…………………………………….……………..182 
Figure 5.45 Scatter plot of fibronectin vs. LDH..……………………………………..…..…….183 
Figure 5.46 Scatter plot of fibrinogen vs. LDH..………………………………………….……183 
Figure 5.47 Scatter plot of collagen IV vs. LDH.……………………………………………....183 
Figure 5.48 Scatter plot of collagen VI vs. LDH.……….……………………………………...183 
Figure 5.49 Scatter plot of serum vs. WST-1..…………….……………………………………184 
Figure 5.50 Scatter plot of uncoated vs. WST-1..…………….………………………...………184 
Figure 5.51 Scatter plot of plasma vs. WST-1..………………………………………………...184 
Figure 5.52 Scatter plot of fibronectin vs. WST-1..……………….……………………………184 
Figure 5.53 Scatter plot of fibrinogen vs. WST-1..…………………….……………………….185 
Figure 5.54 Scatter plot of collagen IV vs. WST-1 .……………………….………...…………185 
Figure 5.55 Scatter plot of collagen VI vs. WST-1..………………………….………………...185 
Figure 5.56 Scatter plot of invasion vs. Nicoletti..…………….………………………………..186 
Figure 5.57 Scatter plot of invasion vs. LDH..…………………….……………………………186 
Figure 5.58 Scatter plot of invasion vs. WST-1..………………….……………………………187 
Figure 5.59 Scatter plot of Nicoletti vs. LDH..…………………………………………………188 
Figure 5.60 Scatter plot of Nicoletti vs. WST-1..……………………….………………………188 
Figure 5.61 Scatter plot of WST-1 vs. LDH..…………………………………………………..188 
 
Stellenbosch University http://scholar.sun.ac.za
xxiii 
 
LIST OF TABLES 
 
Chapter 2: 
Table 2.1 Summary of previous S. aureus studies containing molecular data conducted in 
South Africa…………………………………………………………………………14 
Table 2.2 PCR primers used during this study………………………………………….……..35 
Table 2.3 S. aureus isolates used as controls for various assays, excluding virulence PCRs....39 
Table 2.4 Control isolates used for PCR investigation of virulence factors and PCR annealing 
temperatures……………………………………………………………...………....39 
Table 2.5 Composition of media used…………………………………………………………41 
Table 2.6 Composition of buffers and solutions used………………………………………....41 
Table 2.7 PFGE clones identified during this study by SmaI digestion.......……………..……45 
Table 2.8 spa-CC identified during this study using the BURP algorithm of RIDOM 
StaphType®…………………………………………………………………...…….52 
Table 2.9 ApaI PFGE clones identified from SmaI clone THW-V, with supporting data from 
spa, agr and SCCmec typing…………………………………………………..……57 
Table 2.10 MLST CC identified and their respective PFGE clone……………………………..58 
Table 2.11 PFGE clones identified, with supporting data from other typing 
techniques……………………………………………………………………...……59 
Table 2.12 The discriminatory power of the typing techniques used during this study……..….60 
Table 2.13 Statistical associations between clonality and the clinical/bacterial characteristics 
using the Fisher’s exact test………………………………………..………………..64 
Table 2.14 Strains selected as representative isolates for further analyses……….…………….65 
Table 2.15 Prevalence of virulence factors as detected through PCR……………..……………68 
Table 2.16 Associations of virulence factors with methicillin-resistance and clonality……..…69 
Stellenbosch University http://scholar.sun.ac.za
xxiv 
 
Table A1 Genotypic PCR results obtained of the prevalence of the selected virulence factors in 
the representative isolates…………………………………………………………...81 
 
Chapter 3: 
Table 3.1 Composition of media and broth used for adherence assays……………...…..…….93 
Table 3.2 Composition of buffers and solutions used for adherence assays……………….….94 
Table 3.3 Statistical associations between adherence and methicillin-resistance using the 
Mann-Whitney and 2-sample t-tests.  Statistically significant values are displayed in 
bold (p < 0.05)………………………………………….………………………….100 
Table 3.4 Statistical associations between adherence and clonality using the Kruskal-Wallis 
test………………………………………………………………………………….100 
Table 3.5 Statistical associations between adherence and patient HIV status using the Kruskal-
Wallis test………………………………………………………………………….101 
Table 3.6 Statistical associations between adherence and bacterial PVL status using the Mann-
Whitney test.  Statistically significant values are displayed in bold………...…….101 
Table B1 Strains selected as representative isolates for further analyses as categorised 
according to molecular typing data and statistical associations…...………………116 
 
Chapter 4: 
Table 4.1 Composition of agar and broth used during invasion and cell death assays……....134 
Table 4.2 Composition of media and buffers used during invasion and cell death assays…..134 
Table 4.3 Statistical associations between invasion/cell death and methicillin-resistance…..146 
Table 4.4 Statistical associations between invasion/cell death and clonality………..……….146 
Table 4.5 Statistical associations between invasion/cell death and patient HIV status…..…..147 
Table 4.6 Statistical associations between invasion/cell death and bacterial PVL status…....147 
Table 4.7 Isolates classified as very cytotoxic according to all three assays……...…………155 
Stellenbosch University http://scholar.sun.ac.za
xxv 
 
Table 4.8 Isolates classified as very cytotoxic according to the Nicoletti and LDH assays 
only…………………………………………………………………………...……155 
Table 4.9 Isolates classified as very cytotoxic according to the Nicoletti assay only………..156 
 
Chapter 5: 
Table 5.1 Representative isolates analysed, classified based on clonality, together with the 
clinical categories and virulence genes they are associated with……...…….…….160 
Table 5.2 Statistical associations between adherence/invasion/cell death and clonality……..163 
Table 5.3 Pearson correlation (r) for the correlation between different assays and the 
corresponding p-value……………………………………………………………..169 
Table 5.4 Pearson correlation (r) for the correlation between different assays and the 
corresponding p-value……………………………………………………………..179 
 
Stellenbosch University http://scholar.sun.ac.za
xxvi 
 
LIST OF DEFINITIONS 
 
Clonal complex: A group of known strains, such as S. aureus, which share a common 
ancestry, i.e. evolved from the same ancestral cell, as determined by a 
specific molecular typing method, such as macro-restriction analyses 
or multi-locus sequence typing. 
Intravascular device: An intravascular catheter inserted directly into a vein or artery. 
Isolate: A micro-organism obtained in pure culture from a clinical specimen. 
Population structure: Clones of S. aureus identified in circulation, as determined by 
specific molecular biology typing techniques (PFGE, spa typing, 
MLST), and the association of these clones with specific clinical 
categories (such as adult/paediatric clones or clones associated with a 
specific gender) or specific bacterial characteristics (such as 
resistance to methicillin). 
Prosthetic device: An artificial object inserted into any human body part other than a 
vein or artery e.g. cardiac pacemaker. 
Strain: A group of micro-organisms within a species e.g. Staphylococcus 
aureus which have the same particular characteristic. 
 
 
Stellenbosch University http://scholar.sun.ac.za
xxvii 
 
LIST OF ABBREVIATIONS 
 
+   positive 
-   negative 
aa   amino acid 
AIDS   Acquired immunodeficiency syndrome 
AIP   Auto-inducing peptide 
ATCC   American Type Culture Collection 
BHI   Brain-heart infusion 
BJ   Bone-and-joint 
BURP   Based-Upon Repeat Pattern 
°C   degrees Celsius 
CA   Cardiac 
CA-MRSA  Community-associated methicillin-resistant Staphylococcus aureus 
cap5/8   Capsule 5/8 gene 
CBSI   Catheter-related blood stream infection 
CC   Clonal complex 
CDC   Centres for Disease Control and Prevention 
CHIPS  Chemotaxis inhibitory protein 
chp   Chemotaxis inhibitory protein gene 
clfA/B   Clumping factor A/B gene 
cna   Collagen binding protein 
CnIV   Collagen type IV 
Stellenbosch University http://scholar.sun.ac.za
xxviii 
 
CnVI   Collagen type VI 
coa   Coagulase gene 
CO2   Carbon dioxide 
CPT   Cape Town 
dlv   double-locus variant 
DNA   Deoxyribonucleic acid 
DMSO  Dimethyl sulfoxide 
eap   Extracellular adherence protein gene 
Eap   Extracellular adherence protein 
ECM   Extracellular matrix 
EDTA   Ethylenediaminetetraacetic acid 
ELISA  Enzyme-linked immunosorbent assay 
EMRSA  Epidemic methicillin-resistant Staphylococcus aureus 
ENT   Ear, nose and throat 
ESRF   End-stage renal failure 
eta   Exfoliative toxin A gene 
etb   Exfoliative toxin B gene 
EtBr   Ethidium bromide 
EY   Eye 
Ex   Excluded 
FCS   Foetal calf serum 
Fg   Fibrinogen 
FITC   Fluorescein isothiocyanate 
Fn   Fibronectin 
Stellenbosch University http://scholar.sun.ac.za
xxix 
 
fnbA/B  Fibronectin binding pretein A/B gene 
Fnbp(s)  Fibronectin-binding protein(s) 
h   hour 
HA-MRSA  Hospital-associated methicillin-resistant Staphylococcus aureus 
HCl   Hydrochloric acid 
HIV   Human immunodeficiency virus 
hla   Alpha toxin gene 
hlb   Beta toxin gene 
hld   Deta toxin gene 
hlg   Gamma toxin gene 
hlgv   Gamma variant toxin gene 
HREC   Human Research Ethics Committee 
HSA   Human serum albumin 
hVISA  heterogenous vancomycin-intermediately resistant S. aureus 
HVR   Hyper-variable region 
icaA   Biofilm A gene 
ICAM-1  Endothelial cell adhesion molecule 
IEC   Immune evasion cluster 
IgG   Immunoglobulin-G 
incl.   including 
IVD   Intra-vascular device 
IWG-SCC International Working Group on the classification of Staphylococcal Cassette 
Chromosome Elements 
kb   kilobase 
Stellenbosch University http://scholar.sun.ac.za
xxx 
 
KZN   KwaZulu Natal 
LA-MRSA  Livestock-associated methicillin-resistant Staphylococcus aureus 
LDH   Lactate dehydrogenase 
M   Molar 
mg   milligram 
mg/ml   milligram per millilitre 
MgCl2   Magnesium chloride 
MHB   Mueller-Hinton broth 
min   minute 
ml   millilitre 
MLST   Multi-locus sequence typing 
mm   millimetre 
mM   millimolar 
MOI   Multiplicity of infection 
MRA   Macro-restriction analyses 
MRSA  Methicillin-resistant Staphylococcus aureus 
MSSA   Methicillin-susceptible Staphylococcus aureus 
MSCRAMM  Microbial surface components recognising adhesive matrix molecule 
µg   microgram 
µg/ml   microgram per millilitre 
µl   microliter 
µM   micromolar 
Na   Not applicable 
NaCl   Sodium chloride 
Stellenbosch University http://scholar.sun.ac.za
xxxi 
 
NCTC   National Collection of Type Cultures 
NHLS   National Health Laboratory Service 
nm   nanometre 
NP   Necrotising pneumonia 
ns   not significant 
NSBI   Nosocomial blood stream infection 
NT   non-typeable 
nuc   Nuclease gene 
OD   Optical density 
o/n   overnight 
ORIF   Open-reduction and internal fixation 
PBP   Penicillin-binding protein 
PBS   Phosphate-buffered saline 
PCP   Pneumocystis pneumonia 
PCR   Polymerase chain reaction 
PEARLS  Pan-European Antimicrobial Resistance Using Local Surveillance 
PFGE   Pulsed-field gel electrophoresis 
PI   Propidium iodide 
PMNs   Polymorphonuclear cells 
pmol   picomol 
PROST  Prosthetic device 
PSM   Phenol-soluble modulins 
PTA   Pretoria 
PVL   Panton-Valentine leukocidin 
Stellenbosch University http://scholar.sun.ac.za
xxxii 
 
rEap   Recombinant extracellular adherence protein 
RE   Restriction enzyme 
RO   Reverse osmosis 
rpm   revolutions per minute 
RT   room temperature 
s   second 
sak   Staphylokinase gene 
SCCmec  Staphylococcal Cassette Chromosome mec 
SCIN   Staphylococcal complement inhibitor 
scn   Staphylococcal complement inhibitor gene 
SCV   Small colony variant 
SD   standard deviation 
sdrC/D/E  SDR-repeat proteins C/D/E genes 
SE   Staphylococcal enterotoxin 
sea   Staphylococcal enterotoxin A gene 
seb   Staphylococcal enterotoxin B gene 
sec   Staphylococcal enterotoxin C gene 
sed   Staphylococcal enterotoxin D gene 
see   Staphylococcal enterotoxin E gene 
seg   Staphylococcal enterotoxin G gene 
seh   Staphylococcal enterotoxin H gene 
sei   Staphylococcal enterotoxin I gene 
sej   Staphylococcal enterotoxin J gene 
sel   Staphylococcal enterotoxin L gene 
Stellenbosch University http://scholar.sun.ac.za
xxxiii 
 
sem   Staphylococcal enterotoxin M gene 
SEM   Standard error of the mean 
sen   Staphylococcal enterotoxin N gene 
seo   Staphylococcal enterotoxin O gene 
sep   Staphylococcal enterotoxin P gene 
SERAM  Secreted expanded repertoire adhesive molecules 
SLST   Single locus sequence typing 
spa-CC(s)  spa-Clonal complex(es) 
SSSS   Staphylococcal Scalded Skin Syndrome 
SSTI   Skin and soft tissue infection 
ST   Sequence type 
TAE   Tris-acetic acid-EDTA buffer 
TBE   Tris-boric acid-EDTA buffer 
TE   Tris-EDTA buffer 
Tm   annealing temperature 
UK   United Kingdom 
UPGMA  Unweighted pair group method with arithmetic mean 
USA   United States of America 
UT   Urinary tract 
V   Volts 
V/cm   Volts per centimetre 
VNTR   Variable-number tandem repeat 
WT   wild-type 
w/v   weight per volume 
Stellenbosch University http://scholar.sun.ac.za
xxxiv 
 
y   year 
 
 
 
Stellenbosch University http://scholar.sun.ac.za
1 
 
CHAPTER 1: General introduction 
 
1.1 The Organism 
 
Staphylococci are Gram-positive cocci, occurring mainly as irregular grape-like clusters, but can 
also be found singly, in pairs, tetrads or short chains.  The organism is non-motile, non-spore 
forming and as a rule, catalase positive[1].  On solid agar, Staphylococcus aureus colonies are 
usually smooth, slightly raised and often pigmented, ranging from creamy-yellow to orange.  S. 
aureus is a facultative pathogenic bacterium that is considered to be one of the most important and 
significant human pathogens. Although S. aureus has successfully adapted as a human pathogen or 
a coloniser, the organism can quite easily play both roles, i.e. be both a pathogen and coloniser[2, 3].  
Humans are natural reservoirs of S. aureus, as are cattle and pigs[4].  The most common site of 
colonisation is the nose, but other sites, such as the nasopharynx, axillae and groin may also be 
colonised[1].  According to previous studies, carriage of the organism in the anterior nares of up to 
50% of adults can be found, of which 30% are persistently colonised[2, 5] by the organism.  Van 
Belkum et al.[5] classified human nasal carriage into persistent carriage or colonisation and non-
carriers or intermittent carriers. 
 
S. aureus possesses many surface factors, as well as secreted molecules and enzymes which aid 
with host colonisation and cellular invasion[2, 6] and can eventually lead to a wide range of clinical 
infections  and even death.  Infections caused by this organism may involve skin and soft tissue, 
bone and joints or organs, such as the lungs or kidneys.  However, this can easily lead to sepsis, as 
well as septic shock, which, in turn, is associated with vascular damage and multiple organ 
failure[7].  Previous staphylococcal infection is not always required, as seen in cases involving food 
poisoning and toxic shock syndrome[2, 8]. 
 
Whole genome sequencing of two related methicillin-resistant Staphylococcus aureus (MRSA) 
isolates revealed that the organism is much more complex in pathogenicity than originally thought.  
The genome complexity revealed the ability of S. aureus to acquire useful genes through lateral 
gene transfer[9].  Several genomes from clinical and laboratory S. aureus isolates have been 
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sequenced and include methicillin susceptible Staphylococcus aureus (MSSA) and MRSA isolates 
(http://www.ncbi.nlm.nih.gov/genome/154).  Basic genome analyses revealed the presence of two 
domains in the S. aureus chromosome: the 1st domain contained the vast majority of house-keeping 
genes, while the 2nd contained the vast majority of acquired genes responsible for virulence or drug-
resistance[10]. 
 
After investigating the clonal nature of S. aureus using revised multi-locus sequence typing (MLST) 
data, Feil et al. identified no significant difference in the distribution of MLST sequence types 
(STs) between colonising and invasive isolates[11].  They were also able to conclude that point 
mutations, and not homologous recombination, are the main mechanism of evolution which gives 
rise to new alleles, and that homologous recombination plays a role in the long-term evolution of 
the organism[11]. 
 
1.1.1 Methicillin-resistant S. aureus (MRSA): 
 
S. aureus infections were initially treated with sulphonamides, which were soon replaced by 
penicillin.  Although initially very effective, resistance through the production of penicillinase was 
acquired shortly after penicillin’s introduction[12].  Resistance to these two drugs lead to the 
chemical alteration of the penicillin-nucleus, and cloxacillin and methicillin were synthesised, both 
penicillinase resistant.  Yet, once again, resistance was soon acquired and MRSA was born, 
resistant to most currently licenced classical beta-lactam antibiotics [13]. 
 
MRSA emerged as a major clinical and epidemiological hospital-associated problem in the 1980s[2], 
even though Jevons described the first MRSA isolate in the 1960s[14].  After the identification of S. 
aureus strains resistant to methicillin in Britain in the early 1960s[14], MRSA has become a major 
global health concern and is commonly associated with serious infections, such as sepsis, 
endocarditis and osteomyelitis[15].  It was realised during the 1990s, using molecular fingerprinting 
techniques, that epidemic MRSA clones are capable of spreading between the continents and that a 
clone can replace another epidemic MRSA clone[16].  Using fingerprinting techniques, scientists in 
New York City were able to identify MRSA clusters and outbreaks in various hospitals in the 
city[17].  It was also soon realised that many of these early MRSA clones were widespread across the 
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planet[18].  This is still the case today.  A MRSA clone may be dominant for a while in a given 
geographic area, where after it is replaced by another MRSA clone.  Two different MRSA clones 
can also co-dominate a specific setting over a period of time[19]. 
Unlike its counterpart, MRSA possesses the mecA gene that confers resistance to nearly all β-lactam 
antibiotics.  The mecA gene encodes for an alternative penicillin-binding protein (PBP)-2, namely 
PBP-2’ or PBP-2a, which has a remarkably low binding affinity to β-lactam antibiotics[20].  PBPs 
are involved in cross-linking of the peptidoglycan of the bacterial cell wall and normally display 
very high binding capacities to β-lactam antibiotics[20].  The mecA gene is located on a mobile 
genetic element called the Staphylococcal Chromosome Cassette mec (SCCmec) and was only 
described in the year 2000[21].  This mobile element’s ability to integrate into and excise from the S. 
aureus genome is regulated by the ccr cassette (also carried on the element) which encodes for 
recombinase genes[21].  This makes MRSA quite different from other forms of antibiotic resistance, 
the fact that the resistance gene (mecA) is integrated into the host genome. 
 
The development of a multi-locus sequence typing (MLST) scheme for the typing of S. aureus 
showed that the vast majority of MRSA isolates were part of clonal complex (CC) 5, CC8, CC22, 
CC30 and CC45[22, 23].  MRSA isolates have also been identified in other CCs, especially 
community-associated MRSA (CA-MRSA) isolates, which display more diversity in origin.  Some 
clones occur very infrequently and usually in very small numbers, and are regarded as sporadic 
clones, such as CC509 and ST1048 isolates[23].  No single common genetic factor distinguishes 
epidemic and sporadic clones[24].  It has also been established that MRSA infections can be 
seasonal, depending on the geographic region[25]. 
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1.1.1.1 Staphylococcal Chromosome Cassette mec (SCCmec): 
 
Being able to assign a SCCmec type correctly is an important requirement for epidemiological 
studies.  SCCmec typing can also be utilised for the investigation into the origin and evolution of 
contemporary MRSA clones[26]. 
 
SCCmec was first described as a novel mobile genomic element, capable of site- and orientation-
specific integration into and precise excision from any S. aureus genome due to recombinase genes 
of the invertase/resolvase family, called chromosome cassette recombinase genes (ccrAB or 
ccrC)[21, 27, 28].  A defining feature of any SCCmec type is the presence of two gene complexes, the 
mec complex (responsible for conferring resistance to methicillin through the mecA gene) and the 
ccr gene complex (responsible for integration into and excision from the bacterial genome).  At 
least eleven different SCCmec types have been identified and described to date.  This is based on 
the combination of the mec and ccr gene complexes, of which numerous classes and allotypes have 
been described.  Several PCR-based typing schemes have been designed for the identification of 
SCCmec elements in clinical S. aureus isolates[29-33] and also for the sub-typing of some SCCmec 
types[34].  Refer to Figure 1.1 (A & B) for a structural comparison of SCCmec types I - VIII.  
Guidelines have been published for the classification of newly discovered SCCmec types[35]. 
 
SCCmec types I, II and III are today still predominantly associated with hospital-associated MRSA 
(HA-MRSA)[36].  They are the largest of the SCCmec elements and carry numerous other genes on 
them, such as Tn554 (conferring resistance to erythromycin and spectinomycin), IS431 
(chromosomal deposit site for other resistance genes), and integrated plasmids, such as pUB110 and 
pT181[37, 38].  SCCmec type IV is smaller and commonly devoid of most other resistance genes and 
was originally associated with community-associated MRSA strains (CA-MRSA)[36, 39].  The 
description of SCCmec type V, also associated with CA-MRSA, lead to the discovery of the ccrC 
gene[27].  This type is also small, lacks additional resistance genes and carries genes for a restriction-
modification system[27]. 
SCCmec type VI was originally misclassified as a variant of type IV, but this element possessing a 
different ccrAB allotype lead to its reclassification[40].  SCCmec type VII was detected in Japanese 
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CA-MRSA isolates, was relatively large and found to contain an additional ccrC gene[41].  IS431 
and Tn554 were also identified to be present on this CA-MRSA associated SCCmec type[41]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Structures of SCCmec types I – VI (A) and SCCmec types V – VIII (B).  Adapted 
from IWG-SCC[35]. 
A 
B 
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SCCmec type VIII was identified in a Canadian epidemic MRSA isolate.  Complete sequence data 
of this element revealed it was generated through recombination[42]. 
SCCmec types IX and X were more recently identified in 2011 in S. aureus strains of MLST 
CC398, commonly associated with livestock-associated MRSA (LA-MRSA) strains[43].  These 
SCCmec types also carried genes conferring resistance to heavy metals and were distinct from those 
normally found in human S. aureus strains[43], suggesting they originated in non-human 
staphylococcal species.  SCCmec type XI was discovered in clinical MRSA isolates from the UK 
and Denmark, as well as bovine milk samples from the UK[44].  This SCCmec type carried a mecA 
homologue, designated mecALGA251, arsenic resistance genes and a β-lactamase gene, blaZ[44].  
ST398 MSSA isolates have also recently been identified in humans, which were not acquired from 
any animals[45]. 
 
Although SCCmec is predominantly associated with antibiotic resistance, there are reports of 
SCCmec II and III elements carrying phenol-soluble modulin (PSM) genes[46] (psm-mec/PSM-mec), 
which are normally encoded in the core genome of S. aureus.  psm-mec genes have recently also 
been identified in SCCmec II[47] and VIII elements[48].  PSMs are thought to be involved in 
phagosomal escape, but their exact functions still remain unknown[49].  Otto et al. has identified 
PSMs to be involved in virulence using in vivo infection models[49-51]. 
 
1.1.1.2 The evolution of MRSA: 
 
Initially it was thought that mecA was acquired only once by S. aureus[52], but today we know that 
mecA was transferred to various clones of S. aureus.  Analyses of >3000 S. aureus isolates from 
Latin America, the USA and Europe showed that the Iberian and the Brazilian/Hungarian clones are 
related to the Archaic clone, the first MRSA clones[53] (ST250-MRSA-I)[54].  The fact that the 
Archaic (ST250-MRSA-I) and Iberian (ST247-MRSA-I) clones possessed the same SCCmec type, 
SCCmec I, while the Brazilian/Hungarian (ST239-MRSA-III) clones possessed SCCmec III was 
more proof that mecA was acquired more than once by S. aureus[53].  DNA microarray data 
generated by Fitzgerald et al. identified five distinct S. aureus clonal backgrounds that have 
received the SCCmec element (i.e. the mec gene cluster), thus supporting the theory of multiple 
independent acquisition events[55].  Analyses of MSSA strains collected during the 1960s revealed 
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that all early MRSA isolates had the same phenotypic and genetic properties as these MSSA 
isolates, confirming that the early MRSA isolates were in fact the progeny of these MSSA 
isolates[56]. 
 
MLST analyses of the five lineages identified by Fitzgerald et al.[55] indicate that they have evolved 
from two distinct ancestral lineages, of which the 1st lineages could be traced back to MSSA and 
MRSA isolates from the UK and Denmark from the 1950s – 1960s[12].  The 2nd lineage had a 
completely different MLST profile and was identified in MRSA isolates from Japan and the USA 
(ST5), as well as from paediatric isolates from all over the globe[12].  Four SCCmec elements were 
also identified in unique combinations[12].  Since the identification of the 1st MRSA isolates, 
numerous MRSA clones have spawned from epidemic MSSA isolates[57].  Some of these MRSA 
isolates have now acquired resistance against vancomycin, which has for a long time been regarded 
as the antibiotic of last resort[58]. 
 
Robinson et al. were able to construct evolutionary models of the emergence of the five dominant 
MRSA clones, namely CC5, CC8, CC22, CC30 and CC45, by constructing phylogenetic trees of 
the diversity present in seven S. aureus surface proteins (sas).  They also constructed trees based on 
MLST data and found that the two trees constructed conveyed the same picture[59].  Using these 
models they were able to identify at least 20 MRSA emergence events and concluded that the 
MRSA clones are four times more like to emerge due to SCCmec acquisition by sensitive isolates 
than the replacement of a SCCmec element by another[59].  They also identified SCCmec IV as the 
most common SCCmec type.  In ST5 alone, it has been shown that different SCCmec types have 
been acquired at least on 23 occasions[60].  MLST has become the gold-standard technique to 
employ for investigating the evolutionary history and origin of MRSA[13, 61, 62]. 
 
Although S. aureus evolved predominantly through point mutation, two lineages have been 
described to have evolved though a single chromosomal replacement event of 224 kb and 557 kb 
respectively[54, 63].  One of these replacement events involved two pandemic MRSA clones, ST30 
(CC30) and ST8 (CC8).  A 557 kb chromosomal region of ST8, which included the spa gene, was 
replaced by the same region of ST30, leading to the emergence of ST239 (CC8)[63].  It is due to this 
replacement that ST30 and related STs (spa t012) and ST239 (spa t037) are clustered in the same 
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spa-CC.  A similar exchange of chromosomal fragments has been reported between CC5 and 
CC8[64]. 
 
1.1.1.3 Community-associated MRSA (CA-MRSA): 
 
Since the early 1990s, CA-MRSA has emerged as a serious community health problem, causing an 
array of severe invasive infections, particularly those associated with the skin and soft tissue[65] and 
different forms of necrotising disease, such as necrotising pneumonia[66, 67].  CA-MRSA isolates are 
usually characterised by the presence of either SCCmec IV or V and are usually non-multidrug 
resistant.  Some countries, like the USA, carry a high burden of CA-MRSA infections caused by 
isolates of the USA300 (ST8) complex[67, 68], which has spread also to other parts of the world[69, 70].  
It has recently become clear that the increased virulence seen in isolates of the USA300 and 
USA500 complexes, when compared to other contemporary MRSA clones, is due to the differential 
expression of core genome-encoded virulence determinants, such as α-toxin and PSMs, and not 
primarily due to the acquisition of mobile genetic elements[71], even though PSM has been 
identified on SCCmec elements[48] and PVL is encoded by acquired phages[65, 72].   This has also 
been confirmed using an in vivo rabbit skin abscess model[50, 51]. 
 
There is a lack of data regarding CA-MRSA from Africa.  CA-MRSA used to be identified based 
mainly on clinical definitions, proposed by the CDC in 2000.  However, recent studies have shown 
that clinical data alone is not enough to identify CA-MRSA, and that this should be supplemented 
by molecular typing data, preferentially sequence-based methods such as single-locus sequence 
typing (SLST) (e.g. spa typing), MLST, presence or absence of PVL and type of SCCmec 
carried[73]. 
 
It is known that the worldwide CA-MRSA epidemic caused by isolates of the USA300 clone is 
being driven by MSSA isolates with the same genotypic and phenotypic characteristics[74].  ST8 
PVL+ MSSA isolates can very easily become CA-MRSA clones upon the acquisition of a SCCmec 
IV or V element.  This is  the case for other ST associated with CA-MRSA in Europe and Australia, 
such as ST80 and ST59[75, 76]. 
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1.1.2 The global regulator agr: 
 
Agr is responsible for the regulation of gene expression of numerous I, cytotoxins and enzymes[77].  
agr-dependant factors are also responsible for the mediation of induction of apoptosis by S. 
aureus[78].  The expression of cell-wall associated adherence proteins are upregulated during the 
early stages of infection, and once infection has been established, the expression of invasive factors 
are favoured. 
The agr system consists of a 3kb locus which contains opposing transcription elements and is 
driven by two promoters, P2 and P3[77, 79].  The polycistronic P2 transcript is coded from four genes, 
agrA, C, D and B which encodes for a two-component system as well as its autoinducing peptide 
(AIP).  AgrB is a transmembrane protein and is responsible for the processing of the pro-AIP, 
encoded for by agrD, and secretion of the processed AIP.  The AIP then binds to the signal receptor 
AgrC, which leads to the phosphorylation or dephosphorylation of AgrA, the response regulator, 
which in turn, activates the P2 (RNAII) and P3 (RNAIII) promoters[77, 79].  This quorum-sensing 
pathway activates transcription of the P3 promoter at high cell density.  This is usually a reaction to 
the environmental concentrations of the secreted AIP.  Target cell regulation is achieved by the 
transcript of the P3 promoter, a RNAIII molecule, which is upregulated by activated AgrA.  
Activation of RNAIII can result in the increased expression of secreted proteins and a reduced 
expression of cell surface proteins[80]. 
 
1.1.3 Pathogenicity and virulence of S. aureus: 
 
S. aureus as a species possesses an exceptionally diverse set of virulence factors, some of which 
show a variable prevalence.  The pathogenesis of infection is influenced by both secreted and 
structural products alike, as well as the appropriate regulation of their expression.  A virulence 
factor may be involved in several roles during pathogenesis (pleiotropy), or the same virulence 
function might be performed by several pathogenicity determinants (redundancy)[3].  It is thought 
that some clones are more virulent than other, although this is controversial, and essentially any S. 
aureus genotype associated with humans can cause life-threatening infection[81]. 
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S. aureus has several surface anchored proteins, named “microbial surface components recognising 
adhesive matrix molecules” or MSCRAMMs.  These molecules, such as clumping factors, collagen 
and fibronectin-binding proteins, mediate adherence to host tissues[82] to establish an infection.  
These proteins can interact with an array of host tissue structures, such as collagens, fibronectin, 
fibrinogen serum- and plasma proteins and many more.  MSCRAMMs play a key role during the 
initiation of endovascular, bone and joint and prosthetic-device infections[3].  Different 
MSCRAMMs may be able to adhere to the same host-tissue component.  Opsonisation may be 
prohibited by another MSCRAMM, staphylococcal protein A (spA), known for binding the Fc 
region of eukaryotic IgG[3].  Although it has been shown that spA can be involved in adherence, the 
exact function of this protein, till today, remains unknown.  Polysaccharides associated with 
biofilms, such as those encoded by the ica locus, allow the organism to persist.  Growth as a biofilm 
also aids the organism to evade the host immune system and most antimicrobials[2].  Biofilm-
forming strains are mostly associated with prosthetic devices, such as intravascular catheters or pin 
tracts. 
 
As infection progresses, local tissue destruction, bacterial dissemination and metastatic infection 
may ensue.  The latter two occur, usually as a result of bacterial spread into the bloodstream and 
penetration into surrounding tissue.  Although the basic mechanism of invasion has been described 
in molecular detail[83], limited data exist linking this to wild-type (WT) strains and human 
pathology, apart from in vivo endocarditis models[84]. 
 
Vast arrays of S. aureus proteins also contribute to host immune evasion.  One key guard is the 
assembly of antiphagocytic microcapsules, specifically capsule type 5 and 8.  These components are 
involved with abscess formation, provide protection against phagocytic uptake and enhance 
microbial virulence[85].  A conjugate vaccine has been developed based on capsular polysaccharide 
5 and 8.  Staphylococcal complement inhibitor (SCIN) and chemotaxis inhibitory protein of S. 
aureus (CHIPS) are two other proteins involved in host innate immune evasion.  Both genes are 
carried on β-hemolysin-converting bacteriophages (β C-ɸs)[86], which are phages that integrate 
specifically into the β-hemolysin gene, disrupting it and blocking expression of functional β-toxin.  
SCIN is a C3 convertase inhibitor while CHIPS modulates bacterial chemokine receptors[86].  Both 
SCIN and CHIPS protect S. aureus from the host innate immune system and are thus very important 
virulence factors.  Two other genes are also sometimes found on the same phages (β C-ɸs) and are 
also involved in circumvention of the host innate immune system, namely sak (Staphylokinase) and 
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sea (or sep) (Staphylococcal enterotoxin A or P).  Enterotoxin A, which also acts as a superantigen, 
has the ability to modulate the functions of chemokine receptors, while Staphylokinase has been 
shown to have numerous functions[86].  Together, these genes form an immune evasion cluster (IEC) 
and are highly specific to human strains.  To impede neutrophil extravasation and chemotaxis, a 
large number of proteins are secreted, a prominent member of which is the extracellular adherence 
protein (Eap)[3].  This is a cell-surface associated protein which belongs to the SERAM (secreted 
expanded repertoire adhesive molecules) group of molecules, is not covalently anchored, and 
inhibits wound healing, angiogenesis and inflammation.  This protein has also been designated 
major histocompatibility complex class II analogous protein (Map).  It binds rather promiscuously 
to different monomeric matrix macromolecules, although it discriminatively distinguishes specific 
extracellular matrix aggregates[87], and also serves as an S. aureus invasin[88, 89]. 
 
Some strains excrete a leukocyte-specific toxin called Panton-Valentine leukocidin (PVL), and 
strains carrying the genes for this toxin come from diverse backgrounds[90].  This two component 
toxin induces pores in the membranes of polymorphonuclear neutrophils (PMNs)[91] and is highly 
leukotoxic[72].  This toxin has been associated with necrotising lesions of the skin and subcutaneous 
tissues[65], necrotising pneumonia[66, 92] and other skin and soft tissue infection (SSTIs)[93, 94] caused 
by CA-MRSA strains.  However, it is known that PVL- isolates are just as virulent as their PVL+ 
counterparts in some in vivo infection models[95].  A differential effect on neutrophils by PVL is 
seen when several species are compared (human, rabbit, murine or simian)[91] and it is still thought 
that PVL plays an important cytotoxic role in CA-MRSA pathogenesis, especially for isolates from 
the USA300 clone[68, 69].  PVL can be regarded as a good marker of epidemicity, but its causal role 
in pathogenicity is less clear, i.e. this toxin can be associated with certain genetic backgrounds, but 
PVL+ strains are not necessarily more virulent than their PVL- counterparts[95, 96].  The lukS/F-PV 
genes are generally well conserved among different genetic lineages[97].  Recent data has shown that 
PVL+ isolates can be imported, especially from the Tropics and Subtropics, through nasal 
colonisation and SSTIs[98]. 
Another toxin with leukotoxic properties is γ-toxin.  It has been demonstrated that this toxin causes 
the direct lyses of erythrocytes and leukocytes[3, 72] and can also be involved in abscess formation 
and other invasive skin infections[3].  δ-toxin can also lyse erythrocytes[8] and is related to the 
PSMs[49, 99].  The exfoliative toxins EtA (eta being phage-borne) and EtB (etb being plasmid-based) 
are commonly associated as the cause of Staphylococcal Scalded Skin Syndrome (SSSS), usually a 
superficial skin disorder involving local blistering of the skin[8]. 
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1.1.3.1 Pathogenesis of infection: 
 
In order for S. aureus to initiate an infection it first has to find an appropriate site, where it will have 
to adhere to host tissue.  Adherence and colonisation can be mediated by an array of bacterial 
molecules[100] expressed during the logarithmic growth phase.  Novel adhesins are still being 
described[101].  Adherence, if successful, can result in host cellular invasion by utilising the host 
cellular integrin α5β1 (alpha5-beta1)[102], which is accessed after the bacterial invasin (fnbA/B or 
eap) has bound to fibronectin[103, 104]. 
The organism can persist outside the cell, for instance during wound infections by growing as a 
biofilm on host tissue or prosthetic devices[105] which allows for the organism to escape the host 
immune system, as well as the effect of administered antimicrobials[3].  Once inside the cell, the 
bacteria can grow and persist, usually in the form of small-colony variants, or SCV, only to revert 
later to a more virulent phenotype, and kill the cell.  S. aureus can invade non-professional 
phagocytes, including epithelial and endothelial cells[102].  The organism can also persist in these 
cells and cause toxin-mediated diseases, such as toxic shock syndrome, food poisoning or 
exfoliative disorders. 
S. aureus can also kill the cell immediately after invasion.  Cell death is usually induced through the 
expression of various toxins, especially haemolytic toxins (such as α-toxin) and leukocidin (such as 
PVL)[3].  These toxins are normally expressed during the stationary growth phase. 
 
1.1.3.2 Host cellular invasion: 
 
Although S. aureus has classically been regarded as an extracellular pathogen, mainly due to the 
pathogenesis of infection relying on toxin production, S. aureus has in recent years been recognised 
as a facultative intracellular pathogen[106, 107].  Host cellular invasion can be achieved or hindered by 
a number of bacterial surface proteins, of which FnbPs, Eap and Pls will be discussed further during 
Chapter 3.  Invasion is usually mediated by bridging of the bacterial protein via fibronectin, to the 
host cellular receptors, the integrins α5β1[103]. 
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1.1.4 Clinical outcome of S. aureus infections: 
 
Clinical outcome of S. aureus infection depends not only on host factors, including the site of 
infection, but also on organism factors, such as virulence factors/traits, regulatory fitness and 
susceptibility to antibiotics[108].  Apart from having a greater mortality rate, patients suffering from 
MRSA surgical site infections normally have prolonged period of hospitalisation and also have 
significantly higher medical expenses[109].  The lack of effective anti-MRSA antimicrobial agents 
and the complicated nature of MRSA infections may be two contributing factors.  Meta-analysis has 
also shown that patients suffering from bacteremia due to MRSA had a significantly higher 
mortality rate when compared to their MSSA counterparts[110] and is speculated to be due to the lack 
of effective treatment options for MRSA infections.  After investigating the recurrence of S. aureus 
bacteremia, Chang et al. identified valvular heart disease, liver cirrhosis and deep-seated infections 
as risk factors for relapse[111].  Nafcillin was also identified to be superior to vancomycin for the 
prevention of persistent bacteremia or relapse of MSSA bacteremia[111].  Persistent S. aureus 
bacteremia is associated with worse clinical outcome, independent of the methicillin 
susceptibility[112].  S. aureus can persist through growth as a biofilm, which has primarily been 
associated with the ica gene cluster[113], .  Proteinaceous-based biofilm growth mechanisms have 
also been described[114].  Biofilms are also common in device-related infections[2]. 
 
The following chapter will focus on elucidating the population structure of S. aureus isolates from 
specific clinical sources from the population of patients treated at Tygerberg hospital in the Western 
Cape Province, followed by the selection of representative isolates, which was investigated for the 
presence of selected virulence factors.  The same representative isolates were used to investigate 
their various abilities to adhere to immobilised ligands, which is depicted in Chapter 3.  Chapter 4 
focusses on the cellular invasiveness and host cell death induction abilities of these representative 
isolates, while correlation analyses between the various in vitro results can be found in Chapter 5.  
Chapter 6 provides general conclusions regarding the completed study. 
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CHAPTER 2: The population structure of 
Staphylococcus aureus at Tygerberg hospital 
 
2.1 Introduction 
 
2.1.1 S. aureus in South Africa: 
 
Very little information is currently available regarding the molecular epidemiology and 
pathogenicity of S. aureus in South Africa.  The incidence of methicillin-resistance among a 
collection of S. aureus isolates collected during 1983/84 from seven teaching centres was found to 
be 15%[115].  This number increased to 39% for strains collected during the autumn of 1996 from 
different centres[116], and increased again to 41.5% for all isolates tested and 40.4% for blood 
culture isolates during the SENTRY study in 1998/1999[117].  The PEARLS (Pan-European 
Antimicrobial Resistance Using Local Surveillance) study indicated methicillin-resistance to be 
33.3% for South African strains isolated during 2001/2002[118].  Refer to Table 2.1. 
 
Table 2.1 Summary of previous S. aureus studies containing molecular data conducted in 
South Africa. 
Study Description Main Finding Reference 
Moodley et al. 
2010 
Molecular characterisation of 
national MRSA 
Various MRSA clones 
Low PVL among MRSA 
Low CA-MRSA 
[119] 
Janse van 
Rensburg et al. 
2010 
Molecular characterisation of MRSA 
from CPT 
ST612 dominant MRSA [120] 
Makgotlho et al. 
2009 
Genotyping MRSA from academic 
hospital (PTA) 
SCCmec II-IV 
Low PVL/CA-MRSA 
[121] 
Shittu et al. 
2009 
Molecular characterisation of 
mupirocin-resistant MRSA (KZN) 
Mupirocin-resistance encoding plasmid 
present in isolates 
[122] 
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Table 2.1 cont. Summary of previous S. aureus studies containing molecular data conducted 
in South Africa. 
Shittu et al. 
2009 
Molecular characterisation of MRSA 
(KZN) 
ST239-MRSA-III; ST5-MRSA-III 
Novel MLST STs (MRSA) 
[123] 
Shittu et al. 
2006 
Molecular characterisation mannitol-
negative MRSA (KZN) 
SCCmec IV 
Mannitol-negative S. aureus 
[124] 
MRSA = methicillin-resistant S. aureus; PVL = Panton-Valentine leukocidin; CA-MRSA = community-associated 
methicillin-resistant S. aureus; CPT = Cape Town; ST = sequence type; PTA = Pretoria; SCCmec = Staphylococcal 
Cassette Chromosome mec; KZN = KwaZulu-Natal; MLST = multi-locus sequence typing 
 
The first documented case of a hVISA (heterogenous vancomycin-intermediately resistant S. 
aureus) clinical infection in South Africa, and also for the African continent, was reported in 2005, 
where a 67 year old male suffered a relapse after treatment with vancomycin for  MRSA 
ventriculitis[125].  Eighteen MRSA isolates tested positive for the hVISA phenotype, also in 2005, 
from an academic hospital.  These isolates formed part of S. aureus isolates collected from 
significant clinical sites during the beginning months of 2001 from a large South African teaching 
hospital[126]. 
 
A South African study on MRSA isolates collected nationally to investigate clonal dominance and 
relatedness of these strains, revealed the presence of several internationally described MRSA 
clones, such as ST5-MRSA-I, ST239-MRSA-III, ST612-MRSA-IV, ST36-MRSA-II and ST22-
MRSA-IV[119].  However, no MRSA isolates were included from Tygerberg hospital and this study 
excluded MSSA isolates. 
Twenty years ago the incidence of MRSA at Tygerberg Hospital was 31% among S. aureus strains 
isolated from blood cultures collected during 1985[127].  For 2008, that number was as high as 44% 
for blood culture isolates and 29% for isolates from all specimens (laboratory statistics, NHLS 
Microbiology Laboratory, Tygerberg Hospital).  A genotypic study of 113 S. aureus blood culture 
isolates at Tygerberg Hospital by spa typing identified 49 different spa types that grouped into 
seven clusters[128].  Spa type t037, usually associated with the Brazilian epidemic MRSA clone[13], 
was identified as the dominant spa type.  ST612 was also identified as a dominant MRSA clone in 
another study from Cape Town[120] and has previously only been identified in Australia[129] and 
South Africa[119].  High rates of methicillin-resistance was noted among HIV+ S. aureus carriers 
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with 77.3% of nasopharyngeal S. aureus isolates from HIV+ children in Cape Town resistant to 
cloxacillin[130]. 
 
SCCmec type II and type III possessing MRSA isolates have previously also been described in 
Gauteng by Makgotlho et al.[121].  Some information is available for MRSA isolates from KwaZulu-
Natal (KZN) province.  SCCmec type IV was identified among mannitol-negative MRSA isolates 
collected between 2001 and 2003[124] and ST5-MRSA-III and ST239-MRSA-III clones were 
identified in mannitol-positive isolates collected at the same time[123].  This data correlates with 
what has been published by Moodley et al.[119].  Also, MSSA isolates expressing low and high 
levels of resistance to mupirocin have been identified in KZN province[122]. 
 
2.1.2 S. aureus and HIV/AIDS: 
 
It is important to investigate co-infection of S. aureus and HIV due to the high prevalence of HIV in 
South Africa and the Western Cape.  A 2007 ante-natal survey (burden of disease, Department of 
Health, RSA) determined that on average, 28% of the South African population is HIV+, whereas 
13% of the Western Cape population is infected with the virus. 
Despite the frequency with which S. aureus is isolated in the clinical laboratory, there is a lack of 
published data regarding the association of S. aureus and HIV infection, as well as the clinical 
presentation of S. aureus infections in people living with HIV/AIDS.  It appears as if HIV+ persons 
are at an increased risk for S. aureus colonisation and infection[131].  A rise in nasal colonisation by 
S. aureus of HIV-positive children in the Western Cape has been reported[130]. 
Gordon et al. described two unique S. aureus clones which were capable of persistently colonising 
patients living with HIV/AIDS in a suburban drug treatment centre[132].  These clones also caused 
significant disease as they have been associated with outbreaks in the past.  Gordon et al. also 
speculated that these patients act as a reservoir for these clones upon their introduction back into the 
community[132]. 
When investigating persistent S. aureus nasal carriage in HIV+ patients, Melles et al. found the 
population structure of strains from HIV+ persons to be corresponding strongly with isolates from 
healthy individuals[133].  However, a higher rate of persistent colonisation (as defined by culture rule 
of two nasal swabs two weeks apart) rate was identified among HIV+ patients when compared to 
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that of healthy individuals in the same geographic region.  One factor independently determining 
higher risk of persistent carriage was male sex, while current smoking, Pneumocystis pneumonia 
(PCP) prophylaxis (low-dose intermittent Cotrimoxazole) and antiretroviral therapy were associated 
with a lower risk of persistent carriage[133].  Numerous MSSA MLST CCs were identified, all 
Panton-Valentine leukocidin negative (PVL-). 
 
S. aureus has also been identified as the most common organism isolated from HIV-positive 
patients admitted to 17 Italian infectious diseases wards with nosocomial blood steam infections 
(NBSIs) and catheter-related blood stream infections (CBSI)[131].  An uncommonly brutal 
necrotising fasciitis case involving an HIV+ patient was reported by Olsen et al., which was caused 
by a PVL+ MRSA clone of the USA300/spa1 (ST8) genotype, normally associated with CA-
MRSA[134].  They found that although this clone is associated with CA-MRSA infections, an 
increase in severity of the infections was noted in patients living with HIV/AIDS as S. aureus is not 
frequently reported as the cause of necrotising fasciitis.  However, the USA300/spa1 genotype has 
previously been reported as the causative agent of necrotising fasciitis in HIV+ patients[135].  This 
genotype has also been reported as the cause of the largest number of recurrent CA-MRSA 
infections in a single HIV+ patient, who experienced 24 episodes of soft tissue infections[136] and 
has also been associated with endocarditis among HIV+ patients with CA-MRSA bacteraemia[137].  
The frequency of SSTI caused by CA-MRSA can also be much higher among HIV+ patients when 
compared to their healthy counterparts and HIV infection has been suggested as a risk factor for 
CA-MRSA infection[138]. 
 
2.1.3 Molecular typing of S. aureus: 
 
In order to elucidate the population structure of any infectious agent, it is necessary to investigate 
the molecular epidemiology of representative strains isolated from the study population, as 
phenotypic tests cannot adequately discriminate between various strains.  To achieve this, molecular 
typing techniques are required for the effective discrimination and characterisation of isolates in 
order to establish clonal relatedness and clonal dominance.  Numerous techniques have been 
described for S. aureus typing, of which macro-restriction analysis (MRA) with pulsed-field gel 
electrophoresis (PFGE) is still regarded as the “gold-standard” for it is still the most discriminatory 
classical technique available for S. aureus[139-141] and is fairly inexpensive to perform.  Typing 
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systems are characterised according to the following criteria: typeability; reproducibility; 
discriminatory power; ease of interpretation; data portability and ease of use [139, 142].  However, it 
has been shown that no one typing method is clearly superior above all the rest [139].  PFGE has lost 
support due to the technique being very labour intensive, as well as the requirement for experienced 
labour and for normalised and curated restriction pattern databases.  As a result of this, there is a 
tendency towards sequence-based methods, e.g. spa typing (the most prominent example for single 
locus sequence typing) or multi-locus sequence typing (MLST) to discriminate between S. aureus 
isolates [140, 141], due to the increasing accessibility and affordability of DNA sequence technology 
and the ease with which data can be exchanged between laboratories. However, these techniques do 
not always discriminate between strains as effectively as PFGE. 
 
2.1.3.1 Macro-restriction analysis (MRA) with pulsed-field gel electrophoresis (PFGE): 
 
Using this technique for the typing of S. aureus isolates firstly requires the macro-restriction of the 
bacterial genome by an infrequently cutting restriction enzyme (RE), mostly SmaI.  The fragments 
are then separated according to size on an agarose gel using the technique PFGE, which was first 
applied for the separation of yeast chromosomes[143].  The current running through the gel is applied 
at an angle of 120°, resulting in the movement of these large DNA fragments through the agarose 
matrix.  The patterns obtained after staining of the gel are then compared and relatedness of strains 
can be established[142]. 
Although PFGE is currently still regarded as the most discriminatory technique to use for the typing 
of S. aureus, it is very labour intensive, requires specific expertise as well as normalised databases.  
No standard international protocols exist, therefore standardised protocols were developed in the 
USA[68] and Europe[144], where the technique is also used for outbreak investigation in many clinical 
settings because of its high discriminatory ability.  It can also be applied to investigate outbreaks 
caused by other organisms such as Pseudomonas spp. and Klebsiella spp.[142]. 
The use of PFGE, especially for outbreak investigation, is aided by standardised protocols, together 
with previously published guidelines for the interpretation of PFGE restriction patterns[142], and for 
computer software settings[145].  The technique can be applied to S. aureus originating from any 
animal, and is commonly used for establishing clonal relatedness of livestock-associated MRSA 
(LA-MRSA)[4, 146].  The RE ApaI is used for isolates which are non-typeable by SmaI digestion. 
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2.1.3.2 spa typing: 
 
The spa gene encoding for Staphylococcal Protein A, is found in all S. aureus strains. The complete 
sequence of this gene has previously been described[147, 148] and this revealed a 58-amino acid (aa) 
unit responsible for immunoglobulin G (IgG) binding and a 2-16-aa unit possibly involved with cell 
wall binding, named the X-region[148].  The X-region was found to consist of two parts, a variable 
repetitive region (Xr) and a constant region (Xc).  Spa typing
[149] is based on the amplification and 
sequencing of the polymorphic sequence of the Xr region, which is composed of several 21-24 base 
pair (bp) repeats bordered by well-conserved regions[150]. 
This single-locus sequence-based method is rapid, repeatable, easily portable and standardised, and 
can be applied in both local and global epidemiological studies[151], as the technique is capable of 
detecting genetic micro- and macrovariation.  The technique has also been validated in terms of 
outbreak investigations.  It was found that spa typing was able to discriminate molecular and 
epidemiologically linked strains quickly and easily[152], but requires a curated database (referred to 
as the “spa server”). 
Computer software has been designed to facilitate the analysis and interpretation of DNA 
nucleotide sequences[153].  This software also contains a specific algorithm which can be used to 
establish clonal relatedness from spa repeat units[154].  When compared to other typing techniques, 
spa typing was found to be a very powerful technique for the typing of MRSA[155]. 
A comprehensive overview of spa typing, including experimental procedure, can be found in the 
book chapter of Hallin et al[156].  Please refer to Figure 2.1 for a schematic representation of the spa 
gene and the variable-number tandem repeat (VNTR) region of this gene used for determining 
strain relatedness. 
 
 
 
 
 
 
Stellenbosch University http://scholar.sun.ac.za
20 
 
 
Figure 2.1 A schematic representation of the spa gene, adapted from Hallin et al[156].  (a) The 
different segments of the spa gene: S = signal sequence; A-E = IgG binding 
domains; X = C-terminal part (Xr is the VNTR region, while Xc is the constant 
region).  The arrows indicate the cross-localisation of primers.  (b) Repeat structure 
of the Xr region, with Kreiswirth (YHGFMBQBLO) and Ridom (t008) 
nomenclature.  (c) DNA nucleotide sequence of repeat r21/F1. 
 
2.1.3.3 Multi-locus sequence typing (MLST): 
 
A MLST typing scheme was developed for S. aureus[22] in 2000 by Enright et al. and is based on 
the polymorphisms identified in seven housekeeping gene sequences.   Clustering of both MSSA 
and MRSA isolates by MLST agreed well with results obtained by PFGE, confirming that MLST 
was a typing method with high discriminatory power.  Using this technique, Enright et al. also 
established that the population structure of S. aureus is essentially clonal in nature and that a few 
epidemiologically distinct lineages house MRSA isolates[22].  Because of this, MLST was also 
found to be a good technique to study global epidemiology and evolution of S. aureus[22].  Also, 
new implementations of the algorithm eBURST have allowed scientists to divide a MLST data set 
of any size into groups of related isolates, called clonal complexes (CC), and to predict the founding 
or ancestral genotype of each CC[157]. 
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Although a more complicated and expensive technique, the sequencing of seven housekeeping 
genes provides the advantage that MLST can be used to answer questions regarding the 
evolutionary biology of bacterial strains.  However, its expense and labour intensity prohibits the 
technique to be applied in outbreak investigations and routine diagnostics[57, 158]. 
 
2.1.3.4 agr typing: 
 
A hypervariable region is present in the P2 operon, resulting in 4 agr variants (I, II, III and IV), and 
represents a microbial interference mechanism.  The AIP from an agr type can only activate the agr 
response of strains with the same agr type and represses the agr response of strains with different 
agr types[80].  This evolutionary divergence occurred early in the development of the species[159].  
Persons colonised with S. aureus in their anterior nares are usually colonised with strains possessing 
the same agr variant[160].  The agr variant of each S. aureus strain collected can be determined using 
a previously published protocol[160]. 
 
2.1.4 S. aureus in the Western Cape province: 
 
In Cape Town and its surrounding areas, a large proportion of bone and joint (BJ) infections, as 
well as skin and soft tissue infections (SSTI) appear to be caused by S. aureus and are characterised 
by a complicated course.  Patient characteristics associated with persistent infection[112], 
inappropriate therapy[111] or distinct populations of S. aureus strains, including MRSA, may all 
contribute to complicated infection with S. aureus. 
Because we currently lack data describing the population structure or molecular epidemiology of S. 
aureus in this setting, and since studies to investigate the pathogenicity or virulence of dominant 
clones which are part of this population of S. aureus have not been performed to date, it is very 
difficult to correlate patient outcome with a specific S. aureus clone or to associate patient or 
clinical characteristics to clonality.  Numerous spa types have previously been identified at 
Tygerberg hospital in a study of blood culture isolates[128].  Spa type t037, commonly associated 
with the Brazilian/Hungarian clone (ST239-SCCmec III)[13], was identified as the dominant spa 
type among MRSA isolates[128].  However, during this study only blood cultures isolates were 
analysed. 
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2.2 Aims and Objectives 
 
2.2.1 Study aim: 
 
The aim of the research presented in this chapter was to elucidate the population structure of S. 
aureus isolated from specific clinical sites of infection (but excluding blood cultures) in the patients 
at Tygerberg hospital using a variety of molecular biology techniques and to investigate the 
potential association between dominant clones and specific bacterial and clinical categories. 
 
2.2.2 Study objectives: 
 
The objectives of this part of the study were the following 
1. Collect and store a bank of representative S. aureus clinical isolates, together with methicillin-
resistance and patient specific information, including HIV status. 
2. To perform molecular fingerprinting of these isolates through macro-restriction analyses 
(MRA) with pulsed-field gel electrophoresis (PFGE) and protein A typing (spa) of all isolates 
collected and multi-locus sequence typing (MLST) of representative isolates. 
3. To compare the molecular fingerprints to: 
(a) Determine strain relatedness; and 
(b) Establish clonal dominance. 
4. To supplement the molecular fingerprinting data by screening all collected isolates through PCR 
for: 
(a) The SCCmec type present in isolates phenotypically characterised as MRSA;  
(b) The toxin Panton-Valentine leukocidin (PVL); and 
(b) The agr variant present in each isolate. 
5. To perform statistical analyses and investigate if any correlation exist between clonality and the 
following categories: 
(a) Methicillin-resistance (MRSA and/or MSSA); 
(b) Clones associated with HIV infection; 
(c) Derived paediatric and/or adult clones; 
(d) Clones associated with a specific sources of infections; 
(a) Clones associated with a specific gender; and 
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(b) Clones associated with a specific PVL status, i.e. PVL+ and/or PVL- clones. 
6. To randomly select a representative isolate and investigate through PCR the presence of 
numerous virulence determinants from: 
(a) Each major and intermediate PFGE clonal complex; 
(b) Any additional clone(s) associated with any of the categories mentioned in #5 above. 
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2.3 Materials and Methods 
 
2.3.1 Study design and setting: 
 
This was a cross-sectional study undertaken in the molecular laboratory of the Division of Medical 
Microbiology of the Faculty of Medicine and Health Sciences, Stellenbosch University, located at 
Tygerberg Hospital.  Tygerberg hospital is a 1200 bed academic hospital in the Western Cape that 
serves a diverse population. 
 
2.3.2 Ethical considerations: 
 
Ethical approval was granted by the Health Research Ethics Committee (HREC) of the Faculty of 
Medicine and Health Sciences of Stellenbosch University on the 25th March 2010 (N10/03/066).  
Approval was granted for the collection of clinical S. aureus isolates as well as patient specific 
information.  Each isolate collected was assigned a specific study number in an Excel spread sheet 
created to ensure that the identity of the patient remained anonymous.  Exemption for patient 
consent was obtained on the following grounds: (1) patient de-lineated samples would be collected; 
(2) patient information collected for this study was obtained using the National Health Laboratory 
Service (NHLS) laboratory information system. 
 
2.3.3 Sample collection and patient demographics: 
 
S. aureus isolates were collected from the routine clinical specimens sent to the diagnostic 
microbiology laboratory of the NHLS at Tygerberg Hospital for diagnostic purposes, from 10 
September 2009 until 6 September 2010.  Identification and susceptibility testing were done using 
the VITEK II system (BioMerieux, France).  Susceptibility testing was performed using the disc 
diffusion method.  Methicillin susceptibility was interpreted according to CLSI guidelines[161].  
Following isolation and identification, collected isolates were sub-cultured on blood agar plates to 
determine purity.  Only pure cultures were stored at -80°C using the MicroBank system (Pro-Lab 
Diagnostics, Canada).  For each isolate methicillin susceptibility was recorded in an Excel spread 
sheet as well as the following information obtained from the laboratory request form and/or hospital 
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patient information system: the type of specimen and source of the infection.  The following patient 
demographics were captured: age, gender and HIV status (if available).  Only one isolate was 
included per patient. 
 
2.3.4 Chemicals, reagents and media: 
 
All chemicals and reagents used in this study were of analytical and/or molecular biology grade. 
The composition of all media is given in section 2.3.17.  All media used for bacterial growth was 
obtained from Greenpoint NHLS Media laboratory (Greenpoint, South Africa). The composition of 
all buffers is given in section 2.3.17. 
 
2.3.5 Bacterial strains and growth conditions: 
 
The S. aureus strains used in this study as controls are listed in Table 2.3.  All strains were sub-
cultured on 5% Blood agar plates (Greenpoint Media, NHLS, Cape Town) after collection and 
incubated overnight at 37 ºC.  For the extraction of DNA, 10 ml Brain Heart Infusion (BHI) broth 
(Greenpoint Media, NHLS, Cape Town) was inoculated and incubated overnight at 37 ºC. 
 
2.3.6 Total genomic bacterial DNA extraction: 
 
Total genomic DNA was extracted from each isolate collected by using a previously published, 
adapted, rapid lysis method[162].  Briefly, 10 ml BHI was inoculated with a single bead from the 
freezer culture and incubated at 37 °C overnight (o/n).  Thereafter, 1 ml of the bacterial broth was 
transferred to a tube, centrifuged at 14 000 rpm for 2 min and the supernatant aspirated.  The pellet 
was resuspended in 50 µl lysostaphin (100 µg/ml) (Sigma, USA) and incubated at 37 °C.  After 30 
min, 50 µl Proteinase K (100 µg/ml) (Promega, USA) and 150 µl Proteinase K buffer was added to 
the bacterial-lysostaphin suspension and incubated again for 30 min at 37 °C.  Thereafter, the 
bacterial suspension was incubated at 100 °C for 10 min, centrifuged at 14 000 rpm for 2 min and 
the DNA concentration measured using a NanoDrop 1000 spectrophotometer (Thermo Scientific, 
Wilmington, USA). 
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2.3.7 Macro-restriction analyses (MRA) and pulsed-field gel electrophoresis (PFGE): 
 
MRA with pulsed-field gel electrophoresis (PFGE), the “gold-standard” technique used for typing 
S. aureus, was used to obtain a banding pattern after genomic DNA digestion for each isolate.  
Previously published protocols were used[4, 68, 146].  The banding patterns were used to establish 
isolate relatedness through using the criteria as published by Tenover et al[142].  To aid with gel 
image analyses and construction of UPGMA (Unweighted Pair Group Method using Arithmetic 
averages) dendograms, GelCompar II version 6.0 (BioNumerics, Applied Maths, Sint-Martens-
Latem, Belgium) was used.  MRA with PFGE was performed on all isolates collected. 
 
2.3.7.1 Agarose plug preparation: 
 
10 ml BHI was inoculated with a single bead from the stock culture and incubated at 37°C 
overnight (o/n).  The cell suspension concentration was adjusted to an OD610 absorbance reading of 
0.9 using a cell density spectrophotometer (Ultrospec 10, GE Healthcare Life Sciences, USA).  The 
adjusted cell suspension was centrifuged at 14 000 rpm for 2 min and the supernatant aspirated.  
The bacterial pellet was re-suspended in 300 µl 1× TE buffer and equilibrated for 10 min.  A 1.8% 
(wt/vl) agarose (Lonza, Switzerland) solution was made in TE buffer and kept at 55°C in a water 
bath.  4 µl lysostaphin (Sigma, St. Louis, USA) and 300 µl of the 1.8% agarose was added to the 
equilibrated cell suspension, gently mixed, and dispensed into the wells of a small, disposable mold.  
Two plugs were made per isolate.  After allowing the plugs to solidify at room temperature for more 
than 15 min, they were removed and placed in a tube containing at least 4 ml EC lysis buffer and 
incubated at 37 °C for at least 4 h.  The EC lysis buffer was replaced by a wash buffer (TE buffer) 
and agitated on an orbital shaker (MRC Laboratory Equipment, Israel) at 200 rpm for 30 min.  This 
was repeated three more times.  The plugs were prepared for restriction digestion or stored at 4 °C. 
 
2.3.7.2 SmaI and ApaI restriction enzyme digestion: 
 
A 2-3 mm slice was cut off each agarose plug using a sterile scalpel blade and placed in a 1.5 ml 
tube, covered with 200 µl equilibration buffer [1× Buffer Tango (SmaI) or Buffer B 
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(ApaI)(Fermentas Life Sciences, Maryland, USA)] and equilibrated at room temperature for 30 min.  
The equilibration buffer was removed and replaced with 200 µl restriction enzyme solution (30U 
SmaI in 1× Buffer Tango or 30U ApaI in 1× Buffer B) (Fermentas Life Sciences,  USA) and 
incubated according to the manufacturers recommendations for 4 h (SmaI @ 25 °C; ApaI @ 37 °C).  
PFGE was performed directly after the enzyme digestion. 
 
2.3.7.3 Pulsed-field gel electrophoresis (PFGE): 
 
A 1% (w/v) pulsed-field certified agarose (Bio-Rad Laboratories, USA) solution was made in 0.5× 
TBE buffer (diluted from 10× TBE buffer) and equilibrated at 55 °C.  The plug slice was loaded 
directly on the end of the comb tooth (30 tooth comb).  At least three size standards (S. aureus 
strain NCTC 8325-4) were included in each gel.  After all the plug slices were loaded onto the 
comb, the comb was placed into the comb holder and the equilibrated agarose poured carefully into 
the gel casting.  The gel was allowed to solidify at room temperature for 1 h, where after it was 
subjected to PFGE.  2 l 0.5× TBE buffer was poured into the CHEF DR-III apparatus and allowed 
to cool to 14 °C (approx. 1 h).  PFGE was performed using a contour-clamped homogenous electric 
field apparatus, i.e. a CHEF DR-III system (Bio-Rad Laboratories, USA).  The running parameters 
used were as follows: SmaI: 200 V (6 V/cm); initial switch, 5 s; final switch, 40 s; temperature at 14 
ºC; run time, 21 h; ApaI: 200 V (6 V/cm); initial switch, 5 s; final switch, 15 s; temperature at 14 
ºC; run time, 20 h.  After electrophoresis, the gel was stained for 30 min in 500 ml reverse osmosis 
(RO) water containing 50 µl ethidium bromide (EtBr) (10 mg/ml) (Sigma, USA) and de-stained for 
30 min in 500 ml RO water only. 
 
2.3.7.4 PFGE gel analysis and UPGMA dendrogram construction: 
 
The gel was visualised in a Bio-Rad Gel Doc (Bio-Rad Laboratories, USA) system using the 
Quantity One v.4.6.2 (Basic) software package (Bio-Rad Laboratories, USA) and saved as a TIFF 
image for further analyses using the GelCompar II version 6.0 (BioNumerics, Belgium) software 
package.  The first, middle and last lane[145] of each gel was the reference size standard NCTC 
8325-4, which was used to normalise each gel.  Percent similarities were identified through the Dice 
coefficient and a UPGMA dendogram was created to visualise clusters.  The band position 
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tolerance was set at 1.5% and optimisation at 0.5%.  The pulsed-field clusters were identified at a 
similarity coefficient of 80%[68].  Pulsed-field clusters were assigned alphabetical names, THW-A to 
THW-EE. 
 
2.3.8 spa typing: 
 
spa typing involves sequencing of the hyper-variable region (HVR) of the X-region of the spa gene, 
analysis of the DNA sequence through bioinformatics and assigning a specific number to the 
sequence, thus elucidating the spa type[152, 156] after synchronisation of the local database with the 
spa server (www.ridom.de/spa-server/).  spa-type nomenclature according to Harmsen et al. was 
used[153].  Subsequently, spa types were clustered into spa-Clonal Complexes (spa-CC) by the 
algorithm BURP (Based Upon Repeat Pattern).  spa typing was performed on all isolates collected. 
 
2.3.8.1 DNA amplification and detection: 
 
Total genomic DNA was extracted as in section 2.3.6.  PCR reactions were set-up in the PCR 
laboratory of the Division of Medical Microbiology, NHLS Tygerberg Hospital.  All PCR reactions 
were performed on PCR thermal cyclers, either a Verity (Applied Biosystems, USA) or a GeneAmp 
PCR system 9700 (Applied Biosystems, USA).  A total volume of 25 µl was used containing the 
following components: 12.5 µl GoTaq PCR Master mix (Promega, USA) containing 1.5 mM 
MgCl2; 1 pmol of each primer; 1 µl crude DNA; and PCR grade water.  A negative control 
containing all reagents but no DNA was included in each run.  Primer set 1[149] (Table 2.2) was used 
to screen all isolates.  In instances where no amplification was observed with primer set 1, set 2 or 
3[156] (Table 2.2) was used. 
The following cycle conditions were used: initial denaturation at 95 °C for 6 min; 30 cycles of 
denaturation at 95 °C for 45 s, primer annealing at 62 °C for 45 s and extension at 72 °C for 60 s; 
and a final extension at 72 °C for 6 min.  The PCR reactions were kept at 4 °C until they were 
analysed. 
PCR products were analysed by agarose gel electrophoresis and separated on a 1% (wt/vl) agarose 
gel in 1× TAE (diluted from 50× TAE) at 100 V for 1 h.  5 µl ethidium bromide (10 mg/ml) 
(Sigma) was added per 100ml of agarose solution.  5 µl of each PCR reaction was subjected to 
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electrophoresis and a 100 bp molecular weight marker (Fermentas Life Sciences, USA) was 
included in the 1st lane of each gel.  Gel images were visualised with a Bio-Rad Gel Doc (Bio-Rad 
Laboratories) using the Quantity One v.4.6.2 software package, or with an Alliance 2.7 Imaging 
system (UVITEC, UK) using the Alliance v.14.15 software package (UVITEC, UK).  All gel 
images were saved as TIFF files. 
 
2.3.8.2 DNA nucleotide sequencing: 
 
The 20 µl of each PCR reaction remaining was used for DNA sequencing.  DNA nucleotide 
sequencing was outsourced to Inqaba Biotechnologies (South Africa), where the PCR fragments 
were purified and sequenced using the same forward and reverse primers using during the PCR 
reaction.  Chromatograph sequence files received from Inqaba Biotechnologies were visually 
inspected with the RIDOM StaphType software package before subjected to bioinformatics-based 
analyses for spa type elucidation. 
 
2.3.8.3 DNA nucleotide sequence analysis: 
 
The software package RIDOM StaphType v.2.1.1 (RIDOM GmbH, Germany)[153] was used for spa 
type elucidation and assignment of clonal complexes (CC).  After input of the sequence file (ABI 
format), the software searches for a 5’ and 3’ signature sequence indicating the beginning and end 
of the repeat units.  Thereafter, the repeat units were identified, the spa type assigned and the 
sequence saved in the local database.  Spa types were clustered into spa-CC using the built-in 
algorithm BURP (Based Upon Repeat Patter), which aligns the spa types and groups them into 
clusters.  Spa types were clustered at a cost of less or equal to 5 repeats and spa types shorter than 
four repeats were excluded from analyses, as these types were too short to deduce ancestry. 
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2.3.9 Multi-locus sequence typing (MLST): 
 
MLST involved the sequencing of internal fragments of seven housekeeping genes and assigning a 
unique number to each allele identified, thus allowing for the elucidation of a specific sequence type 
(ST) based on the allelic profile.  MLST was performed according to a previously published 
protocol[22].  Allelic profiles were obtained using the website http://saureus.mlst.net.  Subsequently, 
sequence types (ST) were clustered into clonal complexes (CC) using eBURST v.3., available at 
http://saureus.mlst.net/eburst.  MLST was performed on a randomly selected representative of each 
major (>10 PFGE types) and intermediate (4 – 9 PFGE types) PFGE CC.  MLST was not 
performed on PFGE clones classified as minor clones.  Two isolates were selected from THW-C as 
two subgroups, based on spa-typing) were identified within this PFGE clone. 
 
2.3.9.1 DNA amplification, detection and nucleotide sequencing: 
 
Total genomic DNA was extracted as in section 2.3.6.  PCR reaction were set-up and amplicons 
detected as in section 2.3.8.1.  Primer sets 4-10 (Table 2.2) were used at a Tm of 55°C.  DNA 
nucleotide sequencing was performed as described in section 3.8.2. 
 
2.3.9.2 DNA nucleotide sequence analysis: 
 
ST were clustered into a CC if they had 6/7 similar allelic profiles.  All ST identified were also 
compared to all ST available on the MLST server and again, ST were clustered into a CC if they 
had 6/7 similar allelic profiles. 
 
2.3.10 SCCmec typing: 
 
SCCmec typing was performed according to a previously published protocol[29] to allow for the 
rapid and easy identification of the SCCmec types I-VI element present in the genome of each 
MRSA strain collected.  SCCmec typing was performed on MRSA isolates only.  This multiplex 
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PCR-based protocol employs ten primer sets, of which each set is specific to the mec complex, ccr 
complex, J1 region or J3 region of one SCCmec type only. 
Total genomic DNA was extracted as in section 2.3.6.  PCR reactions were set-up and amplicons 
detected as in section 2.3.8.1.  However, 1 mM MgCl2 (Fermentas Life Sciences, USA) was added 
to the master mix.  Primer sets 11-20 (Table 2.2) were used at a Tm of 53°C.  PCR products were 
analysed by agarose gel electrophoresis and separated on a 3% (wt/vl) agarose gel in 1× TAE 
(diluted from 50× TAE) at 100 V for 3 h.  Apart from the negative control and clinical isolates, one 
positive control for each SCCmec type (I-VI) (Table 2.3) was included in each run. 
 
2.3.11 agr typing: 
 
The agr variant present in each S. aureus strain collected was identified using a previously 
published PCR protocol[160].  This protocol utilises a universal forward primer for all four agr types 
and four reverse primers, one specific for each agr type. 
Total genomic DNA was extracted as in section 2.3.6.  PCR reaction were set-up and amplicons 
detected as in section 2.3.8.1.  Primers 21-25 (Table 2.2) were used at a Tm of 56 °C and a 
concentration of 5 pmol/µl each primer.  PCR product were analysed by agarose gel electrophoresis 
and separated on a 2% (wt/vl) agarose gel in 1× TAE (diluted from 50× TAE) at 100 V for 2 h.  
Apart from the negative control and clinical isolates, one positive control for agr type I-IV (Table 
2.3) was included in each run. 
 
2.3.12 PCR detection of Panton-Valentine leukocidin (PVL): 
 
All isolates collected were screened through PCR for the toxin PVL according to a previously 
published protocol[65].  Primer set 26 was used and these primers allowed for the simultaneous 
detection of lukS-PV and lukF-PV[65]. 
Total genomic DNA was extracted as in section 2.3.6.  PCR reactions were set-up and amplicons 
detected as in section 2.3.8.1.  Primer set 26 (Table 2.2) was used at a Tm of 62 °C.  PCR product 
were analysed by agarose gel electrophoresis and separated on a 1% (wt/vl) agarose gel in 1× TAE 
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(diluted from 50× TAE) at 100 V for 1 h.  Apart from the negative control and clinical isolates, 
strain MW2 (Table 2.3) was included with each run as a positive control. 
 
2.3.13 PCR detection of selected virulence factors: 
 
S. aureus possess an array of virulence factors, involved in various different functions, including 
adherence, invasion, tissue destruction and evasion of the host immune system[82, 85, 86, 113, 163-167].  
The same representative isolate of each major and intermediate PFGE CC which was randomly 
selected for the MLST analyses (see section 2.3.9) was also used for the PCR detection of numerous 
virulence factors. 
Total genomic DNA was extracted as in section 2.3.6.  PCR reactions were set-up and amplicons 
detected as in section 3.8.1.  Primer sets 27 to 64 (Table 2.2) were used.  All virulence factors were 
screened through uniplex PCR, except for the ones mentioned in the next paragraph.  PCR products 
were analysed by agarose gel electrophoresis and separated on a 1% (wt/vl) agarose gel in 1× TAE 
(diluted from 50× TAE) at 100 V for 1 h.  Apart from the negative control and clinical isolates, a 
selected isolate was included with each run as a positive control (Table 2.4). 
 
The genes coa, nuc and sed were simultaneously detected through multiplex PCR.  0.5 pmol of 
primer was used for coa and 2 pmol of primer for nuc and sed.  sea and sec were also 
simultaneously detected though multiplex PCR.  1 pmol of primer was used for each gene.  seg, sej 
and sel were detected through multiplex PCR.  1 pmol of primer used for each gene.  hld and hlg 
was simultaneously detected through multiplex PCR.  0.5 pmol primer was used for hlg and 2 pmol 
primer for hld.  An additional 1.5 mM MgCl2 (Fermentas Life Sciences, USA) was added to all of 
the above mentioned multiplex PCR, bringing the final MgCl2 concentration to 3 mM.  The PCR 
products for all multiplex reactions were separated using a 3% (wt/vl) agarose gel at 100 V for 3 h 
in 1% TAE buffer. 
During set-up and optimisation of the PCR assays, a control isolate was selected as a positive 
control.  All PCR amplicons were first subjected to DNA nucleotide sequencing, as in section 
2.3.8.2, to verify the identity of the PCR amplicon, before the selected primer pairs were used to 
determine the presence of the specific virulence factor in the clinical isolates.  Please refer to Table 
2.4 for the PCR annealing temperatures used for each virulence factor. 
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2.3.14 Statistical analyses: 
2.3.14.1 Associations between clonality and clinical/bacterial characteristics: 
 
The Fisher’s exact test was used to investigate if any association existed between clonality and the 
following clinical/bacterial characteristics: 
(a) Methicillin-resistance (MRSA and/or MSSA); 
(b) Clones associated with HIV infection; 
(c) Derived paediatric and/or adult clones; 
(d) Clones associated with a specific sources of infections; 
(e) Clones associated with a specific gender; and 
(f) Clones associated with a specific PVL status, i.e. PVL+ and/or PVL- clones. 
 
A confidence interval of 95% was used and an association between clonality and a category was 
regarded as statistically significant if a p-value < 0.05 was obtained.  For all statistical 
investigations, the software package Stat v.12 was used and performed by Prof C. Lombard of the 
Biostatistics Unit of the Medical Research Council. 
 
2.3.14.2 Associations between virulence factors and methicillin-resistance or clonality: 
 
The Fisher’s exact test was also used to investigate if any associations existed between the virulence 
factors and methicillin-resistance (i.e. MSSA and/or MRSA), and also between the virulence factors 
and clonality.  A confidence interval of 95% was used and an association was regarded as 
statistically significant if a p-value < 0.05 was obtained. 
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2.3.14.3 Discriminatory power of typing techniques: 
 
A discriminatory index (DI) with confidence intervals (CI) was calculated for PFGE and spa typing 
as published previously[168]. 
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2.3.15 List of PCR primers used during the study: 
 
Table 2.2 PCR primers used during this study. 
 
# Primer Sequence (5’-3’) PCR (bp) Application Source 
1 
1095F AgACgATCCTTCggTgAgC 
200-500 spa typing [153] 
1517R gCTTTTgCAATgTCATTTACTg 
2 
239F ACTAggTgTAggTATTgCATCTgT 
± 1200 spa typing [156] 
1717R TCCAgCTAATAACgCTgCACCTAA 
3 
1084F ACAACgTAACggCTTCATCC 
± 550 spa typing [156] 
1618R TTAgCATCTgCATggTTTgC 
4 
arcC-F TTgATTCACCAgCgCgTATTgTC 
550 MLST [22] 
arcC-R AggTATCTgCTTCAATCAgCg 
5 
aroE-F ATCggAAATCCTATTTCACATTC 
500 MLST [22] 
aroE-R GgTgTTgTATTAATAACgATATC 
6 
glpF-F CTAggAACTgCAATCTTAATCC 
550 MLST [22] 
glpF-R TggTAAAATCgCATgTCCAATTC 
7 
gmk-F ATCgTTTTATCgggACCATC 
500 MLST [22] 
gmk-R TCATTAACTACAACgTAATCgTA 
8 
pta-F GTTAAAATCgTATTACCTgAAgg 
550 MLST [22] 
pta-R GACCCTTTTgTTgAAAAgCTTAA 
9 
tpi-F TCgTTCATTCTgAACgTCgTgAA 
500 MLST [22] 
tpi-R TTTgCACCTTCTAACAATTgTAC 
10 
yqi-F CAGCATACAggACACCTATTggC 
550 MLST [22] 
yqi-R CgTTgAggAATCgATACTggAAC 
11 
CIF2-F2 TTCgAgTTgCTgATgAAgAAgg 
495 
SCCmec I; 
J1 
[29] 
CIF2-R2 ATTTACCACAAggACTACCAgC 
12 
ccrC F2 gTACTCgTTACAATgTTTgg 
449 
SCCmec V; 
ccr 
[29] 
ccrC R2 ATAATggCTTCATgCTTACC 
13 
RIF5 F10 TTCTTAAgTACACgCTgAATCg 414 
SCCmec III; 
J3 
[29] 
RIF5 R13 ATggAgATgAATTACAAggg    
14 
SCCmec V 
J1-F 
TTCTCCATTCTTgTTCATCC 
377 
SCCmec V; 
J1 
[29] 
SCCmec 
V J1-R 
AgAgACTACTgACTTAAgTgg 
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Table 2.2 cont. PCR primers used during this study. 
15 
dcs F2 CATCCTATgATAgCTTggTC 
342 
SCCmec I, II, 
IV, VI; J3 
[29] 
dcs R1 CTAAATCATAgCCATgACCg 
16 
ccrB2 F2 AgTTTCTCAgAATTCgAACg 
311 
SCCmec II, IV; 
ccr 
[29] 
ccrB2 R2 CCgATATAgAAWgggTTAgC 
17 
kdp F1 AATCATCTgCCATTggTgATgC 
284 
SCCmec II; 
J1 
[29] 
kdp R1 CgAATgAAgTgAAAgAAAgTgg 
18 
SCCmec III 
J1-F 
CATTTgTgAAACACAgTACg 
243 
SCCmec III; 
J1 
[29] 
SCCmec III 
J1-R 
gTTATTgAgACTCCTAAAgC 
19 
mecI P2 ATCAAgACTTgCATTCAggC 
209 
SCCmec II, III; 
mec 
[29] 
mecI P3 gCggTTTCAATTCACTTgTC 
20 
mecA P4 TCCAgATTACAACTTCACCAgg 
162 
mecA 
control 
[29] 
mecA P7 CCACTTCATATCTTgTAACg 
21 agrF ATgCACATggTgCACATgC - agr I-IV [160] 
22 agrR1 gTCACAAgTACTATAAgCTgCgAT 439 agr I [160] 
23 agrR2 TATTACTAATTgAAAAgTgCCATAgC 572 agr II [160] 
24 agrR3 gTAATgTAATAgCTTgTATAATAATACCCAg 321 agr III [160] 
25 agrR4 CgATAATgCCgTCCTACCCg 657 agr IV [160] 
26 
luk-PV-1 ATCATTAggTAAAATgTCTggACATgATCCA 
433 PVL + [65] 
luk-PV-2 gCATCAASTgTATTggATAgCAAAAgC 
27 
fnbA-F ggCCAAAATAgCggTAACC 
228 fnbA [163] 
fnbA-R gTgAATATgTggCACACTg 
28 
fnbB-F ggAgCggCCTCAgTATTCTT 
201 fnbB [82] 
fnbB-R AgTTgATgTCgCgCTgTATg 
29 
clfA1 gTAggTACgTTAATCggTT 
210 clfA [164] 
clfA2 CTCATCAggTTgTTCAgg 
30 
clfB-F TggCggCAAATTTTACAgTgACAgA 
404 clfB [113] 
clfB-R AgAAATgTTCgCgCCATTTggTTT 
31 
eap-CON1 TACTAACgAAgCATCTgCC 
200 eap [165] 
eap-CON2 TTAAATCgATATCACTAATACCTC 
32 
cna F TTCACAAgCTTggTATCAAgAgCATgg 
452 cna [113] 
cna R gAgTgCCTTCCCAAACCTTTTgAgC 
33 
sdrC F CgCATggCAgTgAATACTgTTgCAgC 
731 sdrC [113] 
sdrC R gAAgTATCAggggTgAAACTATCCACAAATTg 
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Table 2.2 cont. PCR primers used during this study. 
34 
sdrD F CCACTggAAATAAAgTTgAAgTTTCAACTgCC 
467 sdrD [113] 
sdrD R CCTgATTTAACTTTgTCATCAACTgTAATTTgTg 
35 
sdrE F gCAgCAgCgCATgACggTAAAg 
894 sdrE [113] 
sdrE R gTCgCCACCgCCAgTgTCATTA 
36 
icaA F TCAgACACTTgCTggCgCAgTC 
936 icaA [113] 
icaA R TCACgATTCTCTCCCTCTCTgCCATT 
37 
cap5 F gTCAAAgATTATgTgATgCTACTgAg 
361 cap5 [85] 
cap5 R 
ACTTCgAATATAAACTTgAATCAAATgTTATA
CAg 
38 
cap8 F gCCTTATgTTAggTgATAAACC 
173 cap8 [85] 
cap8 R ggAAAAACACTATCATAgCAgg 
39 
sak F AAggCgATgACgCgAgTTAT 
210 sak [86] 
sak R gCgCTTggATCTAATTCAAC 
40 
NUC-F166 AgTTCAgCAAATgCATCACA 
400 nuc [166] 
NUC-R565 TAgCCAAgCCTTgACgAACT 
41 
COA-F2591 CCgCTTCAACTTCAgCCTAC 
204 coa [166] 
COA-R2794 TTAggTgCTACAggggCAAT 
42 
Chp-F TTTACTTTTgAACCgTTTCCTAC 
350 chp [86] 
Chp-R CgTCCTgAATTCTTAgTATgCATATTCATTAg 
43 
Scn-F AgCACAAgCTTgCCAACATCg 
180 scn [86] 
Scn-R TTAATATTTACTTTTTAgTgC 
44 
hla F CTgATTACTATCCAAgAAATTCgATTg 
209 hla [167] 
hla R CTTTCCAgCCTACTTTTTTATCAgT 
45 
hlb-F gTgCACTTACTgACAATAgTgC 
309 hlb [167] 
hlb-R gTTgATgAgTAgCTACCTTCAgT 
46 
hld F AAgAATTTTTATCTTAATTAAggAAggAgTg 
111 hld [167] 
hld R TTAgTgAATTTgTTCACTgTgTCgA 
47 
hlg F TTggCTggggAgTTgAAgCACA 
306 hlg [113] 
hlg R CgCCTgCCCAgTAgAAgCCATT 
48 
hlgvF gACATAgAgTCCATAATgCATTYgT 
390 hlg variant [167] 
hlgvR ATAgTCATTAggATTAggTTTCACAAAg 
49 
eta F CgCTgCggACATTCCTACATgg 
676 eta [113] 
eta R TACATgCCCgCCACTTgCTTgT 
50 
etb F gAAgCAgCCAAAAACCCATCgAA 
419 etb [113] 
etb R TgTTgTCCgCCTTTACCACTgTgAA 
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Table 2.2 cont. PCR primers used during this study. 
51 
tst F AgCCCTgCTTTTACAAAAggggAAAA 
306 tst [113] 
tst R CCAATAACCACCCgTTTTATCgCTTg 
52 
SEA-F1170 TAAggAggTggTgCCTATgg 
180 sea [166] 
SEA-R1349 CATCgAAACCAgCCAAAgTT 
53 
seb-F gACATgATgCCTgCACCAggAgA 
355 seb [113] 
seb-R AACAAATCgTTAAAAACggCgACACAg 
54 
SEC-F97 ACCAgACCCTATgCCAgATg 
371 sec [166] 
SEC-R467 TCCCATTATCAAAgTggTTTCC 
55 
SED-F578 TCAATTCAAAAgAAATggCTCA 
339 sed [166] 
SED-R916 TTTTTCCgCgCTgTATTTTT 
56 
see-F TgCCCTAACgTTgACAACAAgTCCA 
532 see [113] 
see-R TCCgTgTAAATAATgCCTTgCCTgAA 
57 
SEG-F322 CCACCTgTTgAAggAAgAgg 
432 seg [166] 
SEG-R753 TgCAgAACCATCAAACTCgT 
58 
SEH-F260 TCACATCATATgCgAAAgCAg 
463 seh [166] 
SEH-R722 TCggACAATATTTTTCTgATCTTT 
59 
SEI-F71 CTCAAggTgATATTggTgTAgg 
529 sei [166] 
SEI-R637 CAggCAgTCCATCTCCTgTA 
60 
SEJ-F349 ggTTTTCAATgTTCTggTggT 
306 sej [166] 
SEJ-R654 AACCAACggTTCTTTTgAgg 
61 
SEL-F158 CACCAgAATCACACCgCTTA 
240 sel [166] 
SEL-R397 CTgTTTgATgCTTgCCATTg 
62 
sem-F CTATTAATCTTTgggTTAATggAgAAC 
300 sem [167] 
sem-R TTCAgTTTCgACAgTTTTgTTgTCAT 
63 
sen-F ATgAgATTgTTCTACATAgCTgCAAT 
680 sen [167] 
sen-R AACTCTgCTCCCACTgAAC 
64 
seo-F AgTTTgTgTAAgAAgTCAAgTgTAgA 
180 seo [167] 
seo-R ATCTTTAAATTCAgCAgATATTCCATCTAAC 
65 
sep-F AATCATAACCAACCGAATCA 
520 sep [86] 
sep-R TCATAATGGAAGTGCTATAA 
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2.3.16 Control strains used during the study: 
 
Table 2.3 S. aureus isolates used as controls for various assays, excluding virulence PCRs. 
Strain Application Other designation Reference 
NCTC8325-4 PFGE size reference standard - [68, 142] 
ATCC BAA-38 SCCmec I E2125 [29] 
ATCC 1681 SCCmec II, agr II HFH-29994 
www.atcc.org; 
[160] 
ATCC BAA-39 SCCmec III HUSA304 [29] 
MW2 SCCmec IV; PVL + ATCC BAA-1707 [29, 65] 
ATCC 1688 SCCmec V HFH-30032 www.atcc.org 
ATCC BAA-42 SCCmec VI HDE288 [29] 
ATCC 1680 agr I HFH-29568 www.atcc.org 
ATCC 1683 agr III HFH-30364 www.atcc.org 
THW-101 agr IV - This study 
 
Table 2.4 Control isolates used for PCR investigation of virulence factors and PCR annealing 
temperatures. 
Gene Name Control isolate Tm (°C) Reference 
fnbA Fibronectin binding protein A COL 56 This study 
fnbB Fibronectin binding protein B COL 60 This study 
clfA Clumping factor A COL/ 
NCTC8325-4 
56 This study 
clfB Clumping factor B Newman 55 This study 
Eap Extracellular adherence protein Newman 56 This study 
cna Collagen binding protein ATCC25923 64 This study 
sdrC Serine-aspartate repeat protein C Newman 64 This study 
sdrD Serine-aspartate repeat protein D Newman 64 This study 
sdrE Serine-aspartate repeat protein E Newman 64 This study 
icaA Biofilm cluster NCTC8235-4 66 This study 
cap5 Capsular polysaccharide 5 NCTC8325-4 60 This study 
cap8 Capsular polysaccharide 8 MW2 58 This study 
sak Staphylokinase NCTC8325-4 58 This study 
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Table 2.4 cont. Control isolates used for PCR investigation of virulence factors and PCR 
annealing temperatures. 
coa Coagulase ATCC23235 56 This study 
nuc Nuclease ATCC23235 56 This study 
chp Chemotaxis inhibitory protein ATCC BAA38 54 This study 
scn Staphylococcal complement inhibitor ATCC 23235 45 This study 
hla α toxin NCTC8325-4 56 This study 
hlb β toxin 6850 56 This study 
hld δ toxin NCTC8325-4 56 This study 
hlg γ toxin NCTC8325-4 56 This study 
hlg-variant γ toxin (variant) LAC 59 This study 
eta Exfoliative toxin A ATCC 1861 68 This study 
etb Exfoliative toxin B ATCC 1861 60 This study 
tst Toxic shock syndrome toxin-1 ATCC 700699 60 This study 
sea Staphylococcal enterotoxin A ATCC 700699 56 This study 
seb Staphylococcal enterotoxin B ATCC BAA38 66 This study 
sec Staphylococcal enterotoxin C ATCC 700699 56 This study 
sed Staphylococcal enterotoxin D ATCC23235 56 This study 
see Staphylococcal enterotoxin E ATCC 700699 60 This study 
seg Staphylococcal enterotoxin G ATCC 19095/ 
ATCC 23235 
64 This study 
seh Staphylococcal enterotoxin H ATCC19095 58 This study 
sei Staphylococcal enterotoxin I ATCC 700699 66 This study 
sej Staphylococcal enterotoxin J ATCC 19095 64 This study 
sel Staphylococcal enterotoxin L ATCC 23235 64 This study 
sem Staphylococcal enterotoxin M ATCC 19095 52 This study 
sen Staphylococcal enterotoxin N ATCC19095 54 This study 
seo Staphylococcal enterotoxin O ATCC19095 54 This study 
sep Staphylococcal enterotoxin P THW-17 45 This study 
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2.3.17 Composition of media, buffers and solutions: 
 
Table 2.5 Composition of media used. 
Media Composition 
5% Blood agar plate 
15 g pancreatic digest of casein; 15 g papaic digest of soy meal; 5 g 
NaCl; 15 g agar; 
Bring to volume of 1 l 
Autoclave 
pH to 7.3 
Cool to 45-50 °C; add 5% (v/v) sterile defibrinated blood; mix 
BHI broth 
17.5 g brain heart extract; 10 g peptone; 2 g glucose; 5 g NaCl; 2.5 
g disodium hydrogen phosphate 
Bring to volume of 1 l 
Autoclave 
pH 7.4 
 
Table 2.6 Composition of buffers and solutions used. 
Buffer/Solution Composition 
TE buffer 10 mM Tris-HCl; 1 mM EDTA (pH 8) 
EC lysis buffer 
6 mM Tris-HCl; 1 M NaCl; 100 mM EDTA; 0.5% Brij-58; 0.2% 
Na-deoxycholate; 0.5% Na-lauroylsarcosine 
10× TBE 0.89 M Tris; 0.89 M Boric acid; 20 mM EDTA 
Proteinase K buffer 0.1 M Tris (pH 7.5) 
50× TAE 2 M Tris; 50 mM EDTA; 2 M glacial acetic acid (pH 7.6) 
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2.4 Results 
 
2.4.1 Sample collection: 
 
367 consecutive, non-duplicate S. aureus isolates were collected from the same number of patients 
over a period of one year, from 10th September 2009 till 6th September 2010. 
 
2.4.2 Methicillin-resistance: 
 
56 (15.3%) of the isolates collected displayed phenotypic resistance to methicillin by automated 
susceptibility testing using the Vitek II system or by the disc-diffusion method[161] and were 
recorded as MRSA isolates. 
 
2.4.3 Patient demographics: 
 
28.9% (n=106) of the isolates were also classified as paediatric cases (newborn to 12 years), while 
71.1% (n=261) of the isolates were classified as adult cases (13 years and older). 
59.4% (n=218) of the isolates were collected from males, 40.3% (n=148) were collected from 
females and 0.3% (n=1) from a post-mortem sample of a patient with unknown gender.  The mean 
age was 30 years and ranged from 3 days to 87 years. 
23.2% (n=85) of the isolates were collected from persons with a known HIV status, of which 24.7% 
(n=21) of these isolates were collected from HIV+ persons, representing 5.7% of the whole 
collection.  A break-down of HIV status according to methicillin-resistance is given in Figure 2.2. 
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Figure 2.2 The distribution of isolates collected according to patient HIV status and methicillin-
resistance. 
 
2.4.4 Clinical sources of collected isolates: 
 
95.9% (n=352) of the isolates were collected from known clinical sources.  According to the 
clinical information provided by the requesting clinician, the isolates could be categorised as 
originating from 14 infection sources: skin and soft tissue (n=201); bone and joint (n=56); 
respiratory tract (n=28); prosthetic devices (n=21); eye (n=10); urinary tract (n=8); ear, nose and 
throat (n=6); intravascular devices (n=6); post mortem (n=4); deep seated abscesses (n=4); 
abdominal (n=3); cardiac (n=2); obstetrics and gynaecology (n=2); and dental (n=1).  The 
remaining 4.1% (n=15) of the isolates were collected from unknown sources.  Two of the post-
mortem isolates were taken from lungs and one from the heart.  A break-down of the number of 
isolates collected per source is provided in Figure 2.3. 
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Figure 2.3 The distribution of isolates collected according to source. 
 
2.4.5 Macro-restriction analyses (MRA) with pulsed-field gel electrophoresis (PFGE): 
 
99.7% (n=366) of the collected 367 isolates were typeable by SmaI restriction analysis and resulted 
in the generation of 269 unique PFGE types, which could be grouped into 31 PFGE clones and 21 
singletons at a 80% similarity cut-off on the UPGMA dendogram.  The clones were further 
classified based on the number of isolates and unique PFGE types as major (> 10 isolates and PFGE 
types), intermediate (4-9 isolates and PFGE types) or minor (2-3 isolates and PFGE types). 
 
THW-C was identified as the dominant clone and was composed of 17.2% (n=63) predominantly 
MSSA isolates.  THW-A and THW-V had 12.6% (n=46) MSSA isolates each.  The dominant 
MRSA clone identified was THW-O and was composed of 23.2% (n=13) MRSA isolates (3.5% 
total isolates). 
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69.4 % (n=254) of the typeable isolates grouped into eight major clones, 16.9% (n=62) grouped into 
ten intermediate clones and 7.9% (n=29) grouped into 13 minor clones.  Please refer to Table 2.7 
for the number of isolates and PFGE types, as well as the methicillin susceptibilities of each clone 
identified and Figure 2.4 for a collapsed version of the UPGMA dendogram representing the whole 
population. 
 
Table 2.7 PFGE clones identified during this study by SmaI digestion.  The clones were 
classified as major, intermediate or minor based on the number of isolates and 
unique PFGE types. 
Name Status # isolates 
# PFGE 
types/patterns 
Methicillin- 
resistance 
THW-A 
Major 
46 28 MSSA 
THW-C 63 27 Mixed (92% MSSA) 
THW-E 16 12 MSSA 
THW-O 13 11 Mixed (92% MRSA) 
THW-S 16 14 MSSA 
THW-V 46 31 MSSA 
THW-Y 17 15 MSSA 
THW-EE 37 27 MSSA 
THW-B 
Intermediate 
6 5 MRSA 
THW-G 7 5 MSSA 
THW-J 6 6 Mixed (67% MSSA) 
THW-L 6 6 MRSA 
THW-N 8 8 MRSA 
THW-W 5 4 MSSA 
THW-X 5 5 MSSA 
THW-Z 6 5 MSSA 
THW-AA 9 8 MRSA 
THW-BB 4 4 Mixed (50% MSSA) 
THW-D 
Minor 
3 2 MSSA 
THW-F 3 3 MSSA 
THW-H 2 2 MSSA 
THW-I 3 2 Mixed (67% MSSA) 
THW-K 2 2 MSSA 
THW-M 2 2 MSSA 
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Table 2.7 cont. PFGE clones identified during this study by SmaI digestion.  The clones were 
classified as major, intermediate or minor based on the number of isolates 
and unique PFGE types. 
THW-P 
Minor 
2 2 MRSA 
THW-Q 2 2 MSSA 
THW-R 2 2 MSSA 
THW-T 2 2 MSSA 
THW-U 2 2 MSSA 
THW-CC 2 2 MSSA 
THW-DD 2 2 MSSA 
ST Singletons 21 21 Mixed (86% MSSA) 
# = number of 
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Figure 2.4 cont. Collapsed UPGMA dendogram of the 366 typeable S. aureus isolates. 
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Figure 2.4 cont. Collapsed UPGMA dendogram of the 366 typeable S. aureus isolates. 
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Figure 2.4 cont. Collapsed UPGMA dendogram of the 366 typeable S. aureus isolates. 
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Figure 2.4 cont. Collapsed UPGMA dendogram of the 366 typeable S. aureus isolates. 
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2.4.6 spa typing: 
 
The spa types of 99.7% (n=366) isolates were determined and one isolate was non-typeable (NT).  
127 unique spa types were identified.  Thirty five of these spa types were identified as novel types, 
of which one was identified as novel due to the identification of a novel repeat unit.  78 spa types 
(21.3%, n=78) represented single isolates in this study.  All isolates possessed a single spa type. 
The dominant spa type was t891 (13.9%, n=51), followed by t002 (5.2%, n=19), t318 (4.9%, n=18), 
t317 (4.4%, n=16) and t174 (4.1%, n=15). 
Using the BURP algorithm of the RIDOM StaphType software, the 127 spa types were clustered 
into 16 spa-CCs (Figure 2.5; Table 2.8).  spa types from 14 (3.8%) isolates were classified as 
singletons, while eight spa types from seven (1.9%) isolates were excluded from the analyses as 
they were too short.  Spa-CC891 was identified as the dominant spa-CC, comprising 17.5% (n=64) 
of the isolates.  Spa-CC021 contained 16.9% of the isolates (n=62), followed by spa-CC 064, which 
contained 15.8% of the isolates (n=58) (Table 2.8). 
 
2.4.7 SCCmec typing: 
 
All MRSA isolates (n=56) were screened to determine which variant of the SCCmec element was 
present in each isolate. 
SCCmec type IV was identified as the dominant variant in 53.6% of the isolates (n=30) and was 
subtyped as SCCmec type IV (n=28) and SCCmec type IV-E (n=2).  SCCmec type I was identified 
in 16.1% of the isolates (n=9), followed by SCCmec type II in 10.7% of the isolates (n=6) and 
SCCmec types III and V in 8.9% of the isolates each (n=5).  One isolate was non-typeable and 
yielded no amplification pattern, except for the mecA internal control. 
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Table 2.8 spa-CC identified during this study using the BURP algorithm of RIDOM 
StaphType®. 
spa-CC spa types # isolates 
Number spa 
types 
Methicillin- 
resistance 
spa-CC891 
020, 032, 891, 1972, 2251, 6572*, 
6613*, 6669*,6717*, 7025*, 7027*, 
7069*, 7181* 
64 13 Mixed 
spa-CC021 
012, 021, 030, 037, 122, 238,  275, 318, 
338, 433, 964, 1152, 1848, 3724, 4600, 
5542, 6539*, 7068*, 7183*, 7209* 
62 20 Mixed 
spa-CC064 
008. 064, 304, 701, 1257, 1443, 1476, 
1779, 2179, 2360, 6538*, 6541*, 6612*, 
7070* 
58 14 Mixed 
spa-CC002 
002, 045, 071, 311, 3794, 5300, 6100, 
6571*, 6614*, 7021*, 7026* 
34 11 Mixed 
spa-CC015 
015, 050, 073, 465, 487, 833, 1156, 
1510, 3554, 5381, 7022*, 7023*, 7036*, 
7182* 
33 14 MSSA 
spa-CC084 084, 085, 346, 853, 1877, 3366, 7071 20 7 MSSA 
spa-CCNF:16 314, 317 18 2 MSSA 
spa-CCNF:14 174, 6570 14 2 MSSA 
spa-CC267 267, 934, 1839 8 3 MSSA 
spa-CC1597 078, 1054, 1597, 7020*, 7098* 8 5 MSSA 
spa-CC888 160, 888, 6537 6 3 MSSA 
spa-CC148 148, 324, 3092 5 3 MSSA 
spa-CCNF:13 164, 881 5 2 MSSA 
spa-CC186 186, 729, 1591, 5351 4 4 Mixed 
spa-CC191/100 100, 191, 3463 3 3 MSSA 
spa-CCNF:15 1931, 7072 2 2 MSSA 
Singletons 
111, 159, 189, 355, 3265, 4545, 6542*, 
6569*, 7059* 
14 9 Mixed 
Excluded 
026, 779, 870, 1200, 5633, 7024*, 
7096* 
8 7 Mixed 
*= Novel spa type; Mixed = methicillin-susceptible and resistant 
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Figure 2.5 Graphical representations of identified spa-clonal complexes.  Blue circles indicate founder types 
and yellow circles indicate sub-founders. 
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2.4.8 agr typing: 
 
The agr type of all isolates were determined and all four agr types were identified, where agr type I 
was the dominant type, identified in 54.2% of the isolates (n=199).  agr type III was identified in 
21.8% of the isolates (n=80), followed by agr type II, identified in 18.5% of the isolates (n=68) and 
agr type IV, identified in 5.4% of the isolates (n=20). 
agr type I was the dominant in both MSSA and MRSA isolates, accounting for 51.4% and 69.6% of 
the isolates respectively, while agr type IV was only identified in MSSA isolates.  The agr 
distribution according to methicillin-resistance can be seen in Figure 2.6 below. 
 
 
Figure 2.6 agr distribution according to methicillin-resistance. 
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2.4.9 PCR detection of Panton-Valentine leukocidin (PVL): 
 
All isolates were screened for the presence of the lukS/F genes and 43.6% (n=160) of the isolates 
tested positive.  49.8% of the MSSA isolates (n=155) were PCR +, while only 9.9% (n=5) of the 
MRSA isolates tested positive (Figure 2.7). 
 
 
Figure 2.7 lukS/F PCR results according to methicillin-resistance. 
 
2.4.10 ApaI MRA and PFGE of clone THW-V: 
 
After all typing data acquired was combined, it was noticed that a good correlation was achieved by 
the results of the various typing techniques.  All isolates from all individual PFGE clones grouped 
into single spa-CCs and possessed the same agr variant respectively.  This was not the case for 
clone THW-V, where four spa-CCs were observed and three agr variants.  It was decided to repeat 
the PFGE analyses, using ApaI restriction enzyme (RE). 
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Restriction using the ApaI RE clearly showed the presence of three clusters using an 80% cut-off 
(Figure 2.8), which correlated with the agr typing and were given a numerical number combined 
with the previously assigned alphabetical name, thus giving THW-V1, THW-V2 and THW-V3 
(Table 2.9). 
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Figure 2.8 Clustering of isolates from clone THW-V by ApaI macro-restriction. 
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Table 2.9 ApaI PFGE clones identified from SmaI clone THW-V, with supporting data from 
spa, agr and SCCmec typing. 
PFGE # isolates Status spa-CC agr PVL 
THW-V1 21 Major 64 I 5% + 
THW-V2 19 Major NF:14 III 47% + 
THW-V3 6 Intermediate 888 II 17% + 
 
2.4.11 Multi-locus sequence typing (MLST): 
 
Based on the molecular data acquired by the previously discussed typing techniques, a 
representative isolate was randomly selected for each major and intermediate PFGE clone (SmaI 
and ApaI digestions).  Two isolates were selected for THW-C as this clone was mixed in resistance, 
one MSSA and one MRSA isolate.  19 MLST STs were identified from 21 isolates, which clustered 
into two MLST CC and 14 singletons using a similarity of 6/7 loci.  To group singletons into clonal 
complexes, eBURST analyses was performed again, using all previous MLST STs submitted to the 
database and MLST STs identified during this study.  This allowed us to group the MLST STs into 
four CCs (CC30, CC8, CC15 and CC5) and seven singletons (ST22, ST121, ST45, ST6, ST12, 
ST97 and ST88) (Table 2.10). 
 
2.4.12 Combined molecular data: 
 
A good correlation was noticed after combination of data obtained by the various typing techniques.  
All major (9 isolates selected) or intermediate PFGE clones (11 isolates selected) had a unique agr 
type, spa-CC and were predominantly or complete PVL+ or PVL-.  Only four clones had both 
methicillin susceptible and resistant isolates: THW-C, THW-J, THW-O and THW-BB.  All PFGE 
clones had a unique MLST ST, except for ST612 which was identified in THW-N and THW-O.  
Spa-CCs were divided into numerous clones by both PFGE and MLST, i.e. spa-CC064 was 
identified in THW A-ST1685-MSSA, THW B-ST36-II and THW L-ST239-II.  A unique SCCmec 
type was present in all MRSA isolates with-in the same clone, except for THW-L where one isolate 
was non-typeable, and THW-C, where both SCCmec types IV (PVL-) and V (PVL +) were 
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identified.  A correlation between MLST, spa and agr typing data was only achieved through ApaI 
MRA for PFGE clustering of clone THW-V. 
 
Table 2.10 MLST CC identified and their respective PFGE clone. 
MLST Methicillin-resistance 
(SCCmec type) 
PFGE 
CC ST Name n 
22 22 MSSA THW-C 63 
30 
1865 MSSA THW-A 46 
36 II THW-B 6 
8 
8 MSSA/V THW-J 6 
612 IV 
THW-N 
THW-O 
8 
13 
239 III/NT THW-L 6 
1862 MSSA THW-G 7 
15 
1 MSSA THW-V2 19 
15 MSSA THW-S 16 
188 MSSA THW-X 4 
45 45 MSSA THW-EE 37 
5 
5 I THW-AA 9 
1863 MSSA THW-Y 17 
1864 MSSA THW-Z 6 
6 6 MSSA THW-V1 21 
121 121 MSSA THW-E 16 
12 12 MSSA THW-V3 6 
97 97 MSSA THW-W 5 
88 88 MSSA/IV THW-BB 4 
      NT = non-typeable 
 
Regarding clones THW-C, THW-J and THW-O, it was noticed that a corresponding MSSA strain 
was present for a MRSA strain with the same spa type, which might suggest local SCCmec 
acquisition events.  Please refer to Table 2.11 below for a breakdown of the typing data according 
to PFGE classification. 
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Table 2.11 PFGE clones identified, with supporting data from other typing techniques. 
PFGE # isolates* Status 
MLST 
spa-CC SCCmec agr 
PVL ± 
(%) ST CC 
THW-A 46 Major 1865 30 21 MSSA III 83% + 
THW-B 6 Intermediate 36 30 21 II III - 
THW-C 63 Major 22 22 891 
59 MSSA 
I mec V 
4 mec IV 
I 
+ 
+ 
- 
THW-D 5 Minor ND ND NF:13 MSSA I - 
THW-E 16 Major 121 121 NF:16 MSSA IV 94% + 
THW-F 3 Minor ND ND NF:16 MSSA IV + 
THW-G 7 Intermediate 1862 8 1597 MSSA I 43% + 
THW-H 2 Minor ND ND 64 MSSA I 50% + 
THW-I 3 Minor ND ND 148 
2 MSSA 
1 mec V 
I 
- 
- 
THW-J 6 Intermediate 8 8 64 
4 MSSA 
2 mec V 
I 
25% + 
- 
THW-K 2 Minor ND ND 64 MSSA I 50% + 
THW-L 6 Intermediate 239 8 21 
5 III 
1 NT 
I - 
THW-M 2 Minor ND ND 64 MSSA I - 
THW-N 8 Intermediate 612 8 64 IV I - 
THW-O 13 Major 612 8 64 
1 MSSA 
12 mec IV 
I 
- 
8% + 
THW-P 2 Minor ND ND 64 IV I - 
THW-Q 2 Minor ND ND 267 MSSA III + 
THW-R 2 Minor ND ND 84 MSSA II - 
THW-S 16 Major 15 15 84 MSSA II 14% + 
THW-T 2 Minor ND ND 84 MSSA II - 
THW-U 2 Minor ND ND 191/100 MSSA II 50% + 
THW-V 
6 (V3) 
14 (V2) 
18 (V1) 
2 
Intermediate 
Major 
Major 
Minor 
12 
1 
6 
ND 
12 
15 
6 
ND 
888 
NF:14 
64 
NF:15 
MSSA 
II 
III 
I 
III 
17% + 
36% + 
6% + 
+ 
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Table 2.11 cont. PFGE clones identified, with supporting data from other typing techniques. 
THW-W 5 Intermediate 97 97 267 MSSA I - 
THW-X 4 Intermediate 188 15 189 MSSA I 25% + 
THW-Y 17 Major 1863 5 2 MSSA II 6% + 
THW-Z 6 Intermediate 1864 5 2 MSSA II 17% + 
THW-AA 9 Intermediate 5 5 2 I II - 
THW-BB 4 Intermediate 88 88 186 
2 MSSA 
2 mec IV 
III 
50 % + 
+ 
THW-CC 2 Minor ND ND 1597 MSSA I - 
THW-DD 2 Minor ND ND ST MSSA I + 
THW-EE 37 Major 45 45 15 MSSA I 16% + 
* = Isolates classified as “singletons” and “excluded spa types” using BURP analyses were excluded; ND = not 
determined 
 
PFGE displayed the highest discriminatory index, while PFGE clustering using 80% as a cut-off 
value displayed the highest DI for clustering of individual isolates into clonal complexes.  Please 
refer to Table 2.12- 
 
Table 2.12 The discriminatory power of the typing techniques used during this study. 
Technique # strains included # types/clonal complexes DI 95% CI 
PFGE 366 269 0.991 0.988-0.993 
PFGE/80% clustering 366 31 0.918 0.905-0.931 
spa typing 366 127 0.965 0.956-0.974 
spa/BURP 366 16 0.890 0.877-0.902 
 
 
2.4.13 Statistical analyses: 
 
All major and intermediate clones were selected to investigate if any associations existed between 
clonality and the following categories: (a) methicillin-resistance (MRSA and/or MSSA); (b) 
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Paediatric and/or adult derived clones; (c) clones associated with a specific source/site of infections; 
(d) clones associated with a specific gender; and (e) clones associated with a specific PVL status, 
i.e. PVL+ and/or PVL- clones.  All clones were selected to investigate if any association existed 
between clonality and HIV status. 
A significant association was found between clonality and methicillin-resistance (p=0.0001) for all 
major clones and nine intermediate clones, as well as PVL status (p=0.0001) for all major and 
intermediate clones.  No association was found between clonality and adult or paediatric infections 
(p=0.644) for all major clones, as well as for gender (p=0.092).  A significant association was found 
between clonality and adult infections (p=0.001) for three intermediate clones, THW-B, THW-G 
and THW-J.  An association between clonality and gender (p=0.04) was also identified for a single 
intermediate clone only, THW-W.  THW-A, THW-C and THW-E were the only major clones for 
which an association was identified between clonality and source of infection (p=0.001), in this 
case skin and soft tissue infections (SSTI). A statistical trend  was observed for the intermediate 
clones THW-B, THW-BB and THW-G, although this was not significant (p=0.07) (Table 2.13). 
Regarding HIV status, only the minor clones THW-K and THW-P were found to be associated with 
an HIV+ status (p=0.0001).  An association with HIV status was also found for clones THW-C and 
THW-O (p=0.0001), however, due to the large number of strains within these clonal complexes 
collected from patients with an unknown HIV status, we were unable to determine what the true 
correlation with HIV status is.  It should be noted that the highest incidence of a positive HIV status 
was found in these two clones respectively, and THW-C was the dominant MSSA clone while 
THW-O was the dominant MRSA clone (Table 2.13). 
 
2.4.14 Selection of representative isolates: 
 
The main aim of the population analysis described in this first part of the study, was to select 
representative isolates for further analysis.  Further analyses of the representative isolates focused 
on genotyping the presence of numerous virulence factors as well as investigating phenotypic host-
pathogen interaction characteristics, such as cellular invasiveness and cell death induction. 
As a representative of a specific clonal complex, we randomly selected an isolate from each major 
and intermediate PFGE clone identified using the “=rand()” function of MS Excel in “column 1” 
and copied the values obtained into “column 2”, and the values of “column 2” into column 3.  The 
members of each clonal complex were then arranged based on the values of “column 3” from 
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smallest to largest.  The isolate with the smallest number was selected.  The isolates (n=20) were 
selected to ensure that they were representative of at least two categories each where statistical 
significance was found, except for clone THW V2-ST1-MSSA and THW Z-ST1864-MSSA. 
A representative isolate was also selected from the two clones where an association was established 
with an HIV+ status, THW-K and THW-P [HIV + (ass.)].  As the highest incidence of an HIV+ 
status was found in the dominant MSSA clone, THW-C, as well as the dominant MRSA clone, 
THW-O, an isolate from all the patients with an HIV+ status of THW-C and THW-O was also 
selected [HIV+ (isol.)].  The MLST STs of these four isolates were also determined.  The final 
isolate selected as a representative was the only MRSA isolate which possessed a non-typeable 
SCCmec element, THW L-ST239-Unknown.  Please refer to Table 2.14 for a complete breakdown 
of the isolates selected for further analyses. 
 
2.4.15 Virulence factor PCRs: 
 
All 25 representative isolates tested positive for fnbA/B, clfA/B, eap, coa, nuc and hld, while hla, 
hlg-variant, sak and sea were identified in 20 or more isolates.  The genes tst, hlb, sec, seh, sej, sep 
and eta were scarce, testing positive in only four or less isolates and sed, sel and etb were 
completely absent.  The following genes were identified in a selected number of isolates: cna (n = 
13), sdrD (n = 15), sdrE (n = 16), icaA (n = 16), cap5 (n = 14), hlg (n = 20), scn (n = 17), sdrC (n = 
11), cap8 (n = 11), chp (n = 11), seb (n = 6), see (n = 11), seg (n = 9), sei (n = 12), sem (n = 10), sen 
(n = 11) and seo (n = 10). 
Genotypically, we found the presence of numerous invasins (fnbA/B, eap) in all the isolates 
selected and tested.  Virulence factors primarily involved in adhesion were also identified in all the 
selected isolates (clfA/B), while some adhesion factors were present in fairly high numbers (cna, 
sdr) together with icaA locus, associated with biofilm growth and persistence. Genes encoding 
proteins associated with cell death induction were very common (hla, hlg, hlg-variant), as were 
those associated with host immune evasion (cap5/8, scn, chp), while toxin genes were generally 
scarce. 
Fifteen isolates tested positive for at least two sdr genes (associated with adherence), while either 
cap5 or cap8 was present in each isolate, but never both.  At least 20 isolates tested positive for 
either scn, chp, sak, sea or sep (or a combination of these), genes commonly associated with an 
innate immune evasion cluster (IEC) carried on β-hemolysin-converting bacteriophages[86].  This 
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correlates well with the low prevalence of and expression of hlb, as it is known that these phages 
integrate into this gene[86].  sem, sen and seo were also identified as a cluster in nine isolates. 
Please refer to Appendix A (Table A1) for a complete breakdown of the virulence factors identified 
in every isolate, and to Table 2.15 for the prevalence of each virulence factor. 
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Table 2.13 Statistical associations between clonality and the clinical/bacterial characteristics using the Fisher’s exact test. 
PFGE 
MLST 
(ST:CC) 
Status 
Category (p-value) 
Methicillin- 
resistance 
Paediatric and/or adult 
Source of 
infection 
Gender PVL HIV 
THW-A 1865:30 Major 0.0001 (S) 0.644 0.0001 0.092 0.0001 ND 
THW-B 36:30 Intermediate 0.0001 (R) 0.001 (adult) 0.007 0.114 0.0001 ND 
THW-C 22:22 Major 0.0001 (S) 0.644 0.0001 0.092 0.0001 0.0001 (HIV status) 
THW-E 121:121 Major 0.0001 (S) 0.644 0.0001 0.092 0.0001 ND 
THW-G 1862:8 Intermediate 0.0001 (S) 0.001 (adult) 0.007 0.114 0.095 ND 
THW-J 8:8 Intermediate 0.005 0.001 (adult) 0.07 0.114 0.0001 ND 
THW-K 8:8 Minor ND ND ND ND ND 0.0001 (HIV+ status) 
THW-L 239:8 Intermediate 0.0001 (R) 0.917 0.07 0.114 0.0001 ND 
THW-N 612:8 Intermediate 0.0001 (R) 0.917 0.07 0.114 0.0001 ND 
THW-O 612:8 Major 0.0001 (R) 0.644 0.07 0.092 0.0001 0.0001 (HIV status) 
THW-P 612:8 Minor ND ND ND ND ND 0.0001 (HIV+ status) 
THW-S 15:15 Major 0.0001 (S) 0.644 0.07 0.092 0.0001 ND 
THW-V Various Major 0.0001 (S) 0.644 0.07 0.092 0.0001 ND 
THW-W 97:97 Intermediate 0.0001 (S) 0.917 0.07 0.04 (M) 0.0001 ND 
THW-X 188:15 Intermediate 0.0001 (S) 0.917 0.07 0.114 0.0001 ND 
THW-Y 1863:5 Major 0.0001 (S) 0.644 0.07 0.092 0.0001 ND 
THW-Z 1864:5 Intermediate 0.0001 (S) 0.917 0.07 0.114 0.0001 ND 
THW-AA 5:5 Intermediate 0.0001 (R) 0.917 0.07 0.114 0.0001 ND 
THW-BB 88:88 Intermediate 0.005 0.917 0.007 0.114 0.0001 ND 
THW-EE 45:45 Major 0.0001 (S) 0.644 0.07 0.092 0.0001 ND 
F = female; M = male; ns = not significant; ND = not determined; ST = sequence type; CC = clonal complex; PVL = Panton-Valentine leukocidin; R = resistant; S = sensitive 
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Table 2.14 Strains selected as representative isolates for further analyses. 
Isolate 
name 
PFGE Clinical data Status 
MLST 
ST 
MLST 
CC 
spa-CC SCCmec agr PVL Statistical association 
THW38 THW-A Lip abscess Major 1865 30 21 NA III + MSSA/PVL+/SSTI 
THW382 THW-B 
Laparotomy 
(day 15 post-operation) 
Inter 36 30 21 II III - MRSA/PVL-/Adults/SSTI 
THW146 THW-C Abscess left knee Major 22 22 891 NA I + MSSA/PVL+/SSTI 
THW393 THW-C 
Septic left tibia with 
external fixation 
Major 22 22 891 NA I + HIV+ (isol.) 
THW366 THW-E Chronic folliculitis Major 121 121 NF:16 NA IV + MSSA/PVL+/SSTI 
THW262 THW-O 
Pyrexia, specimen from 
intracostal drainage site 
Major 612 8 64 IV I - MRSA/PVL- 
THW65 THW-G Septic ORIF Inter 1862 8 1597 NA I - MSSA/Adults 
THW271 THW-J Sinus fungal infection Inter 8 8 64 V I - PVL-/Adults 
THW81 THW-L Sepsis, pin tract Inter 239 8 21 III I - MRSA/PVL- 
THW70 THW-N 
Sepsis, nosocomial 
MRSA 
Inter 612 8 64 IV I - MRSA/PVL- 
THW195 THW-K Impetigo Minor 8 8 64 NA I - HIV+ (ass.) 
THW273 THW-P 
Pus from hand 
Minor 612 8 64 IV I - HIV+ (ass.) 
THW93 THW-O Sepsis Major 612 8 64 IV I - HIV+ (isol.) 
THW99 THW-L Septic wound Inter 239 8 21 UK I - Non-typeable SCCmec 
THW122 THW-S Sepsis Major 15 15 84 NA II - MSSA/PVL- 
THW412 THW-V2 No clinical data supplied Major 1 15 NF:14 NA III - MSSA 
THW224 THX-X Wound sepsis Inter 188 15 EX NA I - MSSA/PVL- 
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Table 2.14 cont. Strains selected as representative isolates for further analyses. 
Isolate 
name 
PFGE Clinical data Status 
MLST 
ST 
MLST 
CC 
spa-CC SCCmec agr PVL Statistical association 
THW17 THW-Y Wound sepsis Major 1863 5 2 NA II - MSSA/PVL- 
THW235 THW-Z Measles Inter 1864 5 2 NA II + MSSA 
THW264 THW-AA Conjunctivitis Inter 5 5 2 I II - MRSA/PVL- 
THW64 THW-V1 
Suspect TB, pericardial 
fluid 
Major 6 6 64 NA I - MSSA/PVL- 
THW356 THW-EE Hip abscess Major 45 45 EX NA I - MSSA/PVL- 
THW368 THW-V3 Wound infection Inter 12 12 888 NA II + MSSA/PVL+ 
THW241 THW-W ESRF Inter 97 97 267 NA I - MSSA/PVL-/Males 
THW255 THW-BB 
Infected leg 
Inter 88 88 186 IV III + PVL+/SSTI 
ass. = associated; isol. = isolated; ESRF = end-stage renal failure; ORIF = open reduction and internal fixation; Inter = intermediate; NA = not applicable; Ex = excluded; SSTI = 
skin and soft tissue 
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The genes sdrC and sei were the only virulence factors associated with both methicillin-resistance 
and clonality, where both sdrC and sei were associated with MRSA isolates of CC5 and CC8.  The 
gene see was associated with methicillin-resistance and identified only in MRSA isolates.  The 
genes cap5 and cap8 were associated with different clonal complexes, where cap5 was associated 
with CC5, CC8 and CC22 isolates, while cap8 was associated with CC15 and CC30 isolates.  The 
genes seg, sem and seo were also associated with the same CCs, namely CC5, CC22 and CC30.  
The gene sdrE displayed a broad association, and included isolates from CC5, CC8, CC15 and 
CC22, while hlgv was associated with CC5, CC8 and CC15 isolates.  Please refer to Table 2.16 for 
the associations of individual virulence factors with methicillin-resistance and/or clonality. 
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Table 2.15 Prevalence of virulence factors as detected through PCR. 
Gene Name Prevalence (%) Gene Name Prevalence (%) 
fnbA Fibronectin binding protein A 100 hlg γ-toxin 76 
fnbB Fibronectin binding protein B 100 hlg-variant γ-toxin (variant) 80 
clfA Clumping factor A 100 eta Exfoliative toxin A 4 
clfB Clumping factor B 100 etb Exfoliative toxin B 0 
eap Extracellular adherence protein 100 tst Toxic shock syndrome toxin-1 12 
cna Collagen adhesin 52 sea Staphylococcal enterotoxin A^ 80 
sdrC Serine-aspartate repeat protein C 44 seb Staphylococcal enterotoxin B 24 
sdrD Serine-aspartate repeat protein D 60 sec Staphylococcal enterotoxin C 4 
sdrE Serine-aspartate repeat protein E 64 sed Staphylococcal enterotoxin D 0 
icaA Biofilm cluster 64 see Staphylococcal enterotoxin E 44 
cap5 Capsular polysaccharide 5* 52 seg Staphylococcal enterotoxin G 36 
cap8 Capsular polysaccharide 8* 48 seh Staphylococcal enterotoxin H 0 
sak Staphylokinase^ 84 sei Staphylococcal enterotoxin I 48 
coa Coagulase 100 sej Staphylococcal enterotoxin J 8 
nuc Nuclease 100 sel Staphylococcal enterotoxin L 0 
chp Chemotaxis inhibitory protein^ 44 sem Staphylococcal enterotoxin M 40 
scn Staphylococcal complement inhibitor^ 68 sen Staphylococcal enterotoxin N 44 
hla α-toxin 96 seo Staphylococcal enterotoxin O 40 
hlb ß-toxin^ 16 sep Staphylococcal enterotoxin P^ 4 
hld δ-toxin 100    
*/^= mutually exclusive
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Table 2.16 Associations of virulence factors with methicillin-resistance and clonality.  
Significant values at a confidence interval of 95% are indicated in bold. 
Virulence factor 
Association with MSSA/MRSA Association with clonality 
MSSA/MRSA p-value Clonality p-value 
fnbA MSSA/MRSA - All clones - 
fnbB MSSA/MRSA - All clones - 
clfA MSSA/MRSA - All clones - 
clfB MSSA/MRSA - All clones - 
cna MSSA 0.428 CC15/CC22/CC30 0.113 
sdrC MRSA 0.049 CC5/CC8 0.030 
sdrD MSSA/MRSA 0.659 CC5/CC22 0.897 
sdrE MSSA 0.397 CC5/CC8/CC15/CC22 0.043 
icaA MSSA 1.000 CC5/CC15/CC22 0.590 
eap MSSA/MRSA - All clones - 
cap5 MRSA 1.000 CC5/CC8/CC22 0.005 
cap8 MSSA 0.688 CC15/CC30 0.004 
hlg MSSA/MRSA 0.615 CC5/CC8/CC15/CC22/CC30 0.400 
hlg-variant MSSA/MRSA 0.615 CC5/CC8/CC15 0.002 
scn MRSA 1.000 CC5/CC22/CC30 0.799 
chp MSSA 0.414 CC5/CC22/CC30 0.130 
hla MSSA/MRSA 0.400 CC5/CC8/CC15/CC22/CC30 0.640 
sak MSSA/MRSA 1.000 CC5/CC8/CC22/CC30 0.616 
coa MSSA/MRSA - All clones - 
nuc MSSA/MRSA - All clones - 
tst MRSA 0.543 CC30 0.834 
sea MSSA/MRSA 0.615 CC8/CC22/CC30 0.374 
seb MSSA/MRSA 0.653 None 0.731 
sec MSSA 1.000 None 0.240 
sed Not detected NA Not detected NA 
see MRSA 0.049 CC8/CC30 0.113 
seg MSSA 0.229 CC5/CC22/CC30 0.003 
seh MSSA 1.000 None 0.640 
sei MRSA 0.015 CC5/CC8 0.004 
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Table 2.16 cont. Associations of virulence factors with methicillin-resistance and clonality.  
Significant values at a confidence interval of 95% are indicated in bold. 
sej MSSA 0.500 None 0.580 
sel Not detected NA Not detected NA 
sem MSSA 0.211 CC5/CC22/CC30 0.002 
sen MSSA 0.414 CC5/CC22/CC30 0.052 
seo MSSA 0.211 CC5/CC22/CC30 0.002 
sep MSSA 1.000 None 0.640 
eta MSSA 1.000 None 0.640 
etb Not detected NA Not detected NA 
hlb MSSA/MRSA 0.626 CC22 0.497 
hld MSSA/MRSA - All clones - 
NA = not applicable 
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2.5 Discussion 
 
2.5.1 High prevalence of PVL: 
 
A prominent finding of this study is the very high prevalence of PVL identified (43.6%), especially 
among MSSA isolates.  This would suggest that the study isolates acquired virulence factor 
encoding phages before SCCmec elements encoding methicillin resistance.  The high PVL 
prevalence in this study is not in concordance with international findings, suggesting that the 
prevalence of PVL is generally 3-5%[2].  A high PVL prevalence rate has previously only been 
reported in Thailand/Cambodia[96], where PVL was associated with a better clinical outcome, as 
well as in some other African countries[169-172].  The PVL prevalence rate among MRSA isolates in 
this study was 9% vs. 43% in MSSA isolates.  This would suggest that there is a significant 
difference in the PVL prevalence rates of developed vs. developing countries.  More studies are 
required to investigate this further.  This data also suggests that a large proportion of this S. aureus 
population consists of PVL+ MSSA isolates from STs that have been associated with MRSA 
isolates, such as ST22 and ST121[13, 173].  These isolates can thus become a source of new MRSA 
clones upon the acquisition of a SCCmec element.  These STs should be monitored.  It is also worth 
noting that all PFGE complexes associated with SSTI infections are all also associated with PVL+ 
isolates, which indicate either a strong linkage with crucial virulence factors of SSTI infections or a 
pathogenetic role of PVL during SSTI pathogenesis as suggested by Lina et al.[65]. 
 
2.5.2 Diversity of MSSA and MRSA clones identified: 
 
In this study, numerous epidemic MRSA clones have been identified, which have all been described 
in previous international studies[68, 174-176].  The MRSA clones identified in this study include ST22-
MRSA-IV (EMRSA-15), ST5-MRSA-I (EMRSA-3), ST239-MRSA-III (Brazilian/Hungarian 
clone) and ST36-MRSA-II (EMRSA-16), which have all been reported in previous studies from 
South Africa[119, 120, 123], Africa[170] and worldwide[13].  ST612-MRSA-IV was also identified and 
was the dominant MRSA clone.  This clone has previously only been described in Australia and 
South Africa[117, 119, 120].  Evidence also emerged which supports the local emergence of this clone 
(both MRSA and MSSA isolates with the same spa types), which has now seemingly adapted to a 
hospital-based environment in this setting.  However, earlier studies conducted focussed on MRSA 
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only, resulting in a lack of data surrounding MSSA infections.  The reason behind the scarcity of 
CA-MRSA isolates remains unknown. 
Numerous endemic MSSA clones have also been described, such as ST15, ST22, ST45, ST121 and 
ST188[13].  In this study, ST22 was the dominant ST and PFGE clone, THW-C.  The isolates of this 
clone were all predominantly MSSA isolates.  ST1862, ST1863, ST1864 and ST1865 were 
identified as novel STs.  These MSSA backgrounds seem to be endemic to this hospital setting and 
population of S. aureus.  These novel STs clustered within known CCs, all of which have a known 
MRSA ST.  It is therefore likely that they can serve as lineages for the integration of SCCmec 
elements.  ST22 and ST45 are commonly associated with some epidemic MRSA clones[13].  These 
STs are therefore likely candidates for SCCmec acquisition.  Several MSSA clones identified here 
have previously been described from other studies conducted on African isolates[169, 171]. 
There is an obvious lack of a common genetic background between MSSA and MRSA isolates in 
this population and we have a very heterogenous population, especially among the MSSA isolates.   
This either suggests that only some MSSA lineages come into contact with SCCmec elements or 
other bacterial species that can act as possible donors, or only some MSSA lineages can 
successfully sustain the integration of SCCmec elements in the genome. 
 
2.5.3 PFGE as the main typing technique: 
 
Pulsed-field gel electrophoresis was an excellent technique to use to establish clonal relatedness and 
dominance in the investigated setting and showed the highest DI (displayed in Table 2.12) and 
supplementing the PFGE data with data generated through spa, agr and SCCmec typing enhanced 
our ability to elucidate the population structure of S. aureus.  Isolates of the ST239-MRSA-III-t037 
(CC8) background and of the CC30 background were clustered in a single CC by BURP, spa-
CC021.  This is due to the chromosomal integration of a large chromosomal fragment from ST30 in 
ST8, leading to the evolution of ST239[63]. 
PFGE, supplemented with spa typing and MLST has previously been used to successfully 
investigate the population structure of S. aureus[140, 168, 177].  Our data suggest that using both 
techniques in combination yields a better resolution that a single one.  Sequence-based typing based 
on regions of the clfB and fnb genes have also been described and may be worth investigating[178] as 
supplementary techniques to PFGE. 
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2.5.4 Population structure of S. aureus at Tygerberg hospital: 
 
Using molecular information combined with an analysis of clinical category of isolates with strain 
types and strengthening it through statistical associations with clinical categories, we were able to 
effectively describe the population structure of S. aureus at Tygerberg hospital over a one year 
period. 
Our investigation of the population structure revealed the presence of numerous clones.  Some 
clones were exclusively MSSA, while others were exclusively MRSA and some were mixed.  The 
clones will be discussed in more detail from an MLST perspective, as this makes comparisons with 
other studies easier.  MSSA clones will be named according to MLST-methicillin-resistance-PFGE, 
and MRSA clones according to MLST-methicillin resistance-SCCmec type-PFGE.  Mixed clones 
will initially be referred to by MLST-PFGE only. 
 
The dominant clone identified in this population was ST22-THW C (major) and could be sub-
divided based on spa typing, as a sub-founder t022 was also identified within spa-CC891 using the 
BURP algorithm.  ST22-MSSA-THW C contained 59 PVL+ isolates (92%) and was predominantly 
spa t891.  One PVL+ MRSA isolate, ST22-MRSA-V (spa t891) was also identified and has 
previously been reported in Australia[23].  The presence of this MRSA isolate indicates that a 
SCCmec acquisition event has occurred not too long ago.  This MRSA clone could be the first of a 
CA-MRSA lineage that may potentially be associated with SSTI as  ST22-MSSA-THW C was 
found to be statistically associated with SSTI infections caused by PVL+ MSSA isolates.  ST22-
MRSA-V isolates have been identified in India[179] and other ST22-MRSA isolates, such as the 
Barnim clone, in Germany[180].  Four other isolates were also identified to possess spa types closely 
related to spa t022.  These isolates were all PVL- MRSA isolates and contained SCCmec type IV.  
ST22-MRSA-IV is usually associated with the epidemic MRSA clone EMRSA-15, which was a 
dominant clone in the UK for decades[13, 23, 181], Spain[181, 182] since 2004, in non-hospitalised 
patients in Australia since 2002[183] and in Irish hospitals since 2002[184].  It is still one of the 
dominant clones in India[179], Spain[181] and the Atlantic Azores Islands[185] today.  It is worth noting 
that ST22 is a known epidemic MRSA lineage, usually associated with SCCmec IV, ST22-MRSA-
IV/EMRSA-15[186].  Yet here in this population it is established as the dominant MSSA clone, with 
one MRSA isolate with a SCCmec V element.  Only four SCCmec IV containing isolates were 
identified.  The data might thus suggest that this lineage may likely give rise to a CA-MRSA clone 
(possibly ST22-MRSA-IV or ST22-MRSA-V), which can become epidemic. 
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The second dominant clonal complex was CC30.  It consisted out of ST1865-MSSA-THW A 
(major) and ST36-MRSA-II-THW B (intermediate).  Both clones were classified as spa-CC021.  
Strains from ST1865-MSSA-THW A were predominantly PVL+.  This clone was statistically also 
associated with SSTI infections caused by PVL+ MSSA isolates (see Table 2.13 and Table 2.14).  
ST1865 was identified as a novel MLST ST during this study.  ST36-MRSA-II-THW B was 
associated with infections in adults caused by PVL- MRSA isolates.  ST36-MRSA-II is normally 
associated with the epidemic clone EMRSA-16[23, 186] or USA200[68] and is found in Irish 
hospitals[184, 187], the Canary Islands[188], Canada[189] and Spain[182].  ST1865 can act as a possible 
recipient for SCCmec elements. 
CC8 is the 3rd dominant clonal complex and ST8, ST612, ST239 and ST1862 were all identified as 
part of this clonal complex.  Two MRSA STs were identified.  ST612, a double locus variant (dlv) 
of ST8, was the only MLST ST subdivided by PFGE into two clones, THW-O (major) and THW-N 
(intermediate).  ST612-MRSA-IV-THW O was the dominant MRSA clonal complex identified in 
this population and was associated with PVL- MRSA isolates.  This was also the case for THW-N.  
One MSSA isolate was present in THW-O and had the same spa type as a MRSA isolate, t1443.  
This can possibly represent the local acquisition of SCCmec by MSSA isolates, leading to the rise 
of a local MRSA clone.  As only one MSSA isolate was identified, it can be seen that the MSSA 
members have largely been replaced by their MRSA counterparts.  ST612-MRSA-IV has 
previously been described as the dominant MRSA clone in Cape Town[120], South Africa[119] and 
Australia[117] and seems to have adapted to a hospital environment.  ST612 is a double-locus variant 
(dlv) of ST8.  ST239-MRSA-III-THW L was also identified and associated with CC8 and is 
probably the oldest pandemic MRSA clone[23].  This clone has been epidemic on virtually every 
continent, and is prevalent in South America[174, 190], Europe[13], India[179], Finland[191], China[192-194], 
Australia[183], Malaysia[195], Turkey[196], India[197] and various Asian countries[198], including 
Taiwan[199].  ST1862-MSSA-THW G (intermediate) was associated with MSSA SSTI infections in 
adults.  ST1862 was identified as a novel MLST ST.  The final member of this CC was ST8-
MSSA-THW J (intermediate).  ST8-MRSA can be associated with both HA-MRSA (USA500) and 
CA-MRSA (USA300) isolates[13].  In this study, this clone was associated with infections in adults 
caused by PVL- isolates.  All members of this clone carried spa t1476 and two MRSA isolates were 
also present, carrying SCCmec type V.  This data, again, supports the local acquisition of SCCmec 
elements and these ST8-MRSA-V isolates might be the first of a new CA-MRSA clone.  CC8-
MRSA-V CA-MRSA isolates have previously been reported in Australia[183] and Germany[23].  
Other CA-MRSA ST8-MRSA isolates have been reported in the UK[200], Germany[201] and 
Belgium[202]. 
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Three members of CC15 were identified: ST1-MSSA-THW V2 (major), associated with infections 
caused by MSSA isolates; ST15-MSSA-THW S (major), associated with infections caused by PVL- 
MSSA isolates; and ST188-MSSA-THW X (intermediate), also associated with infections caused 
by PVL- MSSA isolates.  ST15 is known worldwide to be associated with MSSA isolates and that 
MRSA isolates from this genetic background are scarce[13], although “early” MRSA isolates have 
been identified from this ST[203].  ST1-MRSA-IV is associated with the USA400 clone[13, 68], a CA-
MRSA clone prevalent in the USA[68], Korea[204], Australia[183], USA[181], UK[205] and China[206]. 
ST45-MSSA-THW EE (major) was identified in a PFGE complex of 37 isolates, was characterised 
as a singleton by MLST, and was associated with PVL- MSSA isolates.  This ST is commonly 
associated with an epidemic MRSA clone, the Berlin clone[23], which has been identified in the UK 
and the Netherlands[13, 23], and is also referred to as the USA600 (ST45-MRSA-IV) clone[68].  This 
ST has been identified in German MSSA and MRSA isolates[180, 207], as well as in isolates from 
patients in nursing homes in Belgium[202].  ST45-MRSA-I has also been identified from marine 
water and intertidal beach sand from public beaches[208] in western Washington state in the USA.  
This ST can be a very likely recipient of a SCCmec element. 
CC5 was composed out of three STs: ST5-MRSA-I-THW AA (intermediate), associated with 
infections caused by PVL- MRSA isolates; ST1863-MSSA-THW Y (major) and ST1864-MSSA-
THW Z (intermediate), both associated with infections caused by PVL- MSSA isolates.  ST1863 
and ST1864 were identified as novel MLST STs during this study and are both single-locus variants 
(slvs) of ST5.  ST5-MRSA-I has previously been associated with the EMRSA-3 clone[13] and has 
been identified in strains from Australia[23], Germany[23] and Argentina[209].  ST5-MRSA-IV is 
associated with the paediatric clone[13].  ST5 isolates, or variants thereof, have been associated with 
reduced susceptibilities to vancomycin[210], especially isolates carrying the SCCmec type II 
elements.  Two MSSA lineages exist which are closely related to ST5 and are endemic to this 
setting.  It is possible that this ST5 emerged locally after it underwent evolutionary changes after 
acquisition of a SCCmec I element.  ST5 has also recently been described as the dominant ST in 
Gabon, Central Africa[211]. 
ST121-MSSA-THW E (major) was associated with SSTI caused by PVL+ MSSA isolates.  This ST 
is commonly only associated with a MSSA background, and has previously been reported[23, 212].  
This ST is a common, global cause of SSTI[213].  Although MRSA isolates have been described 
from this ST, they are usually rare[23]. This ST has also been associated with S. aureus infection in 
cattle[214]. 
ST6 (major) was associated with PVL- MSSA isolates.  This ST is an endemic MSSA lineage. 
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ST12 (intermediate) was associated with PVL+ MSSA isolates.  MRSA isolates of this ST have 
been identified in Ireland, Norway and Australia, and most of them seem to be PVL-[23].  This ST is 
usually only associated with MSSA strains[13].  ST12-MRSA-IV isolates have been identified in 
Ireland[184]. 
ST97 (intermediate) was associated with infections in males caused by PVL- MSSA isolates.  This 
ST can commonly be associated with S. aureus-based disease in cattle[23, 214].  MRSA isolates from 
this ST are quite rare. 
ST88 (intermediate) was associated with SSTI caused by PVL+ isolates and is also commonly 
associated with CA-MRSA, which has been reported in the UK, Abu Dhabi, Spain and Nigeria[23], 
as well as among Chinese paediatric patients[206, 215].  This ST can also be a potential CA-MRSA 
clone in our setting, as it is known that PVL+ SSTIs are commonly associated with CA-MRSA.  
However, to date, CA-MRSA in our setting and in South Africa in general are scarce. 
 
2.5.5 Local SCCmec evolution and acquisition: 
 
Three MRSA clones were also identified which have possibly emerged locally.  Population 
structure data supports the local acquisition of type V SCCmec elements by two clones, leading to 
the emergence of ST22-MRSA-V and ST8-MRSA-V.  These clones are very likely CA-MRSA 
clones and can potentially lead to epidemics.  These strains are fortunately not present in 
abundance.  The 3rd clone which could have emerged locally is the dominant MRSA clone, ST612-
MRSA-IV.  Only one MSSA isolate was identified in this CC, so it is likely that this clone acquired 
the SCCmec type IV element some time ago. 
Also, one isolate from ST239-MRSA-THW J possessed a non-typeable SCCmec element, while the 
remaining isolates possessed SCCmec III elements.  This data suggests that replacement of a 
SCCmec element by another has taken place in this population, resulting in the generation of new 
and different MRSA clones. 
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2.5.6 Statistical association with HIV and other virulence factors: 
 
Two clones were identified to be statistically associated with an HIV+ status: ST8-MSSA-THW K 
(minor) and ST612-MRSA-IV-THW P (minor).  Both clones were classified as MLST CC8, which 
has been reported previously[132, 134, 136].  ST8 isolates have also been reported as USA300 isolates 
and have been associated with necrotising disease in HIV+ persons[134].  ST612 has been described 
as the dominant ST, however from a different PFGE clone.  The statistical association with patient 
HIV status could not be determined due to the high number of patients with an unknown HIV 
status.  Further studies on the association between bacterial clonality and a HIV+ status are 
required. 
 
Regarding the virulence factor investigations, it can be noted that all isolates possessed genes 
involved in adherence (fnbA/B, clfA/B, eap) and invasion (fnbA/B, eap) of host cells. Diep et al. 
identified a similar pattern in their collection of HA- and CA-MRSA isolates[216].  Also, genes 
predominantly involved in the induction of cell death (hla), evasion of the host immune system and 
toxins with superantigenic properties were present in most isolates.  Some toxin genes were only 
moderately present or even completely absent.  All isolates possessed either cap5 or cap8, but never 
both, as has been reported previously[85, 216].  Eighty percent of the isolates possessed the known 
IEC of scn, chp, sak and sea or sep, or a combination of these genes, while 25% possessed all five 
genes.  This correlated very well with the low prevalence of hlb, since this IEC are carried on 
phages which integrate into the hlb gene[86].  Again the data indicates the on-going interaction 
between local S. aureus strains and various phages.  The genes seg, sei, sem, sen and seo, also 
known as the enterotoxin gene cluster, egc, were detected in most isolates and in combinations.  
The egc was completely absent from all CC15 isolates (ST15, ST1 and ST188) as well as ST12, 
ST6 and ST8 isolates.  All five genes were detected in CC5 isolates only.  There seem to be an 
association between the genes present in the egc and clonality, as has been identified before[216, 217].  
Unlike previously published by Deurenberg et al., cna and tst could not be used to distinguish 
CC15 and CC30 isolates[218].  In general, we see variation in the association of certain virulence 
factors with clonality or methicillin-resistance, which probably does not influence pathogenesis, as 
previous studies have shown[219]. 
The expression of core-genome virulence components, such as hla and psmα, has been linked to the 
increased virulence of some CA-MRSA lineages, such as the USA300 complex[50].  The gene hla 
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was identified in 24/25 representative isolates.  Further analyses will reveal which of the isolates 
could be classified as being cytotoxic. 
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2.6 Conclusion 
 
The population studied here is composed out of an extremely diverse population of endemic MSSA 
clones and epidemic MRSA clones, and an absence of a common genetic background between 
MSSA and MRSA isolates has been identified.  The molecular typing techniques used in 
combination were sufficient to elucidate and study the population structure of S. aureus, allowing us 
to identify various clones, some of which were associated with certain clinical categories. 
We were also able to indicate that three of the MRSA clones identified emerged locally through the 
acquisition of SCCmec elements, including the unique, dominant MRSA clone, ST612.  Few of the 
MSSA lineages offer a stable enough genetic background for the maintained integration of SCCmec 
elements, leading to the rise of different MRSA clones. 
A prominent finding of this study is the high PVL prevalence identified.  However, CA-MRSA and 
PVL+ MRSA isolates are scarce in this population.  The MSSA population identified and studied 
can act as perfect reservoirs for potential CA-MRSA clones upon the acquisition of SCCmec 
elements, leading to the rise of PVL+ CA-MRSA clones. 
All the representative isolates selected possessed the genotypic means for the effective adherence to 
cellular matrices, invasion of host cells and induction of host cell death.  Genes associated with host 
immune evasion were also present in high numbers. 
 
In the following chapters host-pathogen interaction characteristics of the selected representative 
isolates will be investigated by focusing on their abilities to adhere to selected ligands, invade host 
cells and also induce the death of these cells. 
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2.7 Appendix A 
 
Table A1 displays the results obtained for all representative isolates for the genotypic PCR 
investigation into the prevalence of the selected virulence factors. 
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Table A1 Genotypic PCR results obtained of the prevalence of the selected virulence factors in the representative isolates. 
Isolate name PFGE 
MLST Invasion Adherence Persistence Other enzymes 
ST CC fnbA fnbB eap clfA clfB cna sdrC sdrD sdrE icaA sak coa nuc 
THW38 THW-A 1865 30 + + + + + + - - - - + + + 
THW382 THW-B 36 30 + + + + + + - + - + + + + 
THW146 THW-C 22 22 + + + + + + - + + + + + + 
THW393 THW-C 22 22 + + + + + + - + + + + + + 
THW262 THW-O 612 8 + + + + + - + + + - + + + 
THW70 THW-N 612 8 + + + + + + + + + + + + + 
THW65 THW-G 1862 8 + + + + + - - + + - + + + 
THW271 THW-J 8 8 + + + + + + - - - - + + + 
THW81 THW-L 239 8 + + + + + - + - - + + + + 
THW195 THW-K 8 8 + + + + + - + - + + + + + 
THW273 THW-P 612 8 + + + + + - + + + + - + + 
THW93 THW-O 612 8 + + + + + - + - + + + + + 
THW99 THW-L 239 8 + + + + + - + - - - + + + 
THW122 THW-S 15 15 + + + + + + - + + - - + + 
THW412 THW-V2 1 15 + + + + + + - - + + - + + 
THW224 THX-X 188 15 + + + + + - + - + + + + + 
THW356 THW-EE 45 45 + + + + + + - + - - + + + 
THW17 THW-Y 1863 5 + + + + + + + + + + + + + 
THW235 THW-Z 1864 5 + + + + + - + - + + + + + 
THW264 THW-AA 5 5 + + + + + - + + + + - + + 
THW64 THW-V1 6 6 + + + + + - - + + - + + + 
THW366 THW-E 121 121 + + + + + + - - - + + + + 
THW368 THW-V3 12 12 + + + + + + - + - + + + + 
THW241 THW-W 97 97 + + + + + - - + + + + + + 
THW255 THW-BB 88 88 + + + + + + - + - - + + + 
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Table A1 cont. Genotypic PCR results obtained of the prevalence of the selected virulence factors in the representative isolates. 
Isolate name PFGE 
MLST Immune evasion Hemolysins Exfoliative Toxins 
ST CC cap5 cap8 scn chp hla hlb hld hlg hlgv eta etb 
THW38 THW-A 1865 30 - + + + + - + + - - - 
THW382 THW-B 36 30 - + + + + - + + - - - 
THW146 THW-C 22 22 + - + + + - + + - - - 
THW393 THW-C 22 22 + - + + + + + + - - - 
THW262 THW-O 612 8 + - - - + - + + + - - 
THW70 THW-N 612 8 + - + - + - + + + - - 
THW65 THW-G 1862 8 + - - - + - + - + - - 
THW271 THW-J 8 8 + - - + + - + - + - - 
THW81 THW-L 239 8 - + + - + - + + + - - 
THW195 THW-K 8 8 + - - + + + + - + - - 
THW273 THW-P 612 8 + - + - + - + + + - - 
THW93 THW-O 612 8 + - + - + - + + + - - 
THW99 THW-L 239 8 - + + - + - + + + - - 
THW122 THW-S 15 15 - + - + + - + + + + - 
THW412 THW-V2 1 15 - + - - + + + + + - - 
THW224 THX-X 188 15 - + + - + - + + + - - 
THW356 THW-EE 45 45 - + - + + - + - - - - 
THW17 THW-Y 1863 5 + - + + + - + + + - - 
THW235 THW-Z 1864 5 + - + + + - + + + - - 
THW264 THW-AA 5 5 + - - - - - + + + - - 
THW64 THW-V1 6 6 + + + - + - + - + - - 
THW366 THW-E 121 121 - + + - + - + + + - - 
THW368 THW-V3 12 12 - + + - + - + + + - - 
THW241 THW-W 97 97 + - + - + - + + + - - 
THW255 THW-BB 88 88 - + + + + + + + + - - 
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Table A1 cont. Genotypic PCR results obtained of the prevalence of the selected virulence factors in the representative isolates. 
Isolate name PFGE 
MLST Superantigens and toxin-mediated disease 
ST CC tst sea seb sec sed see seg seh sei sej sel sem sen seo sep 
THW38 THW-A 1865 30 - + - - - + + - - - - + + + - 
THW382 THW-B 36 30 + + - - - + + - - - - + + + - 
THW146 THW-C 22 22 - + - - - - + - - - - + + + - 
THW393 THW-C 22 22 - + - - - - + - - - - + - + - 
THW262 THW-O 612 8 - + + - - + - - + - - - - - - 
THW70 THW-N 612 8 - + - - - + - - + - - - - - - 
THW65 THW-G 1862 8 - - - - - - + - - - - + + + - 
THW271 THW-J 8 8 + + - - - - - - - - - - - - - 
THW81 THW-L 239 8 - + - - - + - - + - - - - - - 
THW195 THW-K 8 8 + + + - - - - - + + - - + - - 
THW273 THW-P 612 8 - + + - - + - - + - - - + - - 
THW93 THW-O 612 8 - + + - - + - - + - - - - - - 
THW99 THW-L 239 8 - + - - - + - - + - - - - - - 
THW122 THW-S 15 15 - - - - - - - - - - - - - - - 
THW412 THW-V2 1 15 - - - - - - - + - - - - - - - 
THW224 THX-X 188 15 - + - - - - - - - - - - - - - 
THW356 THW-EE 45 45 - + - + - - - - - + - + + + - 
THW17 THW-Y 1863 5 - - - - - + + - + - - + + + + 
THW235 THW-Z 1864 5 - + + - - - + - + - - + + + - 
THW264 THW-AA 5 5 - - - - - - + - + - - + + + - 
THW64 THW-V1 6 6 - + - - - + - - - - - - - - - 
THW366 THW-E 121 121 - + + - - - + - - - - + + + - 
THW368 THW-V3 12 12 - + - - - + - - - - - - - - - 
THW241 THW-W 97 97 - + - - - - - - + - - - - - - 
THW255 THW-BB 88 88 - + - - - - - - + - - - - - - 
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CHAPTER 3: Adherence of representative 
clinical S. aureus isolates to specific 
immobilised human ligands 
 
3.1 Introduction 
 
3.1.1 Host extracellular matrix (ECM) components involved in bacterial adherence: 
 
Fibronectin, fibrinogen and collagen are three of many different extracellular matrix (ECM) 
molecules found in macromolecular structures such as the skin, cartilage or epithelial lining.  Both 
fibronectin and fibrinogen play significant roles in the binding of S. aureus to the skin during 
infections associated with skin diseases such as atopic dermatitis[220].  Fibronectin is a component of 
ECM[221], human plasma and connective tissue[222] and aggregates Gram-positive bacteria[221].  
Mechanical stretching of this protein promotes disruption of bacterial adherence[223] by physically 
destroying epitopes.  Numerous human serum proteins can also act as ligands for S. aureus 
adherence[224].  Fibrinogen-binding is commonly associated with infective endocarditis[225], while 
collagen is commonly required for the colonisation of cartilage[226]. 
 
3.1.2 Staphylococcal adherence proteins: 
 
Numerous bacterial surface proteins can be utilised during the process of adherence to host ligands. 
These proteins are called “microbial surface components recognising adhesive matrix molecules”, 
or MSCRAMM, such as fibronectin-binding proteins A and B[3], Staphylococcal Protein A and 
Clumping factors and are anchored to the bacterial cell wall through a LPXTG motif[100].  The 
organism can establish an infection through the expression of these cell wall-anchored proteins 
during the logarithmic phase of growth, aiding in the infection of host tissue.  Another group of 
bacterial proteins which is involved in this process are the SERAM molecules, or the “secreted 
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expanded repertoire adhesive molecules”[102], such as the extracellular adherence protein (Eap), 
commonly found in supernatant and secreted during the logarithmic phase. 
 
3.1.2.1 Protein A (SpA): 
 
The exact function of Staphylococcal Protein A remains unclear, but it is known that this protein 
can bind the Fc domain of eukaryotic immunoglobulin G (IgG)[147, 148] and inhibit opsono-
phagocytosis[100, 148].  This surface protein also binds strongly to the Fab region VH3 heavy chain-
bearing immunoglobulins (Ig)[227] and to von Willebrand factor (vWF)[227] and has also been 
implicated in the adherence to mesothelial cell monolayers[228].  This protein also binds directly to 
osteoblasts, resulting in the prevention of their proliferation and the induction of apoptosis, 
characteristic for a debilitating disease such as osteomyelitis[229].  Please refer to Figure 3.1 for a 
structural comparison of this protein to other S. aureus surface proteins. 
 
3.1.2.2 Fibronectin-binding proteins (FnbPs): 
 
Adherence to fibronectin by S. aureus can be mediated by fibronectin-binding proteins A and B 
(FnBPA/B) and also aids in the binding of the organism to plasma clots[100, 230].  These proteins are 
present in virtually every clinical S. aureus isolate.  Both genes are fundamental for the invasion of 
eukaryotic cells[102].  The A domain of FnbA has a fibrinogen-binding function[231] and adheres to 
and activates human platelets[83, 232].  Sinha et al. demonstrated that FnBPs are sufficient for the 
invasion of eukaryotic host cells[104].  Adherence to fibronectin by FnbA is mediated by multiple, 
substituting binding regions present on the protein[233], but this protein has to be anchored in the 
bacterial cell wall for it to be fully functional[89], i.e. adhere to and invade mammalian cells.  A 
novel biofilm phenotype, stimulated by FnBPA and FnBPB has also been identified, and occurs 
independently from known ligand binding activities of either protein[114]. 
FnbA can also mediate human T lymphocyte adhesion and co-activation[234]  Please refer to Figure 
3.1 for a structural comparison of this protein to other S. aureus surface proteins. 
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3.1.2.3 SD repeat proteins (Sdr): 
 
These proteins are structurally characterised by the presence of a Serine-Aspartate (Ser-Asp) 
dipeptide rich repeat region called the R domain[100].  ClfA/B are members of this family of proteins 
and three other members, SdrC/D/E have also been identified.  The exact roles of these proteins are 
still poorly understood.  A sdrC+sdrD-sdrE- phenotype has previously been associated with MSSA 
strains[235], while the presence of sdrD was strongly associated with MRSA strains[235]. 
S. aureus possess two distinct fibrinogen-binding proteins, namely clumping-factor A and B 
(ClfA/B), of which ClfA is mainly used to adhere to substances containing fibrinogen or to clump 
in its presence[100, 236].  ClfA has been implicated in infective endocarditis[83, 225] and other 
endovascular diseases[237] and inhibits phagocytosis in the absence of fibrinogen[238] (the exact 
mechanism remains unknown), while ClfB plays a role during colonisation through mediating 
adherence to epithelial  cells[239, 240].  Please refer to Figure 3.1 for a structural comparison of this 
protein to other S. aureus surface proteins. 
 
3.1.2.4 Collagen adhesin (Cna): 
 
This protein is mainly responsible for bacterial adherence to collagen substrates and collagenous 
tissue[100, 241-243] as eight ligand-binding sites are present on the protein[244, 245] and is present in only 
30-60% of clinical isolates[100].  This protein is also required for adherence to human cartilage[246] 
and has been shown to bind human collagen I - VI[226].  This protein is a virulence determinant for 
S. aureus-based experimental endocarditis[247] and keratitis[248].  Please refer to Figure 3.1 for a 
structural comparison of this protein to other S. aureus surface proteins. 
 
3.1.2.5 Extracellular adherence protein (Eap): 
 
This multifunctional protein is known to have a broad specificity for host proteins[249], recognising 
fibronectin, fibrinogen and collagens[83, 250] in vitro.  It is required as a full-length protein to act as 
an invasin for S. aureus[88, 251].  It is present in >96% of all clinical isolates in various sizes and 
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lacks the typical LPXTG domain, although Hussain et al. identified it in all their isolates 
screened[165].  Anti-inflammatory[252] and immune-modulatory roles[253, 254] have been described for 
this protein[83, 251].  It is structurally related to S. aureus superantigens, but does not act as a 
superantigen[255], unlike some of the classical S. aureus superantigens (e.g. TSST-1, SEA, SEB 
etc.). 
 
 
Figure 3.1 The structural organisation of the S. aureus MSCRAMM proteins (a) fibronectin-
binding protein A; (b) collagen-binding protein; (c) clumping factor A; and (d) 
protein A.  S = signal sequence; W = wall-spanning region; M = membrane-spanning 
region and positively charged residues; R = Ser-Asp dipeptide region; Wr = 
octapeptide repeat region; Wc = non-repeated region; * = ligand-binding domains; 
A-D= domains; LPXTG = cell-wall anchor domain.  Adapted from Foster et al.[100]. 
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3.1.2.6 Plasmin-sensitive protein (Pls): 
 
This protein is a member of the Sas (Staphylococcus aureus surface proteins) family and has until 
now only been identified in MRSA isolates carrying the SCCmec I element[83].  This protein acts by 
steric hindrance, resulting in decreased adherence to host cells and decreased invasiveness of host 
cells[256, 257] and experimental data has identified it as a virulence factor involved in septic 
arthritis[258].  Cellular invasiveness can also be predicted by the SCCmec and spa type, in addition to 
the expression of pls[259]. 
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3.2 Aims and Objectives 
 
3.2.1 Study aim: 
 
The aim of the research presented in this chapter was to investigate the abilities of the representative 
S. aureus isolates selected from different clonal complexes, to adhere to various immobilised 
ligands and identify any potential associations between adherence and bacterial characteristics, such 
as clonality.  The same representative isolates as in the previous chapter were used. 
 
3.2.2 Study objectives: 
 
1. To establish a baseline of adherence by using non-coated plastic plates. 
2. To investigate the abilities of the representative isolates to adhere to plates coated with human 
plasma proteins and human serum proteins. 
3. To investigate the abilities of the representative isolates to adhere to plates coated with selected 
human ligands: 
a. Fibronectin (prominent plasma/serum component; prominent matrix component); 
b. Fibrinogen (prominent plasma component); 
c. Collagen IV (important accessible matrix component); 
d. Collagen VI (important accessible matrix component). 
4. To investigate if any statistical associations are present between adherence and: 
a. Clonality; 
b. Methicillin-resistance; 
c. Bacterial PVL status, i.e. PVL+ or PVL-; and 
d. Patient HIV status. 
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3.3 Materials and Methods 
 
3.3.1 Chemicals, reagents and media: 
 
All chemicals, reagents and consumables used during this research were analytical and/or molecular 
biology grade.  Human plasma fibronectin was obtained from Millipore (Billerica, USA), while 
human plasma fibrinogen was obtained from Merck Chemicals (Darmstadt, Germany).  Human 
collagen types IV and VI were obtained from Rockland Inc. (Gilbertsville, USA).  Only human 
derived ligands were used during this study. 
 
3.3.2 Bacterial strains and growth conditions: 
 
All bacterial isolates used were sub-cultured on 5% Blood agar plates (Bio-Merieux, France) after 
collection and incubated overnight at 37 ºC.  The same 25 isolates selected in Chapter 2 were used 
as representative isolates.  Please refer to Table B1 (Appendix B).  2-3 colonies of bacteria were 
used to inoculate 20 ml Mueller-Hinton broth (MHB), which was incubated statically for 16 h at 37 
°C.  The reference isolate NCTC8325-4 was used as a positive control for all adherence assays. 
 
3.3.3 Preparation of human plasma and serum: 
 
Human plasma and human serum proteins, required to coat the clear polystyrene 96-well flat-
bottomed plates (Sarstedt, Germany), were obtained from the blood of a healthy male volunteer 
donor and a healthy female volunteer donor.  Blood was collected in a serum tube for serum 
proteins and an EDTA-containing plasma tube for plasma proteins.  The serum tubes were left at 
room temperature (RT = 25  ̊C) for 3 h after blood collection to allow for clot formation.  All blood 
collection tubes were centrifuged at 2 800 rpm for 30 min, where after the plasma and serum were 
transferred to new, sterile 50ml tubes, which were centrifuged at 1 300rpm for 10 min.  The plasma 
and serum was again transferred to new, sterile 50 ml tubes.  All plasma and serum proteins were 
heat inactivated in a water bath at 56 °C and stored at -20 °C as 1ml aliquots. 
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3.3.4 Coating of 96-well micro-titre plates with human-derived ligands: 
 
96-well plates (Sarstedt, Germany) were coated with a specific ligand using a modified method of 
Peacock et al[163].  Briefly, the specific ligand was diluted in 1× PBS to a concentration of 10 µg/ml, 
of which 100 µl was added to every well of a clear, sterile, 96-well flat-bottomed plate (Sarstedt, 
Germany), from now on referred to as the plate.  The plate was incubated at 37 °C for 1 h and 
washed once with 200 ul 1× PBS per well, using a pump aspirator.  200 µl of 2% human serum 
albumin (HSA) in 1× PBS was added to every well to block any non-specific sites in the wells and 
left at 4 °C o/n, where after the plate was washed ×3 with 200 µl 1× PBS per well.  The plate was 
left to air dry for 5 min in a sterile laminar flow hood before bacterial inoculation.  A plate was 
coated freshly every time an adherence assay was set-up. 
 
3.3.5 Adherence assay: 
 
All adherence assays were performed with standardised bacterial cultures of OD1600nm to allow for 
direct comparisons between isolates.  All isolates and controls were tested in triplicate wells and 
three independent experiments were performed. 
 
Bacterial cultures were prepared as described in section 2.3.2.  After incubation, the cultures were 
centrifuged at 4 000rpm for 5 min and the supernatant discarded.  The bacterial pellet was washed 
once with 1× PBS (complete resuspension of the pellet by vortexing) and centrifuged again (4 
000rpm, 5 min).  The supernatant was discarded and the bacterial pellet was completely 
resuspended in 5 ml 1% HSA/PBS by vortexing.  Following this, the bacterial OD was measured 
and adjusted to OD 1600nm as follows.  Briefly, a 1:10 dilution in 1% HSA/PBS of each bacterial 
culture was prepared inside a cuvette and measured at 600nm.  The amount of bacterial culture 
required for 1ml of adjusted culture at OD 1 was calculated and the bacterial culture was adjusted.  
After adjustment, a 1:10 dilution in 1% HSA/PBS was prepared of the adjusted culture and 
measured at 600nm.  Only adjusted cultures between OD 0.95 - 1.05 were accepted.  Adjusted 
cultures above or below these limits were adjusted for a second time and measured. 
20 µl of the OD 1 bacterial culture was used to inoculate 200 µl MHB in a 1.5 ml tube and 
vortexed, of which 200 µl was used to inoculate a well of a freshly coated plate.  After inoculation, 
the plate was closed and statically incubated at 37 °C with 5% CO2 o/n.  All representative isolates 
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were tested in triplicate wells.  As previously stated, strain NCTC8325-4 was used as a positive 
control isolate.  Two negative controls were included: 200 µl 1× PBS without bacterial inoculum 
and 200 µl MHB without bacterial inoculum. 
After incubation, the medium was exhausted using an aspirator pump and each well was washed 
once with 200 µl 1× PBS.  After the 1× PBS was removed, the plate was allowed to air dry for 5min 
inside a sterile laminar flow hood.  100 µl 0.1% crystal violet solution was added to each well and 
incubated at RT for 30 min.  The crystal violet solution was exhausted and every well was washed 
×3 with 200 µl 1× PBS.  The plate was allowed to air dry under a sterile laminar hood for 5 min, 
where after 200 µl elution buffer was added to every well and incubated at RT o/n to allow for the 
elution of the crystal violet from the adherent bacteria. 
The following day the elution buffer was measured using an ELISA reader, the TECAN Infinite Pro 
200 (Tecan GmbH, Germany) at 620nm. 
Adherence to a specific ligand was expressed as a percentage relative to the positive control, which 
was set at 100%, after subtraction of the PBS negative control from every reading.  The standard 
error of mean (SEM) and the standard deviation (SD) of every mean was determined. 
Adherence of the representative isolates was tested first in uncoated plates, to establish a baseline of 
adherence (presence of no ligand). 
A single 96-well plate included all the representative isolates (n = 25) and the three controls (1× 
positive control (NCTC8325-4) and 2× negative controls (1× PBS, MHB) in triplicate.  Three 
independent experiments were performed. 
 
3.3.6 Statistical associations: 
3.3.6.1 Associations between adherence and methicillin-resistance or clonality: 
 
To investigate if any associations existed between adherence and methicillin-resistance, two tests 
were performed.  Firstly, as a parametric comparison, the 2-sample t-test was also used.  A 
confidence interval of 95% was used and an association was regarded as statistically significant if a 
p-value < 0.05 was obtained.  Secondly, as a non-parametric comparison, the 2-sample Wilcoxon 
rank-sum test (Mann-Whitney test) was used.  An association was regarded as statistically 
significant if a p-value < 0.05 was obtained. 
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To investigate if any associations existed between adherence and clonality, the Kruskal-Wallis test 
was performed as a comparison using non-parametric inference.  In order for us to compare all 
groups in a valid fashion, a group was created which was composed of all the singletons.  An 
association was regarded as statistically significant if a p-value < 0.05 was obtained. 
 
3.3.6.2 Associations between adherence and patient HIV status or bacterial PVL status: 
 
To investigate if any associations existed between adherence and patient HIV status, the Kruskal-
Wallis test was performed as a comparison using non-parametric inference.  An association was 
regarded as statistically significant if a p-value < 0.05 was obtained. 
To investigate if any associations existed between adherence and bacterial PVL status, i.e. PVL-
positive or negative, the 2-sample Wilcoxon rank-sum test (Mann-Whitney test) was used.  An 
association was regarded as statistically significant if a p-value < 0.05 was obtained. 
For all statistical investigations, the software package Stat v.12 was used. 
 
3.3.7 Composition of media, buffers and solutions: 
 
Table 3.1 Composition of media and broth used for adherence assays. 
Media/Broth Composition 
5% Blood 
agar plate 
15 g pancreatic digest of casein; 15 g papaic digest of soy meal; 
5 g NaCl; 15 g agar; 
Bring to volume of 1 l and autoclave 
Adjust pH to 7.3 
Cool to 45-50 °C; add 5% (v/v) sterile defibrinated blood; mix 
MH broth 
2 g dehydrated beef infusion; 17.5 g casein hydrolysate; 1.5 g 
starch; 
Bring to volume of 1 l and autoclave 
Adjust pH to 7.4 
 
 
Stellenbosch University http://scholar.sun.ac.za
94 
 
Table 3.2 Composition of buffers and solutions used for adherence assays. 
Buffer/Solution Composition 
1× PBS 
8 g NaCl; 0.2 g KCl; 1.44 g Na2HPO4; 0.24 g KH2PO4 in 800 ml 
dH2O 
Adjust pH to 7.4 
Add H2O to 1 l and autoclave 
1% HSA/PBS 1:20 of 20% HSA in PBS 
2% HSA/PBS 1:10 20% HSA in PBS 
0.1% crystal violet (500 ml) 
3.75 g crystal violet; 250 ml ethanol (100%); 1.25 g NaCl; 
24 ml formaldehyde (36.5%); 226 ml dH2O 
Elution buffer (500 ml) 25 ml 20% SDS; 475 ml PBS 
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3.4 Results 
 
3.4.1 Adherence per ligand: 
 
We were able to determine the adherence potential of all selected representative isolates to all 
different immobilised ligands tested, as well as an uncoated plate. 
 
Figures 3.2 - 3.8 illustrate the adherence of individual isolates for the uncoated plate and the six 
specific immobilised ligands.  For all seven figures, isolates have been grouped into their respective 
MLST CC and displayed according to HIV status (HIV negative; HIV status unknown; HIV 
positive (associated) [these two clones are statistically associated with HIV+ status] or HIV positive 
(isolated) [these two strains were collected from HIV+ persons]).  Please refer to Appendix B 
(Figures B1 – B7) for a representation of the adherence of each individual isolate for the uncoated 
plate and the plates coated with immobilised ligands. 
 
All isolates tested displayed variability in their adherence, irrespective of the ligand tested.  Some 
isolates displayed a preference for adherence to immobilised fibronectin and fibrinogen, such as the 
isolates from CC8 and CC5.  The CC30, CC15 and ST239 isolates displayed preference towards 
immobilised collagen IV and collagen VI.  Some isolates were also identified to be poor binders to 
the immobilised ligands used, such as the ST88, ST97 and ST45 isolates.  MRSA isolates displayed 
stronger adherence to plasma (p = 0.025), while no statistical associations were identified between 
adherence and patient HIV status or bacterial clonality.  PVL- isolates displayed stronger adherence 
to fibronectin as compared to their PVL+ counterparts (p = 0.034). 
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Figure 3.2 Relative adherence of isolates using an uncoated 96-well plate. 
 
 
Figure 3.3 Relative adherence of isolates using a 96-well plate coated with human plasma 
proteins. 
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Figure 3.4 Relative adherence of isolates using a 96-well plate coated with human serum 
proteins. 
 
 
Figure 3.5 Relative adherence of isolates using a 96-well plate coated with human fibronectin. 
Unknown HIV status 
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Figure 3.6 Relative adherence of isolates using a 96-well plate coated with human fibrinogen. 
 
 
Figure 3.7 Relative adherence of isolates using a 96-well plate coated with human collagen IV. 
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Figure 3.8 Relative adherence of isolates using a 96-well plate coated with human collagen VI. 
 
3.4.2 Statistical associations: 
 
We were able to identify that MRSA isolates adhered stronger in the absence of a ligand (p = 0.016) 
and to plasma proteins (p = 0.025) when compared to their MSSA counterparts, as displayed in 
Table 3.3.  No statistical associations were identified between adherence and clonality, which is 
displayed in Table 3.4, or between adherence and patient HIV status (Table 3.5). 
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Table 3.3 Statistical associations between adherence and methicillin-resistance using the 
Mann-Whitney and 2-sample t-tests.  Statistically significant values are displayed in 
bold (p < 0.05). 
Ligand 
Mann-Whitney test 2-sample t-test 
Association with 
methicillinresistance 
p-value 
Association with 
methicillin-resistance 
p-value 
Uncoated MSSA/MRSA 0.767 MRSA 0.016 
Serum MSSA/MRSA 0.613 MSSA/MRSA 0.365 
Plasma MSSA/MRSA 0.767 MRSA 0.025 
Fibronectin MSSA/MRSA 0.567 MSSA/MRSA 0.335 
Fibrinogen MSSA/MRSA 0.680 MSSA/MRSA 0.080 
Collagen IV MSSA/MRSA 0.440 MSSA/MRSA 0.505 
Collagen VI MSSA/MRSA 0.553 MSSA/MRSA 0.758 
 
Table 3.4 Statistical associations between adherence and clonality using the Kruskal-Wallis 
test. 
Ligand 
Kruskal-Wallis test 
Association with clonality p-value 
Uncoated No association 0.194 
Serum No association 0.152 
Plasma No association 0.530 
Fibronectin No association 0.201 
Fibrinogen No association 0.160 
Collagen IV No association 0.248 
Collagen VI No association 0.292 
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Table 3.5 Statistical associations between adherence and patient HIV status using the Kruskal-
Wallis test. 
Ligand 
Kruskal-Wallis test 
Association with HIV status p-value 
Uncoated No association 0.322 
Serum No association 0.506 
Plasma No association 0.849 
Fibronectin No association 0.581 
Fibrinogen No association 0.210 
Collagen IV No association 0.104 
Collagen VI No association 0.055 
 
We were also able to identify that PVL-negative isolates adhered stronger in the absence of a ligand 
(p = 0.010) and to fibronectin (p = 0.034) when compared to the PVL-positive isolates, which is 
displayed in Table 3.6. 
 
Table 3.6 Statistical associations between adherence and bacterial PVL status using the Mann-
Whitney test.  Statistically significant values are displayed in bold. 
Ligand 
Mann-Whitney test 
Association with PVL status p-value 
Uncoated Negative 0.010 
Serum No association 0.364 
Plasma No association 0.250 
Fibronectin Negative 0.034 
Fibrinogen No association 0.468 
Collagen IV No association 0.364 
Collagen VI No association 0.904 
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3.5 Discussion 
 
Regarding associations made for the remainder of this chapter regarding adherence being a strain-
specific or clonal trait, it is worth noting that these associations are made based on a small number 
of isolates included for the different MLST clonal complexes, while CC8 is over-represented.  More 
representative isolates could not be included, as the techniques used for the in vitro characterisation 
are not high-throughput methods.  The representative isolates were selected to represent each major 
and intermediate PFGE clones identified as described in  Chapter 2  as well as minor clones based 
on clinical data (patient HIV status) and a specific bacterial characteristic (non-typeable SCCmec).  
Clonal complex 8 is over-represented among the selected representative isolates, mainly due to the 
inclusion of 2 isolates statistically associated with HIV-positive patients and 1 isolate from the HIV-
positive patient from the dominant MRSA clone, ST612.  The researchers were unable to make any 
deduction for CC45, CC6, CC121, CC12, CC97 and CC88 as only one isolate for each CC was 
included for further analyses. 
 
The representative isolates selected displayed a diverse range of adherence to any specific 
immobilised ligand, for all ligands tested, as well as for adherence in the absence of a specific 
ligand.  No significant difference was observed for adherence to any of the ligands tested, between 
isolates from HIV+ and/or HIV- persons.  It is worth noting that genotypically, all representative 
isolates were positive for all proteins involved in adherence to the immobilised ligands tested, yet 
diversity was displayed during the in vitro adherence to the individual ligands. 
 
3.5.1 Discussion per ligand: 
 
Regarding adherence in the absence of a specific ligand (uncoated plate), our selection of 
representative clinical isolates displayed lower adherence compared to the positive control, with a 
median adherence of 31.9% (range 13.7 – 55.3%) of the reference strain.  Isolates of CC22, CC30, 
CC8 and CC5 displayed a diverse range of adherence.  In this instance, adherence for these CCs 
seems to be a strain specific characteristic, as opposed for CC15, where it seems to be a clonal trait.  
Please refer to Figures B1 and 3.2.  A statistical association was only identified using the 2-sample 
t-test, which indicated that MRSA isolates adherence was stronger in the absence of a ligand, when 
compared to MSSA isolates (p=0.016) and is displayed in Table 3.3. 
Stellenbosch University http://scholar.sun.ac.za
103 
 
Isolates of CC8 again displayed the greatest range of adherence to human plasma proteins, adhering 
up to 126% relative to the positive control.  Fibronectin and fibrinogen are components of the 
human plasma that are likely to act as ligands for bacterial adherence.  The median adherence was 
62.3% (range 28.4 - 126.1%), lower than the control, for this collection of isolates.  Isolates of 
CC22, CC8 and CC15 adhere to human plasma proteins in a strain-specific manner.  Adherence for 
CC30 and CC5 isolates seems to be a clonal trait.  Please refer to Figures 3.3 and B2.  Plasma was 
the only other ligand where a statistical association could be identified, also using the 2-sample t-
test.  Again, MRSA isolates adhered stronger to human plasma proteins, when compared to MSSA 
isolates (p=0.025).  Please refer to Table 3.3., Section 3.4.2. 
A similar picture is seen for human serum (fibronectin as common component), with CC8 isolates 
adhering up to 134% relative to the control.  The median adherence was 81.2% (range 37.6 – 
121.8%), lower than the control.  Adherence to human serum proteins was a strain-specific 
characteristic for isolates of CC30, CC8, CC15 and CC5, while it was clone-specific characteristic 
for CC22 isolates.  Please refer to Figures B3 and 3.4. 
 
The median adherence to human fibronectin for this collection of isolates was 80% (range 48.5 – 
138.5%), lower than the control.  Isolates from CC8 isolates again displayed the greatest degree of 
adherence, adhering up to 138% relative to the control.  Adherence to human fibronectin was a 
clonal trait for isolates of CC 30 and15 and a strain-specific trait for isolates of CC22, CC8 and 
CC5.  Please refer to Figures B4 and 3.5.  PVL-negative isolates adhered stronger to fibronectin 
than the PVL-positive isolates. 
The majority of isolates displayed a significant ability to adhere to human fibrinogen, with a median 
adherence of 110% (range 43.8 – 276.2%) for this collection of isolates, higher than the control.  
Only isolates of CC15 displayed a clone-specific trait for adherence to human fibrinogen.  
Regarding isolates of CC22, CC30, CC8 and CC5, adherence was a strain-specific characteristic.  
Adherence for CC8 isolates ranged from 73.2% - 276.2%, where 5/9 isolates of this CC displayed 
adherence of >100%.  Please refer to Figures B5 and 3.6. 
The adherence profiles obtained for both collagens tested appeared similar to each other and yet 
very different from the previously discussed ligands.  Strong adherence to at least collagen IV as an 
immobilised ligand was seen and strong adherence towards collagen VI was also noticed.  The 
isolates displayed a very broad range of adherence for both collagens tested. 
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The median adherence was 213.3% for this collection of isolates for human collagen IV (range 41.3 
– 528.7%).  Although CC22 isolates adhered very strongly to collagen IV (mean 197%) and isolates 
of CC5 displayed a moderate adherence to collagen IV (mean 50%), adherence to collagen IV was a 
clonal trait for both CCs.  Pertaining to eisolates of CC30, CC8 and CC15, adherence to collagen IV 
was a strain-specific characteristic.  Adherence for isolates of CC30 ranged from 177% - 347%, 
while for CC15 at ranged from 105% - 493%.  The isolates of CC8 could be re-grouped into smaller 
clusters based on adherence: cluster 1 contained MRSA isolates (adherence 505% - 528%), and 
cluster 2 contained both MRSA and MSSA isolates (adherence 48% - 135%).  The strongest 
adherence to collagen IV was displayed by the ST6 isolate (665%), while the ST121 (383%) and 
the ST12 (458%) isolates also displayed very strong affinities to immobilised collagen IV.  Please 
refer to Figures B6 and 3.7. 
The median adherence for this collection of isolates for human collagen VI was 99% (range 36.1 – 
285.3%), while a CC8 MRSA isolate displayed the strongest adherence to collagen VI (285%).  
Adherence to collagen VI was a clonal characteristic for CC5 isolates, while those of CC22, CC30, 
CC8 and CC15 displayed a strain-specific adherence preference towards this immobilised ligand.  
Two C8 MRSA isolates and one CC15 isolate displayed very strong adherence (200%) to collagen 
IV.  The CC12 (183%) and the CC6 (191%) isolates also displayed strong adherence to collagen VI.  
Please refer to Figures B7 and 3.8. 
 
3.5.2 Discussion per clonal complex: 
 
Regarding the CC22 isolates, we see a strain-specific adherence pattern to all immobilised ligands, 
except for human serum, which is rich in fibronectin, and collagen IV.  A different pattern is 
observed for purified human fibronectin, where THW146 (ST22-MSSA) display stronger adherence 
than THW393 (ST22-MSSA).  Both isolates display a preference for human collagen IV (>175%) 
and fibrinogen (>100%), while THW146 only displays preference for collagen VI (>100%).  Please 
refer to Figure 3.9. 
Regarding the CC30 isolates, we see a strain specific adherence pattern for collagens IV and VI, 
fibrinogen and the uncoated plate.  Adherence to fibronectin and human plasma (rich in fibronectin) 
seems to be a clonal trait.  THW382 (ST36-MRSA-II) adheres strongly to collagen IV (>150%) and 
fibrinogen (90%).  THW38 (ST1865-MSSA) displayed extremely strong adherence to collagen IV 
(350%) and strong adherence towards collagen VI (130%).  Please refer to Figure 3.10. 
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Figure 3.9 Adherence of CC22 isolates in the absence/presence of various immobilised human 
ligands. 
 
 
Figure 3.10 Adherence of CC30 isolates in the absence/presence of various immobilised human 
ligands. 
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Regarding the CC8 isolates, we see a general diverse pattern of adherence, which seems to be a 
strain-specific characteristic for all ligands tested.  Interestingly, both ST239 isolates, THW99 
(ST239-MRSA-NT) and THW81 (ST239-MRSA-III), display very strong adherence to collagen VI 
(200-300%) and extremely strong adherence to collagen VI (>500%).  These isolates also display 
strong adherence to fibrinogen (100%) and only moderate adherence to fibronectin and plasma 
(50%).  THW81 displays relatively strong adherence to serum (> 100%) while THW99 does not.  
Please refer to Figure 3.11. 
 
 
Figure 3.11 Adherence of CC8 isolates in the absence/presence of various immobilised human 
ligands. 
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All four ST612 isolates (THW93, 273, 70 and 262 – ST612-MRSA-IV) display strong to very 
strong adherence to fibrinogen (175-275%) and also strong adherence to fibronectin (100-140%) 
and plasma (100-125%) (Figure 3.11).  ST612 was the dominant MRSA clone identified and has 
previously been reported in Australia[117] and South Africa[120] only.  Fibronectin may play a role in 
SSTI and 2/4 isolates were classified as SSTI by source.  Fibrinogen and fibronectin co-operate for 
heart valve/endothelial infection, thus making the ability to adhere strongly to these two ligands 
essential for establishing infective endocarditis[84]. 
 
Regarding the isolates of CC15, adherence to fibrinogen, plasma and serum seems to be a strain 
specific trait and is moderate to high.  Adhere to fibronectin is relatively high and seems to be a 
clonal trait.  Adherence to the collagens also seems to be a strain specific trait.  Adherence of 
THW224 (ST188-MSSA) and THW412 (ST1-MSSA) to collagen VI is strong (100-200%) and to 
collagen IV is very strong (300-500%).  Please refer to Figure 3.12. 
 
 
Figure 3.12 Adherence of CC15 isolates in the absence/presence of various immobilised human 
ligands. 
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Regarding the isolates of CC5, adherence in general is low to moderate and appears to be a strain 
specific trait for all ligands tested.  THW17 (ST1863-MSSA) display relatively strong adherence to 
fibronectin and serum (80-90%) and also the strongest adherence to both the collagens (60-70%), 
although adherence is only moderate.  THW235 (ST1864-MSSA) adhere relatively strong to 
fibrinogen (80%), while THW264 adhere the strongest adherence to plasma proteins and to no 
ligand (uncoated plate).  Please refer to Figure 3.13. 
 
 
Figure 3.13 Adherence of CC5 isolates in the absence/presence of various immobilised human 
ligands. 
 
Regarding the singletons, we cannot make any deductions regarding adherence being a strain or 
clonal trait as only one isolate was analysed for every ST.  THW368 (ST12-MSSA), THW366 
(ST121-MSSA) and THW64 (ST6-MSSA) displayed strong preference for adherence towards the 
collagens, adhering strongly to collagen VI (100-200%) and very strongly to collagen IV (400-
700%).  The THW64 isolate also displayed strong adherence towards fibronectin, fibrinogen, 
plasma and serum (100% all).  THW255 (ST88-MRSA-IV) and THW356 (ST45-MSSA) adhered 
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strongly to serum only (100%), while the THW241 (ST97-MSSA) displayed strong adherence 
towards collagen IV and fibrinogen (100%).  Please refer to Figure 3.14. 
 
 
Figure 3.14 Adherence of various singleton STs in the absence/presence of various immobilised 
human ligands. 
 
No statistical association was identified between any of the ligands and clonality.  The presence of 
both fnb genes found in this collection is similar to what has been previously reported for isolates 
collected from orthopaedic implants[260]. 
As previously shown by Peacock et al[163], this collection of S. aureus isolates displayed diversity in 
adherence to human fibronectin, but not in the genotypic presence of fnb genes.  In contrast to the 
Peacock study, all selected representative isolates tested PCR-positive for both fnbA and fnbB.  
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Unfortunately, no data is available on the expression of these two genes for this study.  Adherence 
to fibronectin is thus achieved by more than one adhesin working simultaneously, and is 
significantly involved in bacterial adherence to the endothelium in vivo[261]. 
Elgalai et al. also described a collection of wound isolates that displayed a diverse range of 
adherence and similarly to our set of isolates, displayed stronger adherence to fibrinogen than to 
fibronectin.[262].  However, this set displayed stronger adherence to collagen IV.  Seidl et al. 
described no significant adherence potentials to immobilised fibronectin between isolates derived 
from persistent and resolving MRSA infections[263]. 
 
Unlike previously reported by Arciola et al.[260] for orthopaedic implant infections, adherence to 
both human collagen IV and VI varied greatly among the isolates, irrespective of the presence or 
absence of the cna gene, while Campoccia et al. referred to cna, together with bone sialoprotein-
binding protein (encoded by the gene bbp) as crucial virulence factors in the pathogenesis of 
orthopaedic implant infections[264].  This  contradicts the work of Thomas et al[265].  Hartford et al. 
described the adherence of cna mutants to immobilised collagen and found that mutants of the A 
domain of cna bound lower to the immobilised proteins than wild-type strains[266].  De Bentzman et 
al. describe a collection of isolates clinically confirmed to be community-acquired necrotising 
pneumonia (NP) or non-necrotising pneumonia, where the PVL+ NP (cna+) isolates displayed 
stronger adherence towards collagen IV[267] when compared to the PVL- NP (cna-) isolates. 
Indirect evidence by serology suggests that both clfA and clfB are produced in vivo and are 
important factors for valve infection for the promotion of infective endocarditis[268] and were 
expressed by numerous isolates associated with this disease.  This collection of isolates displayed 
strong adherence for fibronectin, followed by fibrinogen even though no blood culture isolates were 
included in this collection. 
Hansen et al. described Eap as a protein which binds “promiscuously to monomeric matrix 
molecules” while selectively recognising extracellular matrix aggregates[250].  There data obtained 
using recombinant Eap (rEap) indicated that the rEap preferred adherence to fibronectin, followed 
by collagen IV and collagen VI, while the organism adhered at low numbers to collagen II and 
virtually nothing to collagen I.  The researchers also found that microfibrils containing collagen IV, 
collagen VI rich baseman membrane-associated networks and fibronectin-containing aggregates 
adhered to Eap as affectively as the monomeric immobilised ligands[250]. 
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3.6 Conclusion 
 
Clinical S. aureus isolates collected at Tygerberg hospital display diversity in their abilities to 
adhere to various immobilised human ligands. 
Some isolates of certain clonal complexes displayed strong adherence to the two types of collagen 
tested, even stronger than for fibronectin or fibrinogen (on a relative level).  MRSA isolates also 
displayed stronger adherence to human plasma proteins than MSSA isolates, while PVL- isolates 
adhered stronger to fibronectin. 
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3.7 Appendix B 
 
Figure B1 Relative adherence of isolates using an uncoated 96-well plate. 
 
 
Figure B2 Relative adherence of isolates using a 96-well plate coated with human plasma 
proteins. 
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Figure B3 Relative adherence of isolates using a 96-well plate coated with human serum 
proteins. 
 
 
 
Figure B4 Relative adherence of isolates using a 96-well plate coated with human fibronectin. 
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Figure B5 Relative adherence of isolates using a 96-well plate coated with human fibrinogen. 
 
 
Figure B6 Relative adherence of isolates using a 96-well plate coated with human collagen type 
IV.  +/- indicate presence/absence of cna gene. 
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Figure B7 Relative adherence of isolates using a 96-well plate coated with human collagen type 
VI.  +/- indicate presence/absence of cna gene. 
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Table B1 Strains selected as representative isolates for further analyses as categorised according to molecular typing data and statistical 
associations. 
Isolate 
name 
PFGE Clinical data Source Status 
MLST 
ST 
MLST 
CC 
spa-CC SCCmec agr PVL Statistical association 
THW38 THW-A Lip abscess SSTI Major 1865 30 21 NA III + MSSA/PVL+/SSTI 
THW382 THW-B 
Laparotomy 
(day 15 post-operative) 
SSTI Inter 36 30 21 II III - MRSA/PVL-/Adults/SSTI 
THW146 THW-C Abscess left knee SSTI Major 22 22 891 NA I + MSSA/PVL+/SSTI 
THW393 THW-C Septic left tibia ex-fix BJ Major 22 22 891 NA I + HIV+ (isol.) 
THW366 THW-E Chronic folliculitis SSTI Major 121 121 NF:16 NA IV + MSSA/PVL+/SSTI 
THW262 THW-O 
Pyrexia, intracostal 
drainage site 
RT Major 612 8 64 IV I - MRSA/PVL- 
THW65 THW-G Septic ORIF BJ Inter 1862 8 1597 NA I - MSSA/Adults 
THW271 THW-J Sinus fungal infection ENT Inter 8 8 64 V I - PVL-/Adults 
THW81 THW-L Sepsis, pin tract PROST Inter 239 8 21 III I - MRSA/PVL- 
THW70 THW-N 
Sepsis, nosocomial 
MRSA 
SSTI Inter 612 8 64 IV I - MRSA/PVL- 
THW195 THW-K Impetigo SSTI Minor 8 8 64 NA I - HIV+ (ass.) 
THW273 THW-P Pus from hand SSTI Minor 612 8 64 IV I - HIV+ (ass.) 
THW93 THW-O Sepsis UK Major 612 8 64 IV I - HIV+ (isol.) 
THW99 THW-L Septic wound SSTI Inter 239 8 21 UK I - Non-typeable SCCmec 
THW122 THW-S Sepsis SSTI Major 15 15 84 NA II - MSSA/PVL- 
THW412 THW-V2 No clinical data supplied UT Major 1 15 NF:14 NA III - MSSA 
THW224 THX-X Wound sepsis SSTI Inter 188 15 EX NA I - MSSA/PVL- 
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Table B1 Strains selected as representative isolates for further analyses as categorised according to molecular typing data and statistical 
associations. 
Isolate 
name 
PFGE Clinical data Source Status 
MLST 
ST 
MLST 
CC 
spa-CC SCCmec agr PVL Statistical association 
THW17 THW-Y Wound sepsis SSTI Major 1863 5 2 NA II - MSSA/PVL- 
THW235 THW-Z Measles EY Inter 1864 5 2 NA II + MSSA 
THW264 THW-AA Conjunctivitis EY Inter 5 5 2 I II - MRSA/PVL- 
THW64 THW-V1 
Suspect TB, pericardial 
fluid 
CA Major 6 6 64 NA I - MSSA/PVL- 
THW356 THW-EE Hip abscess SSTI Major 45 45 EX NA I - MSSA/PVL- 
THW368 THW-V3 Wound infection SSTI Inter 12 12 888 NA II + MSSA/PVL+ 
THW241 THW-W ESRF IVD Inter 97 97 267 NA I - MSSA/PVL-/Males 
THW255 THW-BB Infected leg SSTI Inter 88 88 186 IV III + PVL+/SSTI 
ass. = associated; isol. = isolated; ESFR = end-stage renal failure; ORIF = open reduction and internal fixation; Inter = intermediate; NA = not applicable; Ex = excluded; SSTI = 
skin and soft tissue; BJ = bone and joint; RT = respiratory tract; ENT = ear, nose and throat; PROST = prosthetic device; UK = unknown; UT = urinary tract; EY = eye; CA = 
cardiac; IVD = intravascular device. 
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CHAPTER 4: Host cellular invasiveness and 
host cell death induction of representative 
clinical S. aureus isolates 
 
4.1 Introduction 
 
4.1.1 Pathogenesis of infection: 
 
As previously stated, S. aureus can establish an infection after adherence and invasion of host cells.  
S. aureus can also disseminate from the blood into the surrounding tissue[269].  The host cellular 
integrins α5β1 are utilised as the host cellular receptor for invasion[102, 103], accessed by the bacterial 
protein FnbA/B or Eap[103, 104].  After invasion, the organism has to escape from the phagolysosome, 
or be killed.  If phagosomal escape is successful, the organism can replicate or persist inside the 
host cell or even kill the cell[83, 270] usually through the production of toxins.  However, no clear 
biological concept currently exists for S. aureus and the biological role of phagosomal escape is 
also not clear.  It is also known that different cell types may react in different manners to infection 
by S. aureus[271]. 
 
4.1.2 Host cellular invasins: 
4.1.2.1 Fibronectin-binding proteins (FnbPs): 
 
Sinha et al., amongst other, have clearly demonstrated the role of FnbPs as the main invasin of S. 
aureus through a series of loss/gain of function experiments and identified a fibronectin-dependent 
bridging mechanism to the host cellular integrin α5β1[103, 233] for epithelial, endothelial and fibroblast 
cells.  FnbPs do not require any other S. aureus-specific co-receptors to confer invasiveness and this 
function can be accomplished by either FnbA or FnbB[104] which must be anchored into the 
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bacterial cell wall, as truncation of these proteins results in deficient adherence and cellular 
invasiveness[89].  This is illustrated in Figure 4.1. 
 
 
Figure 4.1 Schematic representation of the co-localisation of the FnbPs-fibronectin bridging 
complex and the human host cellular receptor, α5β1.  Adapted from Hauck et al.[102]. 
 
4.1.2.2 Extracellular adherence protein (Eap): 
 
It has been shown that the protein Eap, with its broad binding capacity, can play a role in the 
cellular invasion of host cells[254, 272], such as fibroblasts and HACAT (keratinocytes) cells and also 
inhibits the recruitment of host leukocytes[252], although it has many other functions, incl. matrix 
binding.  Eap can very easily be used as an invasin in genetic backgrounds where FnbPs are not 
produced or defective, such as for strain Newman[272], whose FnbPs are mutated and secreted.  The 
molecule ICAM-1 (endothelial cell adhesion molecule) has been identified as a major host cellular 
receptor for Eap[251] during the inhibition of leukocyte recruitment.  In order for Eap-based cellular 
invasion of S. aureus to occur, more than one tandem repeat domain of the Eap protein is 
required[88]. 
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4.1.2.3 Plasmin sensitive surface protein (Pls): 
 
Pls, an Sdr-family protein, has so far only been associated with SCCmec type I clinical MRSA 
isolates[37, 273] and significantly reduces the ability of these isolates to adhere to several mammalian 
proteins, including fibronectin and fibrinogen[273].  Expression of this protein also reduces the 
cellular invasiveness of the MRSA isolates[257].  The invasiveness of MRSA can be predicted using 
three properties, as shown by Werbick et al.: (1) expression of pls; (2) SCCmec type; and (3) spa 
type[259].  Pls acts by steric hindrance and affects the adherence and cellular invasiveness of an 
isolate irrespective of the MRSA/SCCmec background[256]. 
 
4.1.3 Phagosomal escape of internalised staphylococci: 
 
Both the induction of host cell death[274, 275] or intracellular persistence[276] can result after 
successful phagolysosomal escape by S. aureus.  However, only a small number of clinical and 
laboratory isolates are capable of phagolysosomal membrane destruction, as the maintenance of 
phagolysosomal integrity after invasion of non-professional phagocytes has been displayed[277].  α-
toxin, a pore forming toxin, has been proposed to be involved in the escape of the organism from 
the phagolysosome[270], which is thought to be a multifactorial process.  Following escape, the 
micro-organism can either be killed by host cells, or it can persist and cause recurrent and/or 
persistent infections[83].  Conflicting data is currently available regarding which virulence factor(s) 
is/are involved in the process of phagosomal escape.  α-toxin has been identified as a requirement 
for vesicular escape in a cystic fibrosis epithelial cell line, CFT-1[278], and in CHO cells (ovary 
hamster cells)[279].  However, in upper-airway epithelial cells, α-toxin is not sufficient to allow for 
the phagosomal escape of S. aureus[280].  Giese et al. clearly demonstrated the synergistic actions of 
both α- and β-toxin in phagosomal escape in human epithelial and endothelial cells[281]. 
 
4.1.4 Intracellular persistence of S. aureus: 
 
S. aureus can survive inside human leukocytes, such as macrophages and non-professional 
phagocytes[270], even though the majority of internalised staphylococci will be killed.  Inside these 
cells, the organism can (1) evade the host immune system and antimicrobials; (2) use mobile cells 
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to disseminate throughout the host and then kill these cells; or (3) kill the cells immediately.  
Macrophages and neutrophils infected by S. aureus display increased expression of anti-apoptotic 
genes, thus allowing bacterial intracellular survival[101, 282, 283], while their viability and mobility is 
initially not affected[284], and has been shown to play a very important role specifically during CA-
MRSA infection[285].  Although multiple virulence factors determine the survival of S. aureus after 
phagocytosis, α-toxin seems to be a key component[284]. 
It is thought that persistence inside non-professional phagocytes can result in recurrent infections, 
such as recurrent tonsillitis[286].  Bacterial isolates with certain genotypic and phenotypic 
characteristics have been associated with persistent infection.  Xiong et al. identified SCCmec II, 
CC30 and spa t016 to be associated with persistent bacteremia[287] in their setting. 
 
4.1.5 Induction of host cell death: 
 
In any given S. aureus strain, host cell death induction is difficult to predict and depends on many 
factors[288], including bacterial genetic background, host cell type and pathway of cell death 
induction to be used.  Various bacterial virulence factors are also involved, of which α-toxin[289, 290] 
and PVL are most prominent. 
 
Intracellular S. aureus, if viable, can exist free in the cytoplasm and kill endothelial cells, partly by 
apoptosis, as shown by nuclear morphology and DNA fragmentation[275].  Metabolically active 
intracellular staphylococci are required for the induction of apoptosis in endothelial cells, which is 
dependent on agr and sigB[7].  Strains with invasive and haemolytic phenotypes are normally 
associated with caspase-dependent induction of apoptosis, while non-invasive haemolytic and non-
haemolytic invasive isolates are not[7].  For the induction of apoptosis in pulmonary epithelial cells, 
bacterial internalisation, as well as bacterial intracellular replication is required[274].  This is not the 
case for all epithelial cell lines. 
 
In mesothelial cells, invasive S. aureus strains producing α-toxin are associated with the ability to 
induce host cell death.  Host cell death is induced via apoptosis, independently of caspases[291].  S. 
aureus biofilms are also able to induce apoptosis in human keratinocytes[292].  S. aureus released 
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from dead or dying cells are capable of re-infecting new cells, thus continuing the progress of 
infection by establishing persistent or recurrent infections, as in the case of osteomyelitis.[293]. 
 
4.1.5.1 α-toxin: 
 
S. aureus α-toxin triggers the activation of caspase and DNA fragmentation in Jurkat T-cells via the 
intrinsic death pathways, irrespective of the cell death receptor[294], resulting in apoptosis of the host 
cell.  However, this toxin can also lead to the destruction of its host cell in a caspase-independent 
manner even if caspases are activated, resembling cell necrosis[295] which is characterised by cell 
swelling and cytoplasmic vacuolation.  In Jurkat T-cells, α-toxin induced apoptosis is exclusively 
facilitated by the mitochondrial pathway, whereas in human peripheral blood mononuclear cells 
(MNC), endogenous tumour necrosis factor-α (TNF-α) and a death receptor-dependant pathway are 
involved[296].  This toxin has also been identified as a prominent factor for causing S. aureus-based 
pneumonia and necrotic disease[297].  In monocyte-derived cells, α-toxin activates the NLRP3-
inflammasome (nucleotide-binding domain and Leucine-rich repeats containing gene family, pyrin 
domain containing 3) which results in the activation of caspase-1, leading to cell necrosis[298].  This 
is also the case in vivo[299].  Low doses of α-toxin usually lead to apoptosis, whereas high doses lead 
to cell necrosis[296]. 
 
4.1.5.2 Panton-Valentine leukocidin (PVL): 
 
The two component toxin PVL, another pore-forming toxin, targets PMNs[91], is encoded by the 
lukS/F genes and is associated with distinct lineages of CA-MRSA[67]and some endemic MSSA 
lineages.  It is one of the main virulence factors required to cause necrotising pneumonia[66, 92] or 
skin-associated infections[65].  However, the role of PVL as a major virulence factor for CA-MRSA 
is questioned, as some studies have shown that PVL- strains are as virulent as their PVL+ 
counterparts[95].  This toxin also displays species and cell-type dependant cytotoxicity[91]. 
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4.1.5.3 Other toxins: 
 
The hemolysin β-toxin, a sphingomyelinase C, induces lysis of erythrocytes depending on the 
amount of sphingomyelin present in the plasma membrane[300].  This toxin can also kill monocytes, 
an action associated with cytokine-related events[300].  δ-toxin is a pore-forming toxin (PFT) which 
has haemolytic activity and can activate neutrophils in vitro[101] and is structurally related to PSMs.  
γ-toxin is one of the most important and prominent leucotoxins produced by S. aureus and is 
secreted by 99% of all strains[101].  PSMs are highly effective leucotoxins (also PFTs) which were 
discovered not too long ago.  They seem to play a very important role in the pathogenesis of MSSA 
and CA-MRSA infections, especially during necrotising disease and in vivo during murine skin 
abscess and bacteraemia models[49].  Other leukocidins, such as LukGH and LukAB, can also be 
expressed by some CA-MRSA, such as USA300 isolates[301, 302].  These toxins also have a cytotoxic 
effect on human PMNs and can work in synergism with PVL to enhance virulence. 
 
4.1.6 Regulation of host cellular invasion and host cell death induction: 
 
Both the global regulators agr and sar are involved in invasion and induction of host cells[78].  Agr-, 
sar- and agr-sar- mutants of a laboratory isolate were able to invade mammalian cells at much 
greater levels than their parent strain, but all failed to induce apoptosis[78].  Agr deficient isolates fail 
to express agr-dependent virulence factors, such as α-toxin and struggle to induce cell death[303].  
USA300 CA-MRSA isolates activate their agr operon in human polymorphonuclear cells (PMNs) 
resulting in PMN lysis by α-toxin[304].  Both of these regulators are also activated upon in vivo 
infection[305].  The organism adapts after internalisation by up-regulating genes involved in 
virulence[306] and iron-scavenging and down-regulating those involved in cell division and nutrient 
transport[276].  Differences exist between the regulation of virulence factors, such as α-toxin, in vivo 
when compared to in vitro conditions[307].  In vivo, the regulator sae plays an important role, which, 
together with agr have been identified as independent up-regulators of virulence[308]. 
Other regulators have also been identified, such as rsr (repressor of sarR), that represses the agr 
locus, thus inhibiting virulence[309]. 
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4.2 Aims and Objectives 
 
4.2.1 Study aim: 
 
The aim of the research presented in this chapter was to investigate the cellular invasiveness and 
host cell death induction of representative S. aureus isolates.  The representative isolates were 
selected from various clonal lineages previously identified to be in circulation and are associated 
with clinical or bacterial characteristics, such as methicillin-resistance, male gender or patient HIV+ 
status.  The same representative isolates as in the previous chapters were used. 
 
4.2.2 Study objectives: 
 
1. To investigate the abilities of the representative isolates to invade human cells using a flow 
cytometry-based assay. 
2. To investigate the abilities of the representative isolates to induce the death of human cells by 
measuring the following three end points: 
a. Hypodiploid nuclei as an indicator of the induction of apoptosis; 
b. LDH release as an indicator of cell necrosis; and 
c. Respiratory activity of mitochondria as an early indicator of cell viability. 
3. To investigate if any statistical associations are present between invasiveness or cell death 
induction and: 
a. Clonality; 
b. Methicillin-resistance; 
c. Bacterial PVL status, i.e. PVL+ or PVL-; and 
d. Patient HIV status. 
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4.3 Materials and Methods 
 
4.3.1 Chemicals, reagents, media and kits: 
 
All chemicals, reagents, consumables and kits used during this research were analytical and/or 
molecular biology grade. 
 
4.3.2 Bacterial strains and growth conditions: 
 
All bacterial isolates used were sub-cultured on 5% blood agar plates (Bio-Merieux, France) and 
incubated overnight at 37 ºC.  2-3 colonies of bacteria were used to inoculate 20 ml Mueller-Hinton 
broth (MHB), which was incubated statically for 16 h at 37 °C. 
 
4.3.3 Control strains and compounds: 
 
The laboratory strain Cowan I was used as an invasive control (positive control) for the flow 
cytometric-based invasion assay.  The S. carnosus strain TM300 was used as a non-invasive control 
(negative control) for the invasion assay and as a non-cytotoxic control (negative control) for all 
three of the cell death assays employed.  The laboratory isolate 6850 was used as a cytotoxic control 
(positive control) for all three cell death assays.  During all cell death assays, Triton-X (Roth, 
Germany) and staurosporine (Roche Diagnostics, Germany) were also included as cytotoxic 
chemical controls (positive controls).  Staurosporine induces cell death through the inhibition of 
protein kinase C, while Triton-X, a detergent, is known to be a potent cytotoxic compound.  All 
buffer compositions are listed in Tables 4.1 and 4.2 at the end of this section. 
 
4.3.4 Flow cytometric invasion assay: 
 
The cellular invasiveness of the representative isolates was determined by adapting a previously 
published flow cytometric-based invasion assay[103, 310].  After the labelling of the bacterial cultures 
with fluorescein isothiocyanate (FITC) (Fluka BioChemika, Switzerland), they were fixed and 
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allowed to invade cultured mammalian cells.  Following this, the fluorescent signals emitted from 
the trypsinised wells were measured using a FACS Calibur (BD Biosciences, USA) and compared 
to that of an invasive control (set at 100%) and a non-invasive isolate (<10% of invasive control). 
 
4.3.4.1 FITC-labelling and fixation of bacteria: 
 
Bacteria were grown in 50 ml tubes as described in section 4.3.2.  The tubes were centrifuged at 4 
000 rpm for 5 min, the supernatant discarded and the bacterial pellet was completely dissolved in 
2.5 ml 1× PBS.  2.5 ml 4% formaldehyde (Roth, Germany) was added to the bacterial suspension 
and mixed thoroughly by vortexing.  The bacterial suspension was incubated for 1 h at 37 °C to 
allow for bacterial fixation, where after the tubes were centrifuged again at 4 000 rpm for 5 min, the 
supernatant discarded and the pellet washed thoroughly with 5 ml 1× PBS by vortexing. 
Next, the FITC-staining solution was prepared as follows: a 4.2% NaHCO3 (Roth, Germany) and a 
5.3% Na2CO3 (Roth, Germany) solution were prepared and 5.8 ml of the 4.2% NaHCO3 solution 
was mixed with 10 ml of the 5.3% Na2CO3 solution, thus preparing the FITC-buffer.  1 mg FITC 
powder was dissolved in 1 ml DMSO (Invitrogen, USA), where after 9 ml of the FITC-buffer was 
mixed with the 1 ml FITC-DMSO solution, thus preparing the FITC-staining solution. 
Following this, the freshly washed bacterial suspension was centrifuged again at 4 000 rpm for 5 
min and the pellet completely dissolved in 3 ml FITC-staining solution.  The bacterial-FITC 
suspension was then incubated at 37 °C for 30 min, centrifuged at 4 000 rpm for 5 min and the 
pellet washed with 1× PBS.  The FITC-labelled bacterial culture was then standardised to OD 1540nm 
as described in Chapter 3, section 3.3.5. 
A fresh overnight culture was fixed, labelled and normalised for every experiment. 
 
4.3.4.2 Mammalian cell culture: 
 
293 cells (adenovirus type 5 DNA-transformed primary human embryonic kidney cells), an 
adherent cell line, were used to investigate the cellular invasiveness of the representative isolates.  
(www.atcc.org) 293 cells were maintained in DMEM/F-12 (Invitrogen, USA) supplemented with 
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10 % FCS (PAA Laboratories, Austria) and 1× Pen/strep mix (100 U/ml Penicillin and 100 µg/ml 
Streptomycin) (Cambrex Bio Science, Belgium).  A medium-sized flask was split twice weekly 1:5 
by 1 ml of 1× Trypsin-EDTA (Invitrogen, USA).  Cells were only used up to passage 25 and 
maintained in humidified air (37°C with 5% CO2). 
 
4.3.4.3 Invasion assay: 
 
293 cells (epithelial cells) were plated in 24-well culture dishes at 300 000 cells/well on the day 
before the assay.  On the day of the assay, the cells were washed once with 500 µl invasion 
medium.  500 µl invasion medium was added to every well and each plate was pre-cooled at 4°C 
for 20 min.  Following this, 50 µl bacterial suspension (adjusted to OD 1540nm) was added to every 
well, resulting in a MOI (multiplicity of infection) ~ 30 and incubated for 1 h at 4°C to allow for 
bacterial sedimentation onto the cell monolayer and to synchronise the following internalisation 
step.  The remaining bacterial suspension was kept in the dark at 4°C for later FLOW-analyses.  
After the initial 1 h incubation, the cells were moved to 37 °C with 5% CO2 for 3 h to allow for 
bacterial invasion.  After invasion, the cells were removed from the incubator, washed once with 1× 
PBS and trypsinised with 200 µl Trypsin-EDTA (Invitrogen, USA).  1 ml stop medium was quickly 
added to each well to stop trypsinisation and the cells were resuspended and collected in FACS 
tubes. 
The following controls were included: strains Cowan I and TM300, as mentioned in section 4.3.3, 
and cells only (without bacteria). 
 
4.3.4.4 Flow cytometry: 
 
After collection of the cells in the FACS tubes, the tubes were centrifuged at 1 000 rpm for 5 min at 
4 °C and the supernatant aspirated with an aspiration pump.  The cell pellet was resuspended in 500 
µl of 1% HSA/PBS, 1 µl/ml monensin (25 mM) (Fluka BioChemika, Switzerland) was added to 
each tube (to neutralise fluorescence quenching) and mixed carefully to not disrupt the cells.  The 
tubes were incubated in the water bath at 37 °C for 15 min and placed on ice.  Before measurement 
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of the cells, 50 µl propidium iodide (PI) (5 µg/ml) (Fluka BioChemika, Switzerland) was added to 
each tube and vortexed to allow for PI-based exclusion of dead cells. 
Cells were analysed on a FACS Calibur (BD, New Jersey, USA), with which a pre-set fixed 
forward and side scatter (FSC/SSC) gating and fixed amplification was used for the 293 cells.  
Fluorescence was analysed in the Fl-1 channel for FITC and Fl-3 channel for PI.  After acquisition, 
histograms of the fluorescence (Fl-1 height) of FSC/SSC-gated cells were obtained.  Less than 2% 
of the cells of the respective cells-only control were included in the fluorescence intensity marker 
(M), which was pre-set. 
The FITC-labelled bacterial suspension was also analysed with the FACS Calibur to determine the 
mean fluorescence intensity of the bacterial population, which was measured also in the Fl-1 
channel. 
 
4.3.4.5 Analyses of flow cytometric data: 
 
The results obtained for the cells were normalised according to the mean fluorescence intensity of 
the respective bacterial population.  The results obtained were expressed as the average of the mean 
values with the SEM (standard error of the mean) of three independent experiments performed in 
duplicate.  Cellular invasiveness of the representative isolates was expressed as a percentage 
relative to the positive control (Cowan I), which was set at 100%.  An arbitrary cut-off value of 
50% (relative to the invasive control Cowan I) was used to discriminate between invasive (≥ 50%) 
and non-invasive (< 50%) isolates. 
 
4.3.5 Induction of cell death assays: 
 
The abilities of the representative isolates to induce the death of host-cells were investigated using 3 
different end points, as no data regarding the potential cytotoxicity of South African S. aureus 
isolates is available and it is known that S. aureus can induce host cell death using a variety of 
pathways, i.e. apoptotic and necrotic.  The Nicoletti assay is a flow cytometric assay that measures 
the proportion of hypodiploid nuclei (an indicator of the induction of apoptosis) present in a 
population of cells.  The 2nd assay used to measure cell death was a cytotoxicity detection kit, where 
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the release of the enzyme lactate dehydrogenase (LDH) into the culture supernatant was measured, 
normally a signal of cell necrosis.  The last assay used was a cell-viability assay using the reagent 
WST-1, which is cleaved to formazan by the mitochondrial dehydrogenases of metabolically active 
cells. 
 
4.3.5.1 Nicoletti assay: 
 
An adapted version of this previously published protocol was used[7, 311].  Bacteria were grown in 50 
ml tubes as described in section 4.3.2 and standardised to OD 1540nm as described in Chapter 3, 
section 3.3.5.  A fresh overnight culture was standardised for every experiment. 
Ea.hy926 (endothelial cells)[312] (human umbilical vein cell line) (www.atcc.org), an adherent cell 
line, were used to investigate the abilities of the representative isolates to induce cell death.  
Ea.hy926 cells were maintained in DMEM/F-12 (Invitrogen, USA) supplemented with 10% FCS 
(Invitrogen, USA) and 1× Pen/strep mix (100U/ml Penicillin and 100 µg/ml Streptomycin) 
(Cambrex Bio Science, Belgium).  A medium-sized flask was split twice weekly 1:4 by 1× Trypsin-
EDTA (Invitrogen, USA).  Cells were only used up to passage 25 and maintained in humidified air 
(37°C with 5% CO2). 
 
Ea.hy926 cells were plated in 24-well culture dishes at 300 000 cells/well on the day before the 
assay.  On the day of the assay, the cells were washed once with 500 µl invasion medium, where 
after 500 µl invasion medium was added to every well and each plate was pre-cooled at 4 °C for 30 
min.  Following this, 50 µl bacterial suspension (adjusted to OD 1540nm) was added to every well, 
resulting in a MOI ~ 30 and incubated for 1h at 4 °C to allow for bacterial sedimentation.  After the 
initial 1 h incubation, the cells were moved to 37 °C with 5% CO2 for 3 h to allow for bacterial 
invasion.  After invasion, the cells were removed from the incubator and washed once with 1× PBS.  
Fresh, full DMEM/F-12 (Invitrogen, USA) media, supplemented with lysostaphin (20 µg/ml) 
(AMBI, USA) was added to every well and the cells were incubated for a further 21 h at 37 °C with 
5% CO2.  After this, the supernatant of each well was transferred to a FACS tube, the cells washed 
once with 500 µl 1× PBS (which was also transferred to its respective FACS tube) and then 
trypsinised with 200 µl Trypsin-EDTA (Invitrogen, USA).  The 24-well plates were shaken slightly 
to dislodge all cells1 ml, stop medium was added to each well to stop trypsinisation, cells were 
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resuspended and transferred to the respective FACS tubes for flow cytometric analyses.  The 
following controls were included: strains 6850 and TM300, as mentioned in section 4.3.3, and cells 
only (without bacteria).  The following chemical controls, known to induce cell death, were also 
included: 1% Triton-X, 1 µM and 0.1 µM staurosporine (Roche Diagnostics, Germany). 
 
After collection of the cells in the tubes, the tubes were centrifuged at 4 000rpm for 5 min at 4 °C 
and the supernatant aspirated with an aspiration pump until 100 µl was left, which was used to 
resuspend the cell pellet with.  500 µl Nicoletti-PI buffer was added to every FACS tube, which was 
vortexed immediately to keep the bacterial pellet resuspended.  The cells were incubated in the dark 
for 1 h at 4 °C and analysed on ice using a FACSCalibur (BD, New Jersey, USA) at 488 nm laser 
excitation. 
Cells were analysed on a FACSCalibur (BD, New Jersey, USA), with which a pre-set fixed forward 
and side scatter (FSC/SSC) gating and fixed amplification was used for the Ea.hy926.  Fluorescence 
was analysed in the Fl-2 channel for PI.  After acquisition, histograms of the fluorescence (Fl-2 
height) of FSC/SSC-gated cells were obtained.  Less than 3% of the cells of the respective cells-
only control were included in the fluorescence intensity marker (M), which was pre-set. The PI 
fluorescence peak from the nuclei of the viable cells-only control was set at channel >1000.  Nuclei 
from apoptosis cells should give a PI fluorescence peak in channels 5-1000, i.e. below that of the 
viable cells. 
 
The results obtained were expressed as the average of the mean values with the SEM of three 
independent experiments performed in duplicate.  The percentage of the number of intact cells 
present, relative to the cells only control which was set at 100%, was determined as x, and the 
equation 1 – x was used to determine induction of host cell death of the representative isolates, i.e. 
the % of dead cells.  An arbitrary cut-off value of 50% (relative to the cytotoxic control) was used 
to discriminate between cytotoxic (≥ 50%) and non/moderately cytotoxic (< 50%) isolates. 
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4.3.5.2 LDH assay: 
 
This assay was performed using the “LDH cytotoxicity” kit (Roche Diagnostics, Germany) as per 
the recommendation of the manufacturer.  Bacteria were grown as in 50 ml tubes as described in 
section 4.3.2 and standardised to OD 1540nm as described in Chapter 3, section 3.3.5.  A fresh 
overnight culture was standardised for every experiment. 
 
Ea.hy926 cells were maintained as described in Section 4.3.5.1.  Ea.hy926 cells were plated in 96-
well culture dishes at 50 000 cells/well on the day before the assay.  On the day of the assay, the 
cells were washed once with 500 µl invasion medium, where after 500µl invasion medium was 
added to every well and each plate was pre-cooled at 4 °C for 30 min.  Following this, 20 µl 
bacterial suspension (adjusted to OD 1540nm) was added to every well, resulting in a MOI ~ 30 and 
incubated for 1 h at 4 °C to allow for bacterial sedimentation.  After the initial 1 h incubation, the 
cells were moved to 37 °C with 5% CO2 for 3 h to allow for bacterial invasion.  After invasion, the 
cells were removed from the incubator and washed once with 1× PBS.  Fresh, full DMEM/F-12 
media (Invitrogen, USA), supplemented with lysostaphin (20 µg/ml) was added to every well and 
the cells were incubated for a further 21 h at 37 °C with 5% CO2.  1 h before the end of the 21 h 
incubation period, Triton-X (1%) was added to its respective wells and the cells were incubated for 
the remaining hour.  After this, the 96-well plate was centrifuged for 10 min at 1 000 rpm, where 
after 25 µl of the supernatant from each well was transferred to the same well in a fresh, sterile 96-
well plate, already containing 150 µl 1× PBS/well and the original plate was stored at 4 °C in the 
dark.  The LDH reaction mixture was prepared fresh every time as per the manufacturers´ 
recommendation and 25 µl of this mixture was added to every well of the plate containing the 
supernatant-PBS mixture.  The plate was then incubated at RT for 30 min, covered in aluminium 
foil, where after the absorbance of each well was measured using an ELISA reader. 
 
The following controls were included: strains 6850 and TM300, as mentioned in section 4.3.3, cells 
only (without bacteria) and media only (without cells and bacteria).  The following chemical 
controls, known to induce cell death, were also included: 1% Triton-X, 10 µM and 1 µM 
staurosporine. 
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The absorbance was measured using a Tecan Reader Infinite F200 Pro (Tecan GmbH, Germany) at 
490nm, with a reference reading at >600nm.  The value obtained from the media only control was 
subtracted from the values obtained for all the remaining controls and all strains tested.  % 
cytotoxicity was determined using the following equation: 
 
 
The value obtained for the cells only control was used as the low control and those obtained for the 
1% Triton-X was used as the high control.  Using the above given formula, when the low control 
value is used as the “experimental value”, the value for the cells only control (negative control) is 
set to 0% cytotoxicity, and when the high control value is used, the value for the 1% Triton-X is set 
to 100% cytotoxicity. 
The results obtained were expressed as the average of the mean values with the SEM of three 
independent experiments each performed in triplicate.  The abilities of the representative isolates to 
induce cell death was measured by the release of LDH from the cytosol into the culture supernatants 
and were expressed as a percentage relative to the 1% Triton-X control, which was set at 100%.  
The % cytotoxicity for strain 6850 was expected to be >70% and that of strain TM300 <10%.  An 
arbitrary cut-off value of 50% (relative to the cytotoxic control) was used to discriminate between 
cytotoxic (≥ 50%) and non/moderately cytotoxic (< 50%) isolates. 
 
4.3.5.3 WST-1 cell viability assay: 
 
This assay was performed using the WST-1 ready-to-use reagent[296] (Roche Diagnostics, Germany) 
as per the recommendation of the manufacturer.  This assay was designed in a 96-well plate format 
for the spectrophotometric quantification of cell viability.  WST-1, a tetrazolium salt, is cleaved to 
formazan by the mitochondrial dehydrogenases of metabolically active cells.  An ELISA reader can 
then be used to measure the absorbance of the sample, thus quantifying the formazan dye. 
Bacteria were grown as in 50 ml tubes as described in section 4.3.2 and standardised to OD 1540nm 
as described in Chapter 3, section 3.3.5.  A fresh overnight culture was standardised for every 
experiment. 
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Ea.hy926 cells were maintained as described in section 4.3.5.1.  Ea.hy926 cells were plated in 96-
well culture dishes at 50 000 cells/well on the day before the assay.  On the day of the assay, the 
cells were washed once with 500 µl invasion medium, where after 500 µl invasion medium was 
added to every well and each plate was pre-cooled at 4 °C for 30 min.  Following this, 20 µl 
bacterial suspension (adjusted to OD 1540nm) was added to every well, resulting in a MOI ~ 30 and 
incubated for 1 h at 4 °C to allow for bacterial sedimentation.  After the initial 1 h incubation, the 
cells were moved to 37 °C with 5% CO2 for 3 h to allow for bacterial invasion.  After invasion, the 
cells were removed from the incubator and washed once with 1× PBS.  Fresh, full DMEM/F-12 
(Invitrogen, USA) media, supplemented with lysostaphin (20 µg/ml) was added to every well and 
the cells were incubated for a further 21 h at 37 °C with 5% CO2.  Following this incubation step, 5 
µl WST-1 reagent (Roche Diagnostics, Germany) was added to every well and mixed by orbital 
agitation for 10 s on an orbital shaker at 100 rpm.  The cells were incubated for another 2 h at 37 °C 
with 5% CO2, where after the absorbance of each well was measured using an ELISA reader. 
The following controls were included: strains 6850 and TM300, as mentioned in section 4.3.3, cells 
only (without bacteria) and media only (without cells and bacteria).  The following chemical 
controls, known to induce cell death, were also included: 1% Triton-X, 1 µM and 0.1 µM 
staurosporine. 
The absorbance was measured using a Tecan Reader Infinite 200 Pro (Tecan GmbH, Germany) at 
490nm, with a reference reading at >600nm.  The value obtained from the media only control was 
subtracted from the values obtained for all the remaining controls and all strains tested. 
The results obtained were expressed as the mean of the mean with the SEM of three independent 
experiments performed in triplicate.  The abilities of the representative isolates to induce cell death 
were determined after the % of viable cells relative to the cells only control, which was set at 100%, 
was deducted from 1 and expressed as a %.  An arbitrary cut-off value of 50% (relative to the 
cytotoxic control) was used to discriminate between cytotoxic (≤ 50%) and non/moderately 
cytotoxic (> 50%) isolates. 
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4.3.6 Statistical associations: 
4.3.6.1 Associations between invasion or host cell death induction and methicillin-resistance 
or clonality: 
 
To investigate if any associations existed between invasion/cell death and methicillin-resistance, 
two tests were performed.  Firstly, as a parametric comparison, the 2-sample t-test was also used.  A 
confidence interval of 95% was used and an association was regarded as statistically significant if a 
p-value < 0.05 was obtained.  Secondly, as a non-parametric comparison, the 2-sample Wilcoxon 
rank-sum test (Mann-Whitney test) was used.  An association was regarded as statistically 
significant if a p-value < 0.05 was obtained. 
To investigate if any associations existed between invasion/cell death and clonality, the Kruskal-
Wallis test was performed as a comparison using non-parametric inference.  In order for us to 
compare all groups in a valid fashion, a group was created which was composed of all the 
singletons.  An association was regarded as statistically significant if a p-value < 0.05 was obtained. 
 
4.3.6.2 Associations between invasion or host cell death induction and patient HIV status or 
bacterial PVL status: 
 
To investigate if any associations existed between invasion or host cell death induction and patient 
HIV status, the Kruskal-Wallis test was performed as a comparison using non-parametric inference.  
An association was regarded as statistically significant if a p-value < 0.05 was obtained. 
 
To investigate if any associations existed between invasion or host cell death induction and bacterial 
PVL status, i.e. PVL-positive or negative, the 2-sample Wilcoxon rank-sum test (Mann-Whitney 
test) was used.  An association was regarded as statistically significant if a p-value < 0.05 was 
obtained. 
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4.3.7 Composition of agar, broth, media and buffers: 
 
Table 4.1 Composition of agar and broth used during invasion and cell death assays. 
Media Composition 
5% Blood 
agar plate 
15 g pancreatic digest of casein; 15 g papaic digest of soy meal; 
5 g NaCl; 15 g agar; 
Bring to volume of 1l and autoclave 
Adjust pH to 7.3 
Cool to 45-50°C; add 5% (v/v) sterile defibrinated blood; mix 
MH broth 
2 g dehydrated beef infusion; 17.5 g casein hydrolysate; 1.5 g 
starch; 
Bring to volume of 1l and autoclave 
Adjust pH to 7.4 
 
Table 4.2 Composition of media and buffers used during invasion and cell death assays. 
Buffer/Solution Composition 
1× PBS 
8 g NaCl; 0.2 g KCl; 1.44 g Na2HPO4; 0.24 g KH2PO4 in 800 ml 
dH2O 
Adjust pH to 7.4 
Add H2O to 1 l and autoclave 
1% HSA/PBS 1:20 of 20% HSA in PBS 
Invasion medium 1%HSA; 10 mM HEPES; white DMEM/F12 
Stop medium 10% FCS in white DMEM/F12 
Nicoletti-PI buffer 0.1% Triton-X; 0.1% sodium citrate; 50 µg/ml PI 
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4.4 Results 
 
This chapter deals with the cellular invasiveness and capabilities to induce host cell death of the set 
of representative S. aureus clinical isolates.  We determined invasiveness in 293 cells using a 
FACS-based assay and the ability to induce cell death using 3 assays for three different end points: 
(1) A FACS-based assay measuring hypodiploid nuclei as a sign of apoptosis; (2) the amount of 
LDH released into the supernatant as a sign of cell necrosis; and (3) the chemical conversion of the 
reagent WST-1 as a sign of cell viability. 
 
4.4.1 Cellular invasiveness: 
 
The cellular invasiveness of the representative isolates was determined using a FACS-based assay 
with FITC stained bacteria, which included bacterial invasive and non-invasive controls.  These 
controls behaved as expected. 
 
As can be seen in Figure 4.2, the cellular invasiveness of the 25 representative isolates were quite 
diverse (range 42.4% - 211.6% relative to the invasive control [Cowan I set at 100%]; mean = 
142.6%; median = 142.2%).  Using an arbitrary cut-off value of 50% to distinguish non-invasive 
from invasive isolates, all isolates, irrespective of the MLST CC were invasive, except for the 
ST121 isolate, THW-366 (MSSA PVL+, associated with SSTI).  Two isolates could be classified as 
highly invasive (>200%): THW-273 (ST612:CC8; HIV+ clone) and THW-356 (ST45:CC45; PVL- 
MSSA).  Due to the inability of the bacterial pellet to dissolve in PBS after fixations, we were 
unable to determine the invasiveness of isolate THW-264 for repeated experiments (ST5:CC5; 
SCCmec I; PVL- MRSA). 
No significant difference in invasiveness was observed between isolates from HIV+ or HIV- 
patients (Figure 4.3). 
The invasiveness of the non-invasive control, TM300, was <10% relative to Cowan I. 
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Figure 4.2 Differences in host cell invasiveness of the representative South African S. aureus isolates in 293 cells, expressed as a percentage 
relative to the invasive control, Cowan I. 
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Figure 4.3 Invasiveness of representative South African S. aureus isolates grouped according to 
MLST CC and displayed according to HIV status. 
 
4.4.2 Induction of host cell death: 
 
The cell death induction abilities of the representative isolates were determined using three different 
assays.  All three assays included cells-only controls and various chemical controls as inducers of 
cell death.  Bacterial cytotoxic and non-cytotoxic controls were also included in every assay. 
 
4.4.2.1 Nicoletti assay: 
 
As can be seen in Figure 4.4, induction of host cell death of the 25 representative isolates was 
diverse (range 23.7% - 79.6% relative to the cells only control [set at 100% and inverted]; mean = 
65.4%; median = 69.6%), although 21 of the isolates killed >60% of the cells they invaded. 
 
 
Unknown HIV status 
HIV negative 
HIV positive (associated) 
HIV positive (isolated) 
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Figure 4.4 Differences in induction of host cell death of the representative South African S. aureus isolates in Ea.hy926 cells, expressed as a 
percentage relative to the cells only control. 
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Using an arbitrary cut-off value of 50% to distinguish non-cytotoxic from cytotoxic isolates, 22/25 
isolates were cytotoxic. 
The following three isolates were non-cytotoxic using this assay: (1) THW-366 (ST121:CC121; 
PVL+ MSSA; associated with SSTI); (2) THW-264 (ST5:CC5; SCCmec I; PVL- MRSA); and (3) 
THW-382 (ST36:CC30; SCCmec II; PVL- MRSA).  Thirteen isolates could be classified as very 
cytotoxic (>70 % cell death) (CC22, CC8, CC15, CC5, CC97, CC88). 
No significant difference in host cell death was observed between isolates from HIV+ or HIV- 
patients (Figure 4.5). 
 
 
Figure 4.5 Induction of host cell death of representative South African S. aureus isolates 
grouped according to MLST CC and displayed according to HIV status. 
 
The cytotoxicity of the non-cytotoxic control, TM300, was <10% relative to the cells only control, 
while that of the cytotoxic control, 6850, was >70%.  The 1% Triton-X control displayed nearly 
100% cytotoxicity, while a dose-dependent response was seen with the staurosporine controls, 
where the 1µM staurosporine control had a cytotoxic effect, while the 0.1µM staurosporine was 
non-cytotoxic. 
Unknown HIV status 
HIV negative 
HIV positive (associated) 
HIV positive (isolated) 
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4.4.2.2 LDH assay: 
 
Induction of host cell death of the 25 representative isolates (as displayed in Figure 4.6), measured 
by the release of LDH into the culture supernatant, was also quite diverse (range 34.1% - 94.3% 
relative to the cytotoxic chemical control [1% Triton-X set at 100%]; mean = 61.4%; median = 
59.6%). 
 
Using an arbitrary cut-off value of 50% to distinguish non-cytotoxic from cytotoxic isolates, 22/25 
isolates were cytotoxic and three non-cytotoxic, of which two were also classified as non-cytotoxic 
using the Nicoletti assay.  The following three isolates were non-cytotoxic using this assay: (1) 
THW-366 (ST121:CC121; PVL+ MSSA; associated with SSTI); (2) THW-264 (ST5:CC5; 
SCCmec I; PVL- MRSA); and (3) THW-99 (ST239:CC8; SCCmec NT).  Using this assay, 9 
isolates could be classified as very cytotoxic (>70% cell death) (CC22, CC30, CC8, CC15, CC45, 
CC88). 
 
No significant difference in host cell death was observed between isolates from HIV+ or HIV- 
patients (Figure 4.7). 
 
The cytotoxicity of the non-cytotoxic control, TM300, was <10% relative to the 1% Triton-X 
control, while that of the cytotoxic control, 6850, was >75%.  The 1% Triton-X control was set at 
100% cytotoxic, while a dose-dependent response was seen with the staurosporine controls, where 
the 10µM staurosporine control had a cytotoxic effect, while the 1µM staurosporine was 
categorised as non-cytotoxic. 
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Figure 4.6 Differences in induction of host cell death of the representative South African S. aureus isolates in Ea.hy926 cells, expressed as a 
percentage relative to the cytotoxic chemical control, 1% Triton-X. 
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Figure 4.7 Induction of host cell death of representative South African S. aureus isolates 
grouped according to MLST CC and displayed according to HIV status. 
 
4.4.2.3 WST-1 cell viability assay: 
 
As can be seen in Figure 4.8, induction of host cell death of the 25 representative isolates, measured 
by the conversion of the chemical WST-1 by metabolically active mitochondria, was also quite 
diverse (range 68% - 27.1% relative to the cells only control [set at 100% and inverted]; mean = 
38.1%; median = 36%). 
 
Using an arbitrary cut-off value of 50% cell viability to distinguish non-cytotoxic from cytotoxic 
isolates, 22/25 isolates were cytotoxic and three were non-cytotoxic, of which the same two isolates 
were previously classified as non-cytotoxic using the Nicoletti and LDH assays.  The following 
three isolates were non-cytotoxic using this assay: (1) THW-366 (ST121:CC121; PVL+ MSSA; 
associated with SSTI); (2) THW-264 (ST5:CC5; SCCmec I; PVL- MRSA); and (3) THW-81 
(ST239:CC8; PVL- MRSA).  Using this assay, 7 isolates could be characterised as very cytotoxic 
(<30% viable cells) (CC22, CC8, CC45, CC88). 
Unknown HIV status 
HIV negative 
HIV positive (associated) 
HIV positive (isolated) 
 
 
 
 
CC22 CC30 CC45 CC15 CC8 CC97 CC88 CC5 CC6 CC12 CC121 
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Figure 4.8 Differences in cell viability after induction of host cell death of the representative South African S. aureus isolates in Ea.hy926 cells, 
expressed as a percentage relative to the cells only control. 
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No significant difference in host cell death was observed between isolates from HIV+ or HIV- 
patients (Figure 4.9). 
 
The cytotoxicity of the non-cytotoxic control, TM300, was >85% relative to the cells only control, 
while that of the cytotoxic control, 6850, was <60%.  The 1% Triton-X control displayed 100% 
cytotoxicity, while a dose-dependent response was seen with the staurosporine controls, where the 
1µM staurosporine control had a cytotoxic effect, while the 0.1µM staurosporine was non-
cytotoxic. 
 
 
Figure 4.9 Cell viability after induction of host cell death of representative South African S. 
aureus isolates grouped according to MLST CC and displayed according to HIV 
status. 
 
4.4.3 Statistical associations: 
 
No association was identified between invasion or cell death and methicillin-resistance, using either 
the Mann-Whitney test or the 2-sample t-test, as displayed in Table 4.3, or between invasion or cell 
Unknown HIV status 
HIV negative 
HIV positive (associated) 
HIV positive (isolated) 
 
 
 
 
CC22 CC30 CC45 CC15 CC8 CC97 CC88 CC5 CC6 CC12 CC121 
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death and patient HIV status (Table 4.5).  No association was also identified between cell death and 
clonality (Table 4.4).  CC8 isolates were the only isolates statistically associated with being 
invasive, displayed in Table 4.4. 
 
Table 4.3 Statistical associations between invasion/cell death and methicillin-resistance. 
Assay 
Mann-Whitney test 2-sample t-test 
Association with 
methicillin-resistance 
p-value 
Association with 
methicillin-resistance 
p-value 
Invasion No association 0.681 No association 0.112 
Nicoletti No association 0.680 No association 0.901 
LDH No association 0.507 No association 0.910 
WST-1 No association 0.577 No association 0.319 
 
Table 4.4 Statistical associations between invasion/cell death and clonality.  Statistically 
significant values are displayed in bold. 
Assay 
Kruskal-Wallis test 
Association with clonality p-value 
Invasion CC8 0.036 
Nicoletti No association 0.295 
LDH No association 0.324 
WST-1 No association 0.706 
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Table 4.5 Statistical associations between invasion/cell death and patient HIV status. 
Ligand 
Kruskal-Wallis test 
Association with HIV status p-value 
Invasion No association 0.628 
Nicoletti No association 0.089 
LDH No association 0.829 
WST-1 No association 0.101 
 
PVL-negative isolates were more invasive than the PVL-positive isolates, which is displayed in 
Table 4.6. 
 
Table 4.6 Statistical associations between invasion/cell death and bacterial PVL status.  
Statistically significant values are displayed in bold. 
Ligand 
Mann-Whitney test 
Association with PVL status p-value 
Invasion Negative 0.004 
Nicoletti No association 0.758 
LDH No association 0.586 
WST-1 No association 0.525 
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4.5 Discussion 
 
The research described in this chapter indicates that the majority of the isolates in this collection of 
representative strains were both invasive and cytotoxic to mammalian cells in the various in vitro 
assays we used. 
 
4.5.1 Host cellular invasiveness: 
 
We were able to establish that 23/25 isolates were invasive, irrespective of the clonal background of 
the isolate.  Most isolates displayed invasiveness equal to the invasive control, Cowan I, while other 
isolates displayed invasiveness significantly more than that of the invasive control.  Irrespective of 
the statistical test used, no association could be identified between invasion and methicillin-
resistance.  An association between clonality and invasiveness was only identified for CC8 isolates.  
But it should be taken into account that this was the only CC with enough isolates.  CC8 isolates 
displayed the greatest diversity in cellular invasiveness, although all of them were classified as 
being invasive.  The CC8 isolates also had the highest median value for invasion of all the CCs.  
The statistical associations are displayed in Tables 4.3 and 4.4 in section 4.4.3 and Figure 4.10 
below. 
 
Isolates of CC22, CC30, CC15 and CC5 displayed little variation in the degree of invasiveness.  It 
is clear that for isolates from these CCs, being invasive is a clonal characteristic.  Fowler et al. also 
previously reported that most S. aureus genotypes are capable of causing invasive diseases, but that 
CC5 and CC30 isolates displayed greater levels of haematogenous complication[313]. 
Being invasive is also a clonal characteristic for isolates from CC8.  However, the isolates from this 
CC displayed a high degree of variation in invasiveness (range = 133.3% - 200.5%).  We can 
therefore say that being invasive is a clonal trait, but the degree of invasiveness is a strain-specific 
characteristic. 
We are unable to make similar conclusions from the data for isolates of CC45, CC6, CC12, CC97 
and CC88 as only one isolate from each CC was characterised. 
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Figure 4.10 Kruskal-Wallis bar-graph of the cellular invasiveness of the representative isolates. 
 
THW-366 (ST121; PVL+ MSSA; associated with SSTI; 42.4% invasiveness) was the only isolate 
classified as non-invasive and also the only agr IV isolate.  This ST has previously been associated 
with CA-MRSA SSTI in children in Portugal[213], hospitalised patients in Russia[212] and rabbits 
from Belgium and Spain[214].  No data on the invasiveness was available from these studies.  Our 
data also contradicts data published by Zautner et al., who identified three ST121 isolates associated 
with recurrent tonsillitis.  The isolates displayed invasiveness of 33.7%, 56.5% and 65.3% relative 
to Cowan I, the invasive control[286]. 
THW-264 (ST5:CC5; SCCmec I; PVL- MRSA) is another isolate of interest as we were unable to 
determine the invasiveness of this isolate due to technical difficulties.  We can however speculate 
that this isolate might be pls+, since this gene is commonly associated with SCCmec I.  It has 
previously been demonstrated that MRSA isolates expressing pls displayed a significantly reduced 
ability to invade host cells[256, 257, 259].  We can hypothesise that this isolate might very likely be non-
invasive.  This isolate was collected from a paediatric patient suffering from conjunctivitis. 
 
Zautner et al. identified a variety of CCs associated with recurrent tonsillitis-causing isolates as a 
result of intracellular persisting S. aureus.  They characterised these isolates and identified many of 
them to be invasive isolates from CC30, CC45, CC8, CC5, CC15 and CC22[286].  Invasive isolates 
from the same clonal complexes were described during this study.  However, this study was notr 
Clonal complex 
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designed to determine association of strains with a specific clinical syndrome, such as recurrent 
tonsillitis. 
Park et al. investigated the association between invasiveness of clinical S. aureus isolates and their 
abilities to cause metastatic infections[314].  They found that invasiveness of endothelial cells is not a 
major determinant of metastatic infections. 
When investigating the expression patterns of HUVEC cells upon internalisation of S. aureus, Stark 
et al. found that innate immune responses dominated, irrespective of the invasiveness of the 
bacterial isolates[315]. 
 
4.5.2 Induction of host cell death: 
 
4.5.2.1 Nicoletti assay: 
 
We were able to establish that 22/25 isolates were cytotoxic, irrespective of the clonal background 
of the isolate.  Fourteen isolates displayed cytotoxicity equal to or more than the cytotoxic control, 
6850, and were classified as very cytotoxic (>70% cell death).  Using this assay, no isolate induced 
>80% cell death. 
 
Isolates of CC22, CC8 and CC15 displayed little variation in the degree of cell death induction and 
it is clear that for these isolates, inducing the death of their host cells is a clonal characteristic. 
Isolates from CC30 and CC5 displayed a high degree of diversity in their respective abilities to 
induce the death of their host cells (CC30 range = 37% - 64.6% cell death; CC5 range = 23.7% - 
79.6%).  For both CCs, some isolates were classified as being cytotoxic, while one isolate from 
every CC was classified as non-cytotoxic.  Thus, the ability to induce the death of host cells for 
isolates of these CCs is a strain-specific characteristic. 
We are unable to make similar conclusions from the data for isolates of CC45, CC6, CC12, CC97 
and CC88 as only one isolate from every CC was characterised. 
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THW-366 (ST121; PVL+ MSSA; associated with SSTI; 30.6% cell death), the only isolate 
classified as non-invasive, was also classified as non/moderately cytotoxic using this assay.  Based 
on the invasion data for the set of isolates, we can therefore say that invasion is required for the 
induction of cell death. 
THW-264 (ST5:CC5; SCCmec I; PVL- MRSA), the isolate for which we could not determine 
invasiveness, was also classified as non/moderately cytotoxic using this assay (23.7% cell death).  
Actually, it was the least cytotoxic of all the representative isolates.  If this isolate were to express 
pls as hypothesised earlier, it would fail to induce the death of host cells since its ability to invade 
the cells in the first place would be impeded. 
The 3rd isolate classified as non/moderately cytotoxic was THW-382 (ST36:CC30; SCCmec II; 
PVL- MRSA), which was able to induce the death of only 36.9% of the cells using this assay, 
although this isolate was invasive (117.6%).  The clone ST36-MRSA-II is usually associated with 
the clone EMRSA-16[23, 186], an epidemic MRSA clone.  One would expect this clone and progeny 
thereof to be cytotoxic as this clone is globally spread.  It is possible that this is the case as the 
Nicoletti assay measured hypodiploid nuclei and this isolate may induce host cell death employing 
pathways other than apoptosis, such as cell necrosis (61.7% cell death using LDH assay). 
 
4.5.2.2 LDH assay: 
 
We were able to establish that 22/25 isolates were cytotoxic, irrespective of the clonal background 
of the isolate.  Nine isolates displayed cytotoxicity equal to or more than the cytotoxic control, 
6850, and were classified as very cytotoxic (>70% cell death).  Two isolates were regarded as 
extremely cytotoxic, as they induced the death of >90% of the cells (THW-70 [ST612:CC8; 
SCCmec IV; PVL- MRSA] and THW-255 [ST88:CC88; SCCmec IV; PVL+ MRSA]).  Both 
isolates were isolated from SSTIs. 
 
Although the isolates of CC22, CC30 and CC15 displayed variation in the degree of cell death 
induction, it is clear from this data that the ability to induce host cell death is a clonal trait, while the 
degree of cell death induction (cytotoxic vs. very cytotoxic vs. extremely cytotoxic) is a strain-
specific characteristic. 
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Isolates from CC8 and CC5 displayed a high degree of diversity in their respective abilities to 
induce the death of their host cells (CC8 range = 45.6% - 91.2% cell death; CC5 range = 34.1% - 
57.7%).  For both CCs, the majority of isolates were classified as being cytotoxic, while one isolate 
from every CC was classified as non-cytotoxic.  Thus, the ability to induce the death of host cells 
for isolates of these CCs is a strain-specific characteristic.  CC8 isolates vary greatly in their 
abilities to induce host cell death. 
 
We are unable to make similar conclusions from the data for isolates of CC45, CC6, CC12, CC97 
and CC88 as only one isolate from every CC was characterised. 
 
THW-366 (ST121; PVL+ MSSA; associated with SSTI; 40% cell death), the non-invasive isolate, 
was once again classified as non/moderately cytotoxic using this assay. 
THW-264 (ST5:CC5; SCCmec I; PVL- MRSA), the isolate for which we could not determine 
invasiveness, was also classified as non/moderately cytotoxic using this assay (34.1% cell death).  
Again, it was the least cytotoxic of all the representative isolates using this assay.  As previously 
hypothesised, the possible expression of pls would hinder this isolates’ invasiveness, rendering it 
non-invasive and not able to induce host cell death. 
The 3rd isolate classified as non/moderately cytotoxic was THW-99 (ST239:CC8; SCCmec NT), 
which was able to induce the death of only 45.6% of the host cells using this assay, although it was 
invasive (146.7%).  It is possible that this isolate can induce host cell death using pathways other 
than cell necrosis, such as apoptosis (72.1% cell death using Nicoletti assay). 
 
4.5.2.3 WST-1 cell viability assay: 
 
We were able to establish that 22/25 isolates were cytotoxic, irrespective of the clonal background 
of the isolate.  Seven isolates displayed cytotoxicity equal to or more than the cytotoxic control, 
6850, and were classified as very cytotoxic (<30% cell viability). 
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Although the isolates of CC22 and CC30 displayed variation in the degree of cell viability, it is 
clear from this data that the ability to induce host cell death is a clonal trait.  The same is true for the 
isolates from CC15, although they displayed very little variation. 
Isolates from CC8 and CC5 displayed a high degree of diversity in their respective abilities to 
induce the death of their host cells (CC8 range = 55.2% - 22.2% cell viability; CC5 range = 68% - 
31.1%).  For both CCs, the majority of isolates were classified as being cytotoxic, while one isolate 
from every CC was classified as non-cytotoxic.  Thus, the ability to induce the death of host cells 
for isolates of these CCs is a strain-specific characteristic, as isolates from both CCs vary greatly in 
their abilities to induce host cell death. 
 
We are unable to make similar conclusions from the data for isolates of CC45, CC6, CC12, CC97 
and CC88 as only one isolate from every CC was characterised. 
 
THW-366 (ST121; PVL+ MSSA; associated with SSTI; 51% cell viability), the non-invasive 
isolate, was once again classified as non/moderately cytotoxic using this assay. 
THW-264 (ST5:CC5; SCCmec I; PVL- MRSA), the isolate for which we could not determine 
invasiveness, was also classified as non/moderately cytotoxic using this assay (68% cell viability).  
Again, it was the least cytotoxic of all the representative isolates using this assay.  As previously 
hypothesised, the possible expression of pls would hinder this isolates’ invasiveness, rendering it 
non-invasive and not able to induce host cell death. 
The 3rd isolate classified as non/moderately cytotoxic was THW-81 (ST239:CC8; SCCmec III; 
PVL- MRSA), which was able to induce the death of only 44.8% of the host cells using this assay, 
although it was invasive (146.7%).  The reason why this isolate is classified as non-cytotoxic using 
this assay is unclear, since both of the previously discussed assays classified this isolate as cytotoxic 
(72.4% cell death using Nicoletti assay; 52% cell death using the LDH assay). 
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4.5.2.4 Combined host cell death induction data: 
 
When combining all the data of the above discussed assays, it can be seen that 23/25 isolates are 
cytotoxic (>50% cell death using all three assays), irrespective of their genetic background, and the 
remaining two isolates are non-cytotoxic (<50% cell death using all three assays).  Irrespective of 
the statistical test used, no association was identified between cell death and methicillin-resistance 
or between cell death and clonality.  Please refer to Tables 4.3 and 4.4 in section 4.4.3. 
Four isolates stood out as they were the only isolates classified as very cytotoxic according to all 
three assays, resulting in >70% cell death for every assay.  This data shows that PVL+ isolates 
(THW146; THW393; THW255) can be as cytotoxic as PVL- isolates (THW262; THW70; 
THW271; THW273; THW412; THW356) in this setting, but PVL- very cytotoxic isolates are more 
common.  A possible cause of this phenotypic display of high levels of cytotoxicity might be due to 
the action of PSMs. 
The same applied for MSSA and MRSA isolates.  Very cytotoxic MRSA and MSSA isolates were 
identified, and no association was identified between methicillin-resistance and cytotoxicity (refer 
to Table 4.3).  Three very cytotoxic MRSA isolates were identified (THW262; THW70; THW255) 
and one very cytotoxic MSSA isolate was identified (THW356).  Also, one non-cytotoxic MSSA 
and a MRSA isolate were identified. 
 
It is interesting to note that the most cytotoxic MRSA isolates all carry SCCmec IV.  For the ST88 
isolate this makes sense as this ST is associated with CA-MRSA.  ST612 has previously been 
described from hospital isolates in South Africa.  This ST might have originated in the community 
and established itself later on in a health care setting.  Table 4.7 provides more information on these 
isolates. 
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Table 4.7 Isolates classified as very cytotoxic according to all three assays. 
Strain Clone* 
Cell death assay (% cell death) Previous statistical 
associations identified Nicoletti LDH WST-1 
THW-262 ST612-MRSA-IV (THW-O) 79.0 71.7 75.1 MRSA/PVL- 
THW-70 ST612-MRSA-IV (THW-N) 73.4 91.2 77.8 MRSA/PVL- 
THW-356 ST45-MSSA (THW-EE) 70.0 80.7 72.2 MSSA/PVL- 
THW-255 ST88-MRSA-IV (THW-BB) 73.6 94.3 70.7 MRSA/PVL+ 
* Clone name represented as [MLST-MSSA/MRSA-SCCmec (PFGE)] 
 
Four isolates were classified as very cytotoxic according to the Nicoletti and LDH assays only 
(Table 4.8).  We can speculate that these isolates are capable of inducing host cell death using both 
apoptotic and necrotic mechanisms.  These isolates were identified from a pus swab of the tibia of 
an HIV+ man, fluid from a sinus fungal infection and pus from a hand infection from another HIV+ 
female. 
 
Table 4.8 Isolates classified as very cytotoxic according to the Nicoletti and LDH assays only. 
Strain Clone* 
Cell death assay (% cell death) Previous statistical 
associations identified Nicoletti LDH 
THW-393 ST22-MSSA (THW-C) 70.8 80.61 None 
THW-271 ST8-MRSA-V (THW-J) 77.6 71.1 PVL- 
THW-273 ST612-MRSA-IV (THW-P) 72.2 76.9 HIV+ 
THW-412 ST1-MSSA (THW-V2) 70.8 87.6 MSSA/PVL- 
* Clone name represented as [MLST-MSSA/MRSA-SCCmec (PFGE)] 
 
Five isolates were classified as very cytotoxic according to the Nicoletti assay only, of which PVL- 
MSSA isolates were most common (Table 4.9). 
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Table 4.9 Isolates classified as very cytotoxic according to the Nicoletti assay only. 
Strain Clone* 
Cell death assay 
(% cell death) 
Previous statistical 
associations identified 
Nicoletti 
THW-81 ST239-MRSA-III (THW-L) 72.4 MRSA/PVL- 
THW-99^ ST239-MRSA-NT (THW-L) 72.1 None 
THW-122 ST15-MSSA (THW-S) 76.1 MSSA/PVL- 
THW-235 ST1864-MSSA (THW-Z) 79.6 MSSA/PVL+ 
THW-241 ST97-MSSA (THW-W) 72 MSSA/PVL-/Males 
* Clone name represented as [MLST-MSSA/MRSA-SCCmec (PFGE)]; ^ = only NT SCCmec 
 
One isolate was classified as very cytotoxic according to both the Nicoletti (70.8% cell death) and 
WST-1 (73.2% cell death) assays: THW-146 (ST22-MSSA [THW-C]), associated with SSTIs 
caused by PVL+ MSSA isolates, and also the dominant MSSA clone.  One isolate was classified as 
very cytotoxic according to the LDH assay (72.4% cell death) only: THW-38 (ST1865-MSSA 
[THW-A]), associated with SSTIs caused by PVL+ MSSA isolates. 
 
Park et al. investigated if any association was present between cytotoxicity of clinical S. aureus 
isolates and their abilities to cause metastatic infections[314].  They found that the ability to induce 
host cell death and be cytotoxic to endothelial cells was not a major determinant of metastatic 
infections. 
 
During the investigation of 10 MRSA (CC45 and CC5) isolates collected during a national clinical 
trial, Seidl et al. determined that all 10 isolates were invasive in human endothelial cells, but only 
some of the isolates were cytotoxic[288].  They also identified an association between in vitro cell 
damage and bacterial virulence using an experimental rabbit infective endocarditis model, where 
infection by cytotoxic isolates resulted in higher bacterial densities in vegetations, kidneys and 
spleen. 
Our data contradicts that of Krut et al., who published cytotoxicity data of a collection of S. aureus 
isolates, which displayed cytotoxicity to be a strain-specific characteristic, and more than half of the 
collection of isolates were classified as non-cytotoxic[316]. 
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4.6 Conclusion 
 
The vast majority of clinical S. aureus isolates included in this study are invasive, although 
differences in the degree of invasiveness are common between different CCs.  ST121 was the only 
ST in this collection classified as non-invasive. 
 
The vast majority of these isolates are also able to induce the death of their host cells, irrespective 
of which time-point in the cell death cycle is measured. 
 
No differences in either the cellular invasiveness or cytotoxicity of isolates from HIV+ and/or HIV- 
persons or PVL+ and/or PVL- isolates were detectable by this approach.  Neither invasiveness nor 
cytotoxicity was statistically associated with methicillin-resistance, although the only isolate 
classified as non-invasive was a MRSA isolate carrying a SCCmec type I element. 
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CHAPTER 5: General discussion 
 
During the previous three chapters (Chapter 2 to Chapter 4), we investigated the population 
structure of S. aureus from specific clinical sources and selected representative isolates for further 
analyses.  We initiated analyses by determining the prevalence of selected virulence genes and their 
association with clonality and methicillin-resistance.  This was followed by studying adherence of 
representative isolates to immobilised human ligands, as well as establishing their cellular 
invasiveness.  The host-pathogen interaction assays were concluded by determining the cytotoxic 
potential of the investigated clones, as measured by three different end points for cell death.  In this 
chapter, the statistical association of selected virulence factors of our representative isolates, as well 
as the statistical associations between the in vitro assays (adherence, invasion and cell death) for 
each individual clonal complex are reported and discussed.  Finally, we investigated if any 
significant associations could be identified between the various in vitro assays used as surrogate 
parameters for virulence potential. 
 
 
5.1 Population Structure: 
 
Using a variety of molecular typing techniques, we were able to elucidate the epidemiology of S. 
aureus isolated from specific site infections at Tygerberg hospital.  We were then able to go one 
step further, and investigated the population structure of the organism by associating dominant 
circulating clones with specific clinical and bacterial characteristics, such as clones associated with 
methicillin-resistance, and clones associated with adult or paediatric patients. 
 
We identified 20 dominant clones, as determined by PFGE and supported by spa-CC and MLST, 
and were able to associate each clone with at least one clinical/bacterial characteristic, and one 
representative isolate was randomly selected from each of the 20 PFGE clones.  Two PFGE clones 
were also associated with a HIV+ status and 1 representative isolate was selected from each one.  A 
further two representative isolates were selected from isolates causing infection in HIV+ patients of 
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the dominant MRSA and MSSA clones, since these clones had the highest prevalence of HIV+ 
status among the patients, while the final representative isolate was selected as it was the only 
MRSA isolate which possessed a non-typeable SCCmec element. 
 
Prevalence of selected virulence factors were first determined through PCR and then analysed for 
an association with specific clones and also methicillin-resistance.  Certain virulence factors such as 
fnbA/B and clfA/B were identified in all the representative isolates.  We were only able to 
investigate the association of virulence factors with clonality in CCs that included more than one 
isolate.  Several virulence factors were found in CC22, CC30, CC5, CC8 and CC15.  Table 5.1 
provides a complete breakdown of the virulence factors associated with each isolate.  The p-values 
obtained after investigation of the association of each individual virulence gene with clonality and 
methicillin-resistance are comprehensively described in Chapter 2, section 2.2.14 and an overview 
is presented in Table 5.1. 
A very heterogenous population of clones was described, suggesting that only some MSSA lineages 
come into contact with SCCmec elements, or that only some MSSA lineages can successfully 
sustain the integration of SCCmec elements in the genome.  The local acquisition of SCCmec 
elements by endemic MSSA clones was also reported during this study, including that of the 
dominant MRSA clone, ST612-MRSA-IV. 
A prominent finding of this study is the high prevalence of PVL identified primarily among the 
MSSA clones.  Many of these MSSA clones were also associated with SSTIs, similar to that of CA-
MRSA strains described internationally.  These PVL+ MSSA clones could potentially evolve and 
become CA-MRSA clones upon SCCmec acquisition.  This study identified novel MRSA clones 
since strains from the same PFGE clonal complex with the same spa type, but opposing methicillin-
resistance patterns, were identified.  Thus, we hypothesis that these MRSA strains acquired their 
respective SCCmec elements locally.  CA-MRSA clones are known to spread easily and can be 
associated with severe infection, such as necrotising fasciitis, which is a complicated infection and 
difficult to treat. 
This study also identified a lack of CA-MRSA clones.  Numerous SCCmec IV clones were 
described, but SCCmec IV is no longer regarded as a classic CA-MRSA element, since numerous 
SCCmec IV MRSA strains have adapted to hospital environments, such as the Paediatric clone[13]. 
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Table 5.1 Representative isolates analysed, classified based on clonality, together with the clinical categories and virulence genes they are associated with. 
Isolate 
name 
PFGE: 
THW- 
Source 
MLST 
ST 
MLST 
CC 
spa-CC SCCmec agr Statistical association Virulence factors 
THW38 A SSTI 1865 30 21 NA III MSSA/PVL+/SSTI fnbA/B; clfA/B; eap; coa; nuc; hld; cap8*; seg*; sem*; seo*; lukS/F* 
THW382 B SSTI 36 30 21 II III MRSA/PVL-/Adults/SSTI fnbA/B; clfA/B; eap; coa; nuc; hld; cap8*; see*; seg*; sem*; seo* 
THW146 C SSTI 22 22 891 NA I MSSA/PVL+/SSTI fnbA/B; clfA/B; eap; coa; nuc; hld; sdrE*; cap5*; seg*; sem*; seo*; lukS/F* 
THW393 C BJ 22 22 891 NA I None1 fnbA/B; clfA/B; eap; coa; nuc; hld; sdrE*; cap5*; seg*; sem*; seo*; lukS/F 
THW366 E SSTI 121 121 NF:16 NA IV MSSA/PVL+/SSTI fnbA/B; clfA/B; eap; coa; nuc; hld; lukS/F* 
THW262 O RT 612 8 64 IV I MRSA/PVL- fnbA/B; clfA/B; eap; coa; nuc; hld; sdrC*; sdrE*; cap5*; hlgv*; see*; sei* 
THW65 G BJ 1862 8 1597 NA I MSSA/Adults fnbA/B; clfA/B; eap; coa; nuc; hld; sdrE*; cap5*; hlgv* 
THW271 J ENT 8 8 64 V I PVL-/Adults fnbA/B; clfA/B; eap; coa; nuc; hld; cap5*; hlgv* 
THW81 L PROST 239 8 21 III I MRSA/PVL- fnbA/B; clfA/B; eap; coa; nuc; hld; sdrC*; hlgv*; sei* 
THW70 N SSTI 612 8 64 IV I MRSA/PVL- fnbA/B; clfA/B; eap; coa; nuc; hld; sdrC*; sdrE*; cap5*; hlgv*; see*; sei* 
THW195 K SSTI 8 8 64 NA I HIV+ fnbA/B; clfA/B; eap; coa; nuc; hld; sdrC*; sdrE*; cap5*; hlgv*; sei* 
THW273 P SSTI 612 8 64 IV I HIV+ fnbA/B; clfA/B; eap; coa; nuc; hld; sdrC*; sdrE*; cap5*; hlgv*; see*; sei* 
THW93 O UK 612 8 64 IV I None1 fnbA/B; clfA/B; eap; coa; nuc; hld; sdrC*; sdrE*; cap5*; hlgv*; see*; sei* 
THW99 L SSTI 239 8 21 UK III None2 fnbA/B; clfA/B; eap; coa; nuc; hld; sdrC*; hlgv*; see*; sei* 
THW122 S SSTI 15 15 84 NA II MSSA/PVL- fnbA/B; clfA/B; eap; coa; nuc; hld; sdrE*; cap5*; hlgv* 
THW412 V2 UT 1 15 NF:14 NA III MSSA fnbA/B; clfA/B; eap; coa; nuc; hld; sdrE*; cap5*; hlgv* 
THW224 X SSTI 188 15 EX NA I MSSA/PVL- fnbA/B; clfA/B; eap; coa; nuc; hld; sdrE*; cap5*; hlgv* 
THW17 Y SSTI 1863 5 2 NA II MSSA/PVL- fnbA/B; clfA/B; eap; coa; nuc; hld; sdrE*; cap5*; hlgv*; seg*; sem*; seo* 
THW235 X EY 1864 5 2 NA II MSSA fnbA/B; clfA/B; eap; coa; nuc; hld; sdrE*; cap5*; hlgv*; seg*; sem*; seo*; lukS/F* 
THW264 AA EY 5 5 2 I II MRSA/PVL- fnbA/B; clfA/B; eap; coa; nuc; hld; sdrC*; cap5*; hlgv*; seg*; sei*; sem*; seo* 
THW64 V1 CA 6 6 64 NA I MSSA/PVL- fnbA/B; clfA/B; eap; coa; nuc; hld 
THW356 EE SSTI 45 45 EX NA I MSSA/PVL- fnbA/B; clfA/B; eap; coa; nuc; hld 
THW368 V3 SSTI 12 12 888 NA II MSSA/PVL+ fnbA/B; clfA/B; eap; coa; nuc; hld; lukS/F* 
THW241 W IVD 97 97 267 NA I MSSA/PVL-/Males fnbA/B; clfA/B; eap; coa; nuc; hld 
THW255 BB SSTI 88 88 186 IV III PVL+/SSTI fnbA/B; clfA/B; eap; coa; nuc; hld; lukS/F* 
* = statistical association (see Table 2.16, Chapter 2); SSTI = skin and soft tissue infection; BJ = bone-and-joint; RT = respiratory tract; ENT = ear, nose and throat; PROST = prosthetic device; UK = unknown; UT = Urinary 
tract; EY = eye; CA = cardiac; IVD = intra-vascular device; 1 = collected from HIV+ patient of dominant MSSA and MRSA clone; 2 = only MRSA with non-typeable SCCmec, fnbA/B = fibronecting binding protein A/B gene, 
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clfA/B = clumping factor A/B gene; eap = extracellular edherence protein gene; coa = coagulase gene; nuc = nuclease gene; hld = delta toxin gene; sdrC/D/E = Sdr repeat protein gene C/D/E, lukS/F = Panton-Valentine 
leucofidin genes S and F; hlgv = gamma toxin variant gene; cap5/8 = capsule gene  5/8; see/g/m/o/i = staphylococcal enterotoxin E/G/M/O/I genes. 
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5.2 In Vitro Host Cell Interactions: 
 
Following the identification of genes coding for selected virulence factors, we investigated how the 
representative isolates interacted with host proteins and host cells in vitro.  We examined their 
ability to adhere to specific human ligands, their cellular invasiveness and their abilities to induce 
the death of cells, using cell-culture experiments.  These results have been combined and will be 
discussed in more detail below for each isolate selected as a representative of its clonal background. 
 
5.2.1 In vitro interactions per clonal complex: 
 
As previously discussed in Chapter 3, strain-specific adherence pattern was noticed for the CC22 
isolates, where THW146 displayed stronger adherence to plasma fibronectin, fibrinogen and both 
collagens tested as compared to THW393, the other CC22 isolate (Figure 5.1).  Irrespective of the 
differences noticed in the isolates’ adherence patterns, both could be classified as being invasive 
and cytotoxic in all the cell death assays used.  The sdrE gene, hypothesised to be involved in 
adherence, was also associated with the isolates of this CC. 
 
 
Figure 5.1 Combined results of all the in vitro assays for CC22 isolates. 
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The fnbA/B and eap genes, required for invasion, were identified in both isolates, as well as hla and 
hld, associated with cell death. 
Regarding Figures 5.1 – 5.6, “uncoated, serum plasma, fibronectin, fibrinogen, collagen IV and 
collagen VI” refers to adherence, “invasion” refers to cellular invasion and “Nicoletti, LDH and 
WST-1” refers to cell death. 
Statistical association between clonality and adherence, invasion or cell death is displayed in Table 
5.2 and has previously been discussed in Chapter 3 and Chapter 4. 
 
Table 5.2 Statistical associations between adherence/invasion/cell death and clonality.  
Statistically significant results (p < 0.05) are displayed in bold. 
Parameter Assay 
Kruskal-Wallis test 
Association with clonality p-value 
Adherence 
Uncoated No association 0.194 
Serum No association 0.152 
Plasma No association 0.530 
Fibronectin No association 0.201 
Fibrinogen No association 0.160 
Collagen IV No association 0.248 
Collagen VI No association 0.292 
Invasion Invasion CC8 0.036 
Cell death 
Nicoletti No association 0.295 
LDH No association 0.324 
WST-1 No association 0.706 
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Regarding the CC30 isolates (Figure 5.2), significant differences were observed in the ability of 
isolates to adhere to collagen IV and VI, where THW38 (ST1864-MSSA) adhered much stronger to 
these two ligands than THW382 (ST36-MRSA-II).  Both isolates were also classified as being 
invasive.  Some diversity was identified relating to the cell death assays.  Both isolates were 
classified as being cytotoxic using the LDH and WST-1 assays, but only THW38 was classified as 
cytotoxic using the Nicoletti assay.  The fnbA/B and eap genes, required for invasion, were 
identified in both isolates, as well as hla and hld, associated with cell death. 
 
 
Figure 5.2 Combined results of all the in vitro assays for CC30 isolates. 
 
Some diversity was also noticed regarding adherence of CC5 isolates (Figure 5.3).  THW17 
(ST1863-MSSA) displayed the strongest adherence towards serum, fibronectin, collagen IV and 
collagen VI, while THW235 (ST1865-MSSA) displayed the strongest adherence towards 
fibrinogen.  THW264 (ST5-MRSA-I) displayed adherence towards plasma only, and was also the 
only isolate for which we could not establish cellular invasiveness.  THW264 was also one of 2 
isolates that was classified as non-cytotoxic.  The remaining two CC5 isolates, THW17 and 
THW235, displayed invasiveness similar to that of the control isolate (Cowan I) and both were 
classified as cytotoxic.  The sdrE gene was associated with the MSSA isolates (THW17 and 
THW235) from this CC, while sdrC was associated with the MRSA isolate, THW264.  This was 
also the only isolate in which hla was not identified and was classified as non-cytotoxic.  hlgv was 
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also associated with all isolates from this CC, while fnbA/B and eap, required for invasion, were 
identified in all isolates, as well as hld, associated with cell death. 
 
 
Figure 5.3 Combined results of all the in vitro assays for CC5 isolates. 
 
Two isolates from CC15 displayed extremely strong adherence towards collagen IV and strong 
adherence towards collagen VI (Figure 5.4).  THW412 (ST1-MSSA) adhered to collagen IV five 
times stronger than the control isolate (NCTC8325-4), while THW224 (ST188-MSSA) displayed 
adherence 3 times stronger.  All 3 isolates were classified as invasive and cytotoxic.  The sdrE gene 
was associated with all isolates of this CC, together with hlgv.  fnbA/B and eap, required for 
invasion, were identified in all isolates, as well as hla and hld, associated with cell death. 
 
As previously discussed, THW64 (ST6-MSSA), THW366 (ST121-MSSA) and THW368 (ST12-
MSSA) displayed extreme preference for adherence to collagen IV and strong adherence to 
collagen VI (Figure 5.5).  All singleton STs were classified as invasive and cytotoxic, except for the 
ST121 isolate, THW366.  The fnbA/B and eap genes, required for invasion, were identified in all 
isolates, as well as hla and hld, associated with cell death.  Even though hla was identified in 
THW366, this isolate was classified as non-cytotoxic. 
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Figure 5.4 Combined results of all the in vitro assays for CC15 isolates. 
 
 
Figure 5.5 Combined results of all the in vitro assays for the singleton STs. 
 
Diversity was noticed regarding adherence to the various ligands for the isolates from CC8 (Figure 
5.6).  As previously discussed, the ST612-MRSA-IV isolates (THW262, THW70, THW273 and 
THW93) displayed strong adherence towards plasma, fibronectin and collagen IV as well as 
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extremely strong adherence towards fibrinogen.  The sdrC and sdrE genes was associated with all 
the ST612-MRSA-IV isolates. 
The ST239 isolates, THW81 (ST239-MRSA-III) and THW99 (ST239-MRSA-NT) displayed 
extreme preference towards collagen IV and collagen VI (Figure 5.6).  All the CC8 isolates were 
classified as being highly invasive and cytotoxic.  It is worth noting that the 2 ST239 isolates were 
classified as being cytotoxic by only 2 of the 3 cell death assays used.  The sdrC gene was 
associated with both ST239 isolates. 
The sdrC and sdrE genes was also only associated with 1/2 ST8 isolates, THW195, while sdrE was 
associated with the only ST1862 isolate.  The fnbA/B and eap genes, required for invasion, were 
identified in all isolates, as well as hla and hld, associated with cell death. 
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Figure 5.6 Combined results of all the in vitro assays for CC8 isolates. 
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5.2.2 In vitro correlation analyses: 
 
Table 5.3 Pearson correlation (r) for the correlation between different assays and the 
corresponding p-value, calculated using the software package STATISTICA v.10.  
Statistically significant (p < 0.05) correlations are displayed in bold. 
Assay Pearson correlation (r) p-value Figure 
Correlation between different adherence assays 
Uncoated vs. serum 0.0498 0.830 5.7 
Uncoated vs. plasma 0.7046 0.00008 5.8 
Uncoated vs. fibronectin 0.6025 0.0014 5.9 
Uncoated vs. fibrinogen 0.6277 0.0008 5.10 
Uncoated vs. collagen IV -0.3363 0.102 5.11 
Uncoated vs. collagen VI -0.2131 0.3065 5.12 
Plasma vs. serum 0.3256 0.1123 5.13 
Plasma vs. fibronectin 0.7099 0.00007 5.14 
Plasma vs. fibrinogen 0.7842 0.000001 5.15 
Plasma vs. collagen IV -0.0596 0.7771 5.16 
Plasma vs. collagen VI 0.0122 0.9538 5.17 
Serum vs. fibronectin 0.4997 0.0110 5.18 
Serum vs. fibrinogen 0.3481 0.0882 5.19 
Serum vs. collagen IV 0.0791 0.7069 5.20 
Serum vs. collagen VI 0.1674 0.4238 5.21 
Fibronectin vs. fibrinogen 0.7439 0.00002 5.22 
Fibronectin vs. collagen IV -0.0852 0.6854 5.23 
Fibronectin vs. collagen VI 0.0339 0.8721 5.24 
Fibrinogen vs. collagen IV -0.1055 0.6157 5.25 
Fibrinogen vs. collagen VI 0.0195 0.9262 5.26 
Collagen IV vs. collagen VI 0.9048 0.00001 5.27 
Correlation between adherence and invasion assays 
Uncoated vs. invasion 0.3279 0.1179 5.28 
Serum vs. invasion 0.5397 0.0065 5.29 
Plasma vs. invasion 0.3923 0.0579 5.30 
Fibronectin vs. invasion 0.4702 0.0204 5.31 
Fibrinogen vs. invasion 0.3121 0.1376 5.32 
Collagen IV vs. invasion 0.1054 0.6241 5.33 
Collagen VI vs. invasion 0.2418 0.2549 5.34 
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5.2.2.1 Correlations between adherence assays (ligands): 
 
Strong correlations (r value ≥ 0.7) were identified between adherence in the absence of a ligand 
(uncoated plates) and plasma (Pearson correlation r = 0.7046, p = 0.00008), fibronectin (r = 0.6025, 
p = 0.0014) and fibrinogen (r = 0.6277, p = 0.0008), which were all significant.  This might suggest 
that the charge of the uncoated plate promotes adherence or that the same surface components are 
involved in adherence in the absence as well as presence of these ligands.  Strong correlations were 
also identified between plasma and fibronectin (r = 0.7099, p = 0.00007) and fibrinogen (r = 0.7842, 
p = 0.0000015), which is expected as human plasma is a rich source of both proteins.  The receptors 
involved in adherence to fibronectin (fnbA/B) and fibrinogen (clfA/B) are probably also involved in 
adherence to human plasma protein coated surfaces.  Adherence to fibronectin (r = 0.4997, p = 
0.0110) also strongly correlated with that of serum, which is also expected as serum is rich in 
fibronectin.  Adherence to fibronectin (r = 0.7439, p = 0.00002) correlated well with that of 
fibrinogen.  Adherence to collagen IV or VI showed no significant correlation with any of the other 
ligands, except each other (r = 0.9048, p = 0.00001).  This might argue for a common adhesin for 
both collagens, or strict co-regulation of the genes.  Data suggests no association between cna gene 
prevalence and adherence to collagen (see Chapter 3, Appendix B, Figures B6 and B7).  r and p-
values are listed in Table 5.3 and the scatter plots of the results correlated are illustrated by Figures 
5.7 – 5.27. 
Statistical trends can be identified between adherence in the absence of a ligand and collagen IV (r 
= -0.336. p = 0.1) where an indirect correlation was identified.  A trend also emerged regarding 
adherence to serum and fibrinogen (r = 0.348, p= 0.09).  This can be expected since human serum is 
rich in fibrinogen. 
 
Regarding all scatter plots throughout this chapter: the solid red line is the correlation curve and the 
dotted red lines indicate the 95% CI area. 
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Figure 5.7 Scatter plot of uncoated vs. serum.  Figure 5.8 Scatter plot of uncoated vs. plasma. 
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Figure 5.9 Scatter plot of uncoated vs. fibronectin. Figure 5.10 Scatter plot of uncoated vs. 
fibrinogen. 
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Figure 5.11 Scatter plot of uncoated vs. collagen IV. Figure 5.12 Scatter plot of uncoated vs. 
collagen VI. 
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Figure 5.13 Scatter plot of plasma vs. serum. Figure 5.14 Scatter plot of plasma vs. 
fibronectin. 
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Figure 5.15 Scatter plot of plasma vs. fibrinogen. Figure 5.16 Scatter plot of plasma vs. 
collagen IV. 
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Figure 5.17 Scatter plot of plasma vs. collagen VI. Figure 5.18 Scatter plot of serum vs. 
fibronectin. 
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Figure 5.19 Scatter plot of serum vs. fibrinogen.          Figure 5.20 Scatter plot of serum vs. 
                                                                       collagen VI. 
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Figure 5.21 Scatter plot of serum vs. collagen VI.    Figure 5.22 Scatter plot of fibronectin vs. 
                                                                                         fibrinogen. 
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Figure 5.23 Scatter plot of fibronectin vs. collagen VI. Figure 5.24 Scatter plot of fibronectin 
                                                                                                 vs. collagen VI. 
 
0 50 100 150 200 250 300
Fibrinogen (%)
0
100
200
300
400
500
600
700
C
ol
la
ge
n 
IV
 (%
)
r = -0.1055, p = 0.6157  
Figure 5.25 Scatter plot of fibrinogen vs. collagen IV. Figure 5.26 Scatter plot of fibrinogen 
                                                                                                 vs. collagen VI. 
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Figure 5.27 Scatter plot of collagen IV vs. collagen VI. 
 
5.2.2.2 Correlations between adherence and invasion assays: 
 
Adherence to serum (Pearson correlation r = 0.5397, p = 0.0065) and fibronectin (r = 0.4702, p = 
0.0204) displayed moderate correlation with invasion.  The correlation between serum and 
fibronectin is expected as serum is rich in fibronectin.  Since FnBPs are used as the main invasin for 
S. aureus, the ability to bind fibronectin would promote invasion of host cells.  Please refer to Table 
5.3 for the r and p-values and Figures 5.28 – 5.34 for the scatter plots of the results correlated.  A 
statistical trend was also identified between invasion and adherence to plasma (r = 0.392, p= 0.06).  
Two subgroups are identified on the scatter plot for collagen IV vs. invasion, of which one displays 
a linear correlation. 
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Figure 5.28 Scatter plot of uncoated vs. invasion.      Figure 5.29 Scatter plot of serum vs.  
                                                                                          invasion. 
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Figure 5.30 Scatter plot of plasma vs. invasion.     Figure 5.31 Scatter plot of fibronectin 
                                                                                         vs. invasion. 
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Figure 5.32 Scatter plot of fibrinogen vs. invasion.   Figure 5.33 Scatter plot of collagen IV vs.  
                                                                                         invasion. 
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Figure 5.34 Scatter plot of collagen VI vs. invasion. 
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Table 5.4 Pearson correlation (r) for the correlation between different assays and the 
corresponding p-value, calculated using the software package STATISTICA v.10.  
Statistically significant (p < 0.05) correlations are displayed in bold. 
Assay Pearson correlation (r) p-value Figure 
Correlation between adherence and cell death assays 
Serum vs. Nicoletti 0.2947 0.1527 5.35 
Uncoated vs. Nicoletti -0.0577 0.7840 5.36 
Plasma vs. Nicoletti 0.0449 0.8313 5.37 
Fibronectin vs. Nicoletti 0.2985 0.1473 5.38 
Fibrinogen vs. Nicoletti 0.3569 0.0799 5.39 
Collagen IV vs. Nicoletti -0.1097 0.6017 5.40 
Collagen VI vs. Nicoletti 0.0741 0.7249 5.41 
Serum vs. LDH 0.1975 0.3440 5.42 
Uncoated vs. LDH 0.0157 0.9408 5.43 
Plasma vs. LDH 0.1604 0.4436 5.44 
Fibronectin vs. LDH 0.0799 0.7043 5.45 
Fibrinogen vs. LDH 0.3179 0.1215 5.46 
Collagen IV vs. LDH -0.1981 0.3424 5.47 
Collagen VI vs. LDH -0.0911 0.6651 5.48 
Serum vs. WST-1 -0.1107 0.5985 5.49 
Uncoated vs. WST-1 0.0078 0.9705 5.50 
Plasma vs. WST-1 -0.0976 0.6426 5.51 
Fibronectin vs. WST-1 -0.2138 0.3049 5.52 
Fibrinogen vs. WST-1 -0.3662 0.0718 5.53 
Collagen IV vs. WST-1 0.3668 0.0713 5.54 
Collagen VI vs. WST-1 0.3006 0.1442 5.55 
Correlation between invasion and cell death assays 
Invasion vs. Nicoletti 0.3283 0.1173 5.56 
Invasion vs. LDH 0.0768 0.7213 5.57 
Invasion vs. WST-1 0.0033 0.9880 5.58 
Correlation between difference cell death assays 
Nicoletti vs. LDH 0.5459 0.0048 5.59 
Nicoletti vs. WST-1 -0.7405 0.00002 5.60 
WST-1 vs. LDH -0.6774 0.0002 5.61 
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5.2.2.3 Correlations between adherence and cell death assays: 
 
Adherence to fibrinogen was the only adherence factor which displayed the strongest, yet weak 
correlations with any of the cell death assays: Nicoletti (Pearson correlation r = 0.3569, p = 0.0799); 
LDH (r = 0.3179, p = 0.1215); WST-1 (r = -0.3662, p = 0.0718).  Adherence to fibronectin 
displayed even weaker correlations: Nicoletti (r = 0.2985, p = 0.1473); WST-1 (r = -0.2138, p = 
0.3049).  Adherence to both collagen IV (r = 0.3668, p = 0.0713) and VI (r = 0.3006, p = 0.1442) 
were weakly correlated only with the WST-1 assay as an indicator of cell death.  Please refer to 
Table 5.4 for the r and p-values and Figures 5.35 – 5.55 for the scatter plots of the results correlated.  
From these scatter plots we can see that cytotoxic isolates (>50% cytotoxicity) display diversity in 
their adherence to all of the immobilised ligands investigated.  It is also worth mentioning that 
statistical trends were also identified between adherence to fibrinogen and the Nicoletti assay (r = 
0.357. p = 0.08), as well as between adherence to collagen IV and the WST-1 assay (r = 0.367, p = 
0.07).  This might indicate that adherence to these ligands could be indicators of bacterial 
cytotoxicity. 
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Figure 5.35 Scatter plot of serum vs. Nicoletti.      Figure 5.36 Scatter plot of uncoated vs.  
                                                                                          Nicoletti. 
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Figure 5.37 Scatter plot of plasma vs. Nicoletti.      Figure 5.38 Scatter plot of fibronectin vs. 
                                                                                          Nicoletti. 
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Figure 5.39 Scatter plot of fibrinogen vs. Nicoletti.    Figure 5.40 Scatter plot of collagen IV vs. 
                                                                                          Nicoletti. 
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Figure 5.41 Scatter plot of collagen VI vs. Nicoletti.   Figure 5.42 Scatter plot of serum vs. LDH. 
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Figure 5.43 Scatter plot of uncoated vs. LDH.      Figure 5.44 Scatter plot of plasma vs. LDH. 
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Figure 5.45 Scatter plot of fibronectin vs. LDH.     Figure 5.46 Scatter plot of fibrinogen vs.  
                                                                                         LDH. 
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Figure 5.47 Scatter plot of collagen IV vs. LDH.     Figure 5.48 Scatter plot of collagen VI vs. 
                                                                                         LDH. 
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Figure 5.49 Scatter plot of serum vs. WST-1.      Figure 5.50 Scatter plot of uncoated vs.  
                                                                                         WST-1. 
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Figure 5.51 Scatter plot of plasma vs. WST-1.     Figure 5.52 Scatter plot of fibronectin vs. 
                                                                                         WST-1. 
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Figure 5.53 Scatter plot of fibrinogen vs. WST-1.      Figure 5.54 Scatter plot of collagen IV vs.  
                                                                                          WST-1. 
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Figure 5.55 Scatter plot of collagen VI vs. WST-1. 
 
 
Stellenbosch University http://scholar.sun.ac.za
186 
 
0 40 80 120 160 200
Invasion (%)
0
20
40
60
80
100
LD
H
 (%
)
r = 0.0768, p = 0.7213
5.2.2.4 Correlations between invasion and cell death assays: 
 
The ability to invade host cells only correlated weakly with the Nicoletti assay as an indicator of 
cell death (Pearson correlation r = 0.3283, p = 0.1732).  From this we can gather that cytotoxic 
isolates are invasive and that invasiveness is required for cytotoxicity.  Please refer to Table 5.4 for 
the r and p-values and Figures 5.56 – 5.58 for the scatter plots of the results correlated. 
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Figure 5.56 Scatter plot of invasion vs. Nicoletti.   Figure 5.57 Scatter plot of invasion vs. LDH. 
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Figure 5.58 Scatter plot of invasion vs. WST-1. 
 
5.2.2.5 Correlations between cell death assays: 
 
Strong correlations were identified between the 3 different in vitro assays used as indicators of cell 
death.  The strongest correlation was identified between the Nicoletti and WST-1 assays (Pearson 
correlation r = -0.7405, p = 0.00002), followed by the WST-1 and LDH assays (r = -0.6774, p = 
0.0002), and the weakest correlation was between the Nicoletti and LDH assays (r = 0.5459, p = 
0.0048).  The lack of correlation between the Nicoletti and LDH assays might be due to the 
different end points measured (Nicoletti measures hypodiploid nuclei; LDH measures release of 
LDH from cell), which might indicate different mechanisms of cell death induction.  Some isolates 
might favour a single mechanism if inducing cell death, whereas other isolates might be capable of 
inducing host cell death using a variety of mechanisms.  Please refer to Table 5.4 for the r and p-
values and Figures 5.59 – 5.61 for the scatter plots of the results correlated. 
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Figure 5.59 Scatter plot of Nicoletti vs. LDH.     Figure 5.60 Scatter plot of Nicoletti vs.  
                                                                                        WST-1. 
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Figure 5.61 Scatter plot of WST-1 vs. LDH. 
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CHAPTER 6: General conclusions 
 
Data on the population structure of S. aureus isolates from specific clinical sites at Tygerberg 
hospital was lacking.  Furthermore, no study has previously been conducted to investigate the 
differences in virulence of various clones in circulation in South Africa.  This study was designed to 
identify important clones circulating in the patient population service by Tygerberg hospital and 
then to investigate the differences in in vitro virulence of these clones using surrogate parameters of 
virulence. 
 
From this investigation we concluded that this population of S. aureus consist of a diverse number 
of endemic MSSA and epidemic MRSA clones and that we attempted to associate with various 
clinical or bacterial characteristics, including source of infection, gender and HIV status.  As we 
were able to demonstrate new SCCmec acquisitions in the population of MSSA that we 
investigated, we can speculate that, upon acquisition of SCCmec elements by this population 
harbouring a remarkably high incidence of PVL encoding genes, highly virulent strains may emerge 
which can possibly lead to outbreaks similar to the CA-MRSA epidemics described in the literature 
elsewhere. 
ST612-MRSA-IV was identified as the dominant MRSA clones, previously only described in South 
Africa and Australia. 
Isolates selected as representatives possessed a diverse pattern of virulence genes determined by 
PCR, of which some were associated with certain clones or with methicillin-resistance or 
susceptibility.  Some genes, such as fnbA/B, clfA/B, eap and hld were identified in all the 
representative isolates. These representative isolates also displayed diverse preferences for various 
immobilised human ligands.  The vast majority of representative isolates were both highly invasive 
and cytotoxic.  We can thus conclude that this S. aureus population consist out of a variety of PVL- 
MRSA and both PVL- and PVL+ MSSA clones, of which representatives displayed diversity in 
adherence to monomeric immobilised human ligands and are both highly invasive and cytotoxic. 
 
The population structure data generated also identified the following prominent findings: (1) a lack 
of CA-MRSA clones; (2) a lack of PVL+ MRSA clones; (3) a lack of a common genetic 
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background between MRSA and MSSA clones; (4) a significantly higher PVL prevalence when 
compared to previously published data, especially among MSSA clones; (5) the local emergence of 
three MRSA clones; and (6) high prevalence of genes associated with cellular adherence and 
invasion, induction of host cell death and host immune evasion. 
The in vitro host-pathogen interaction assays identified the following prominent findings: (1) 
MRSA isolates adhered stronger to plasma and in the absence of a ligand than MSSA; (2) our 
isolates displayed diversity in adherence to various immobilised ligands, where for some adherence 
was a strain-specific, and for others a clonal characteristic; (3) neither invasiveness nor cell death 
induction was associated with methicillin-resistance; (4) the vast majority of representative isolates 
were invasive; (5) the vast majority of representative isolates were cytotoxic; (6) no significant 
difference in adherence, invasiveness or cell death induction was observed between isolates from 
HIV+ and HIV- persons; and (7) PVL- isolates were more invasive than their PVL+ counterparts. 
 
To our knowledge, this is the first study investigating the differences in in vitro functional 
parameters of virulence (i.e. adherence, cellular invasion and cytotoxicity) of various S. aureus 
clones from the African continent.  This is also the first comprehensive study to investigate the 
population structure of S. aureus, isolated from specific clinical sources, at Tygerberg hospital.  No 
data concerning the agr types and prevalence of virulence genes from South African S. aureus 
isolates are currently available.  Of the numerous MRSA clones studied, ST612-MRSA-IV is 
unique as it has only been identified in South Africa and Australia, and seems to be a dominant 
MRSA clone in South Africa.  The dominant MSSA clone, ST22-MSSA could acquire methicillin-
resistance and lead to CA-MRSA infections and possibly outbreaks as a single ST22-MRSA-V 
isolate was also identified, together with four ST22-MRSA-IV isolates. 
Strengths of the study include: (1) elucidating the molecular epidemiology of the collection of 
isolates using the gold standard technique, supplemented with other well established techniques 
(comprehensive investigation); (2) associating prevalent clones with specific clinical/bacterial 
characteristics; (3) identifying novel spa types and MLST sequence types; (4) identifying clones 
associated with HIV+ status; (5) providing the first basic data on in vitro host-pathogen interaction 
from South African S. aureus isolates; and (6) no blood culture isolates were included, as blood 
culture isolates may originate from any specific site of infection. 
Limitations of the study include: (1) severe hampering of the identification of more clones 
associated with HIV+ status due to the unknown HIV status in the majority of patients; (2) only 
isolates from specific clinical sources were included, not blood culture isolates; (3) host-pathogen 
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aspects investigated were relatively non-specific, broad and included only a single isolate for many 
PFGE clones and MLST STs; (4) no molecular mechanisms were investigated; and (5) no in vivo 
data was obtained. 
Several aspects of interest could not be covered by this study.  It would be of interest to study the presence of 
any of the identified clonal complexes in livestock from the same geographical area.  This could be coupled 
with molecular risk assesments to investigate the spreading of virulent clonal complexes.  Patient 
outcome was also not investigated.  The molecular epidemiology and host-pathogen investigation 
performed during this study could be coupled with patient outcome investigation for a more detailed 
clinical–epidemiolical study. 
Several new questions have arisen and this research can lead to the initiation of new projects by 
investigating, for example, the mechanism(s) used by these isolates to induce cell death.  Also, the 
gene expression profiles, focussing on selected virulence genes, could be analysed to investigate 
and establish exactly which genes are involved in the infection process during cellular invasion and 
host cell death induction.  Knock-out mutants could also be created and their functional behaviour 
compared to those of the parental wild-type isolate to investigate molecular mechanisms.  Also, 
more isolates can be selected for analyses, especially from the clones for which only one isolate was 
originally included.  In vivo infection models are currently available which could be utilised to 
investigate the in vivo virulence of isolates.  More detailed retrospective clinical information 
obtained from patient files could shed light on the clinical course of infection, including antibiotic 
treatment, as well as patient outcome. 
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